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 One of the fundamental questions in science is how chromatin transitions from 
actively transcribed euchromatin to silent heterochromatin, and what factors affect this 
transition.  One area of my research has focused on understanding the differences in the 
chromatin structure of active and silent regions in the ribosomal DNA locus (rDNA), a 
heterochromatin region in S. cerevisiae.  Secondly, I have focused on understanding a 
histone methyltransferase Set1, which is involved in both euchromatin and 
heterochromatin regions.  To distinguish actively transcribed open regions of chromatin 
from silent and closed regions of chromatin, we have expressed a DNA 
methyltransferase M.CviPI in vivo to utilize its accessibility to GpC sites.  We have used 
this technique to study changes in nucleosome positioning within the NTS2 region of the 
rDNA in two cases: as a result of a silencing defect caused by the loss of Sir2, a histone 
deacetylase involved in silencing at the rDNA, and as an indicator of active transcription 
by RNA Pol I.  Using this technique, we observed differences between open and closed 
chromatin structure by changes in nucleosome positioning within NTS2.  Additionally, 
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we have observed the presence of bound factors within the 35S rRNA gene promoter 
that are unique to actively transcribed genes.   
 The second area of my research focused on the protein methyltransferase Set1 
that mono-, di-, and trimethylates lysine 4 of histone H3 (H3K4) utilizing the methyl 
group from S-adenosyl methionine (SAM).  Set1 is part of a multi protein complex 
called COMPASS (Complex associated with Set1), and is associated with both actively 
transcribed and silent regions.  Thirty mutants of Set1 were made within the SET domain 
to learn more about the catalytic mechanism of Set1.  The crystal structures of human 
SET domain proteins, as well as sequence alignments and a random mutagenesis of 
yeast Set1, were used to identify conserved amino acids in the SET domain of Set1.  
Mutants were analyzed for their effect on histone methylation in vivo, silencing of RNA 
Pol II transcription within the rDNA, suppression of ipl1-2, and COMPASS complex 
formation.  Our results show that trimethylated H3K4 is required for silencing of RNA 
Pol II transcription at the rDNA.  Overall, we have shown the importance of tyrosine 
residues in SET domain proteins.  To summarize, my research has strived to understand 
chromatin structure and the factors that affect the transition between euchromatin and 
heterochromatin. 
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  NOMENCLATURE 
 
ARS autonomous replicating sequence 
CF core factor 
CLIP chromosome linkage inner nuclear membrane proteins 
COMPASS complex associated with Set1 
FEAR cdc fourteen early anaphase release 
HATs histone acetyltransferases 
HDACs histone deacetylases 
MEN mitotic exit network 
MLL mixed lineage leukemia 
MNase micrococcal nuclease 
Net1 nucleolar silencing establishing factor and telophase regulator 
NTS nontranscribed spacer 
Pol  polymerase  
rDNA ribosomal DNA 
RENT regulator of nucleolar silencing and telophase exit 
SET suvar 3-9, enhancer of zeste, trithorax 
SIR silent information regulators 
TBP TATA-binding protein 
UAF upstream activation factor 
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One of the most fundamental purposes of a cell is to properly maintain, store and 
propagate genetic information.  Eukaryotic cells package genetic information in the form 
of chromosomes made up of DNA, histones and various other proteins that regulate and 
maintain chromatin structure.  Within chromosomes DNA is wrapped around a histone 
octamer of H2A, H2B, H3 and H4 forming a nucleosome (Finch et al., 1977; Richmond 
et al., 1984; Luger et al., 1997; Richmond and Davey, 2003; Wood et al., 2005).  
Neighboring nucleosomes connected by DNA acquire a „beads on a string‟ structure, and 
through interactions between neighboring and distant nucleosomes result in increasing 
levels of complexity to ultimately shape an entire chromosome (Figure 1) (Felsenfeld 
and Groudine, 2003).   
Chromatin structure can be categorized based on the level of gene expression.  
Transcriptionally active euchromatin contains an open, diffuse chromatin structure with 
actively transcribed genes, while transcriptionally silent heterochromatin contains a 
tightly compacted, closed chromatin structure that functions as a barrier to transcription, 
replication, and recombination factors (Frenster et al., 1963; Littau et al., 1964; Grewal 
and Moazed, 2003; Holmquist and Ashley, 2006).  Early studies used electron 
microscopy to directly visualize nuclei purified from calf thymus, identifying two types 
of chromatin structure: condensed, dark regions of chromatin and open diffuse regions of  
____________ 
This dissertation follows the style of Molecular Biology of the Cell. 
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chromatin that were found to be sites of active transcription (Frenster et al., 1963; Littau 
et al., 1964).  These early studies proposed the idea that actively transcribed euchromatin 
would contain a low level of histones when compared to inactive heterochromatin and 
that the majority of transcription would occur in open chromatin regions.  Furthermore, 
they conclude that the majority of chromatin is silenced.   
Silencing of transcription is an essential part of any organism‟s ability to control 
gene expression.  Regions of silent, condensed chromatin form through the association 
of protein factors that spread throughout a chromosomal domain silencing transcription.  
The silencing of specific regions of chromatin, rather than the repression of genes in a 
promoter-dependent fashion, is defined as gene silencing (Moazed, 2001).  In our model 
system Saccharomyces cerevisiae gene silencing occurs in three regions: telomeres 
located at the end of chromosomes, the ribosomal DNA array located on chromosome 
XII, and the silent mating-type loci located on chromosome III.  Though each region 
utilizes many different proteins to restrict gene expression, members of the Silent 
Information Regulators, or SIR proteins, can be found at each of these silent regions 
(Perrod and Gasser, 2003; Rusche et al., 2003).  Once established, euchromatin and 
heterochromatin regions are maintained throughout the following generations.  This 
inheritance of chromatin states is also mirrored by the cell propagating certain patterns 
of histone modifications, and by inheriting associated chromatin regulators such as 
chromatin activators or silencing complexes bound to chromatin.  In our lab we focus on 
the ribosomal DNA locus in S. cerevisiae to study the role of histones and post-




Figure 1. Structure and formation of chromosomes
1
.  A 2nm DNA strand wraps twice around a histone 
octamer of H2A, H2B, H3 and H4 forming a nucleosome.  This simple structure then folds upon itself 
until it ultimately forms an entire chromosome. 
 
    
                                                 
1
 Adapted by permission from Macmillan Publishers Ltd from “Controlling the double helix” by Gary 
Felsenfeld and Mark Groudine, (2003), Nature, 421, 448-453, Copyright 2003 by Nature Publishing 
Group. 
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 All four core histones (H2A, H2B, H3 and H4) have been studied for their role in 
euchromatin and heterochromatin.  Both H3 and H4 play a role in silencing at all three 
heterochromatin regions in S. cerevisiae by maintaining a closed chromatin structure and 
thus repressing transcription (Kayne et al., 1988; Aparicio et al., 1991; Park et al., 2002; 
Sperling and Grunstein, 2009).  These experiments identified specific amino acid 
residues on histone H3 and H4 that are required for silencing at heterochromatin regions, 
and these residues in some cases are well known to undergo post-translational 
modification (Park et al., 2002; Hyland et al., 2005).  Through a combination of 
truncations or complete deletions of the N-terminus as well as site-specific mutagenesis, 
a wealth of information exists on the role of histones on chromatin structure and in 
repression of transcription at heterochromatic regions.  The post-translation modification 
of histones is a strong indicator of euchromatin and heterochromatin regions.  Histones 
can be modified in various ways, most commonly by acetylation, methylation and 
ubiquitylation.  Different combinations of post-translation modifications of histones are 
thought to form a histone code (Jenuwein and Allis, 2001; Berger, 2002).  
There are two ways histone modifications are thought to affect chromatin.  
Simply, addition of modifications can directly affect chromatin structure by masking the 
charge of residues present on histone tails.  This allows the DNA to have a looser 
association with histones and thus allow a more open chromatin structure.  Modifications 
can also serve to create a code that can be read by chromatin-associating proteins that 
will regulate the transition between heterochromatin and euchromatin.  By „reading‟ a 
histone code chromatin-associating proteins can affect gene expression.  It is believed 
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that these chromatin-associating proteins bind different combinations of modifications 
and help recruit other chromatin regulators that will ultimately determine the level of 
gene expression (Quina et al., 2006).  Research in the area of histone modifications has 
branched out into what is termed „cross talk‟, determining how different modifications 
affect each other.  In general, each type of modification is associated with a different role 
in transcription.  Acetylation is associated with actively transcribed regions, while both 
methylation and ubiquitylation are associated with activation and repression of 
transcription.  In defining the role of histone modifications, it is the location of the mark 
on a specific amino acid residue(s) in either euchromatin or heterochromatin and the 
presence or absence of other marks that can influence the final effect of histone 
modifications on a region of chromatin.     
Histone acetylation, the most studied modification, is characterized by histone 
acetyltransferases (HATs) and histone deacetylases (HDACs) which add and remove 
acetyl groups to and from the ε-amino group of lysine residues (Yang, 2004; Shahbazian 
and Grunstein, 2007).  Acetylation is associated with activation of transcription, with 
hyperacetylated regions found in euchromatin, forming an open chromatin structure and 
increasing gene expression, while hypoacetylated regions are associated with 
heterochromatin (Braunstein et al., 1993; Hecht et al., 1995; Braunstein et al., 1996; 
Suka et al., 2001; Bryk et al., 2002; Li et al., 2006a).  Initial studies proposed that the 
acetyl group masks the positive charge of lysine residues, disrupting the interaction of 
histone tails with the negatively charged DNA backbone thus opening the chromatin to 
transcription, replication, and recombination factors (Allfrey et al., 1964; Allfrey and 
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Mirsky, 1964; Vidali et al., 1968; DeLange et al., 1969). Of these early experiments, 
Allfrey et al. was the first to connect acetylated lysines as well as methylated lysines to 
increased transcription by studying their effect on in vitro transcription assays with 
purified calf thymus nuclei (Allfrey et al., 1964; Allfrey and Mirsky, 1964).  Sir2 is a 
histone deacetylase that plays an important role in heterochromatin formation and 
maintenance, transcriptional silencing of RNA Pol II, and repression of recombination in 
S. cerevisiae.  These and other topics on Sir2 will be discussed in further detail below.     
The effect of histone methylation on gene expression depends on the particular 
lysine residue that is methylated.  Histone methylation is an interesting modification 
because of its dual nature in euchromatin and heterochromatin regions in Saccharomyces 
cerevisiae and higher eukaryotes.  Most histone methylation of lysine residues is carried 
out by proteins that contain a very specific and highly conserved SET domain.  The SET 
domain name itself refers to its origins in Drosophila melanogaster, originally 
recognized in proteins encoded by the Drosophila genes Suvar 3-9, Enhancer of zeste, 
and Trithorax, all of which play some role in regulating transcription and were identified 
for their similarity to the human histone methyltransferase MLL1 gene (Jones and 
Gelbart, 1993; Tschiersch et al., 1994).  The role of the SET domain was first defined by 
the discovery of human Suv39H1 and mouse Suv39h1 as histone methyltransferases that 
methylate lysine 9 of histone H3 and function exclusively in heterochromatin regions 
(Rea et al., 2000).  SET domain proteins have been found in a wide range of organisms 
from simple model systems all the way to mouse and human systems.  SET domain 
proteins utilize S-adenosyl methionine (SAM), which provides the methyl group to SET 
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domain proteins to methylate lysine residues.  SAM is formed by AdoMet synthetase 
which transfers the adenosyl part of ATP to methionine, and is employed in all 
methylation reactions, for histones and other proteins as well as DNA methylation.  
Once SAM has been utilized by these proteins, the product S-adenosyl homocysteine is 
produced (Chiang et al., 1996).  Methylation was once considered to be a permanent 
mark until the discovery of two classes of demethylases, LSD (Shi et al., 2004) and 
Jumonji (Tu et al., 2007).  Histone demethylases are discussed in greater in Appendix B.          
Lysine residues can be methylated up to three times by histone 
methyltransferases (HMTases).  In S. cerevisiae, lysine 4, 36, and 79 of histone H3 are 
methylated by Set1, Set2, and Dot1, respectively.  Methylation of lysine 4 of histone H3 
(H3K4) by Set1 is associated with initiation of transcription in actively transcribed 
genes, as well as silent chromatin.  Methylation of lysine 36 of histone H3 by Set2 plays 
a role in actively transcribed genes in transcriptional elongation.  Methylation of lysine 
79 of histone H3 by Dot1 (Disruptor of Telomeric silencing) is associated with silencing 
of transcription at telomeres (Briggs et al., 2001; Roguev et al., 2001; Strahl et al., 2002; 
van Leeuwen et al., 2002).  Like methylation, ubiquitylation is a mark associated with 
active and silent genes, as ubiquitylation of lysine 123 of histone H2B is required for di- 
and trimethylation of H3K4 to occur (Dover et al., 2002; Ng et al., 2003a; Shahbazian et 
al., 2005).  In humans and higher eukaryotes, methylation of H3K4 is solely associated 
with activation of transcription while methylation of lysine 9 of histone H3, a mark 
absent from S. cerevisiae, is associated with silencing of transcription in higher 
eukaryotes.   
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In humans, there are six methyltransferases that act on lysine 4 of histone H3: the 
MLL family, Set1A/Set1B methyltransferases, Set7/9, Ash1L, Smyd3, and Meisetz 
Human H3K4 methyltransferases are discussed in Appendix A.  In yeast there is only 
one, making it a much simpler model system for the study of H3K4 methylation.  Table 
1 summarizes the methyltransferases mentioned in this section.  In yeast methylation of 
H3K4 is carried out by Set1 (Briggs et al., 2001), a histone methyltransferase that is part 
of a multi-subunit complex called COMPASS (Complex associated with Set1) (Miller et 
al., 2001; Roguev et al., 2001).  COMPASS contains eight subunits including: Set1, 
Bre2, Swd1, Spp1, Swd2, Swd3, Sdc1, and Shg1.  These subunits all contain conserved 
domains that are found in other histone methyltransferase complexes, like the human 
MLL family complexes and human Set1A/Set1B complexes.  Although yeast Set1 is 
predominantly studied for its role in actively transcribed genes,  it was first discovered 
for its role in silencing transcription at telomeres and the silent mating type loci (Nislow 
et al., 1997; Krogan et al., 2002) and then only later found to silence transcription at the 
rDNA (Briggs et al., 2001; Bryk et al., 2002).  At the rDNA, cells with a defect in 
silencing due to loss of Sir2 exhibit an increase in trimethylation of H3K4 (Li et al., 
2006a) suggesting a model where low levels of methylated histones are required for 






Table 1.  Summary of histone methyltransferases.  
Model system Histone Methyltransferase Target 
Saccharomyces cerevisiae COMPASS H3K4 
 Set2 H3K36 
 Dot1 H3K79 
   
Mouse Suv39h1 H3K9 
   
Human MLL1-5 complexes H3K4 
 Set1A/Set1B complexes H3K4 
 Set7/9 H3K4 
 Ash1L H3K4 
 Smyd3 H3K4 
 Meisetz H3K4 
   
 Suv39H1 H3K9 
 
COMPASS associates with the c-terminal domain of RNA Polymerase II, when 
phosphorylated at serine 5, in order to trimethylate H3K4 at the promoter regions of 
highly transcribed genes (Santos-Rosa et al., 2002; Ng et al., 2003b).  Phosphorylation 
of the CTD of RNA Pol II at serine 5 is associated with initiation of transcription at the 
promoter region of active genes while phosphorylation at serine 2 is associated with 
elongation.  These characteristics of CTD phosphorylation are conserved from yeast to 
humans (Morris et al., 2005).  COMPASS associates with RNA Pol II through the Paf1 
(Polymerase associated factors) complex (Krogan et al., 2003), a complex conserved 
from yeast all the way to humans with a role in ubiquitylation of histone H2B (Jaehning, 
2010).  Paf1c serves to recruit methyltransferases to the transcriptional machinery and 
therefore has a role in initiation of transcription (recruitment of yeast Set1 COMPASS) 
and in elongation of transcription (recruitment of yeast Set2).  Paf1c also serves to 
recruit proteins important in ubiquitylation of H2B (Jaehning, 2010).    Di- and 
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trimethylation of H3K4 by Set1 is dependent upon ubiquitylation of lysine 123 of 
histone H2B by Rad6 ubiquitin conjugating enzyme and by Bre1 ubiquitin ligase (hereto 
after referred to as Rad6/Bre1) (Dover et al., 2002; Shahbazian et al., 2005).  Histone 
methylation of H3K4 is distributed in a very distinct pattern along actively transcribed 
genes (Santos-Rosa et al., 2002), and this pattern is universal in all systems.  
Trimethylation of H3K4 peaks at the promoter region, dimethylation is in the middle of 
the gene, while monomethylation is found at the end.    
As mentioned above, COMPASS contains eight subunits with conserved 
domains.  Set1 contains the catalytic SET domain and two amino-terminal RNA-
recognition motifs (RRM).  The RRM domains of Set1 (RRM1 and RRM2) bind single 
stranded nucleic acids in vitro (Krajewski et al., 2005) but this binding does not affect 
H3K4 methylation (Tresaugues et al., 2006).  Deletion of both RRM1 and RRM2 causes 
a loss of trimethylated H3K4 only and does not affect dimethylated H3K4 (Schlichter 
and Cairns, 2005).  Recent work has shown that Set1 associates with its own mRNA 
along with Swd1, Spp1, and Shg1 to form SET1RC (SET1 mRNA-associated complex), 
but this association does not rely on either of the RRM domains of Set1 (Halbach et al., 
2009).  The purpose of the RRM domains of Set1 remains unknown.  SET1RC is 
believed to form co-translationally; the complex associates with the Set1 amino acid 
strand as it is translated from the SET1 mRNA and thus couples synthesis of Set1 with 
formation of the complex.   
Spp1 is a subunit of COMPASS that contains a PHD domain that specifically 
recognizes di- and trimethylated H3K4 (Shi et al., 2007), and contains a DNA binding 
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domain that tethers COMPASS to chromatin (Murton et al., 2010).  Swd1, Swd2, and 
Swd3 all contain WD40 domains, and are homologues to the human WD40-containing 
WDR5 that binds dimethylated H3K4 and presents this modified lysine for 
trimethylation to H3K4 methyltransferases in humans (Wysocka et al., 2005b).  Swd1 
weakly binds dimethylated H3K4 (Murton et al., 2010).  Swd2 is ubiquitylated at lysine 
68 and 69 by Rad6/Bre1 and this modification controls whether or not Spp1 is recruited 
by COMPASS and thus whether H3K4 is trimethylated; however, it does not control the 
overall stability of COMPASS as mono- and dimethylation of H3K4 still occurs 
(Vitaliano-Prunier et al., 2008).  These domains are mirrored in human 
methyltransferases and are discussed in Appendix A.    
 Interestingly enough, SET domain proteins have also been found to methylate 
non-histone proteins at lysine residues forming new roles of SET domain proteins 
(Huang and Berger, 2008).  Alternative substrates of human SET domain 
methyltransferases Set7/9 are discussed in Appendix C.  Yeast Set1 dimethylates Dam1, 
a protein involved in chromosome segregation and proper microtubule attachment.  
Methylation of Dam1 is part of the anaphase checkpoint during the cell cycle.  Dam1 is 
part of a large ten subunit complex called the Dam1 complex (Hofmann et al., 1998; 
Cheeseman et al., 2001; Enquist-Newman et al., 2001).  Approximately 16-20 Dam1 
complexes form a single Dam1 ring that encircles microtubules, sliding along the 
microtubule surface creating energy that is used to power chromosome movement and 
thus segregation of chromosomes during anaphase (Westermann et al., 2005; 
Westermann et al., 2006; Wang et al., 2007a; Westermann et al., 2007).  The interaction 
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between the kinetochore complexes located at the centromere of chromosomes and 
microtubules is controlled with phosphorylation by Ipl1 and dephosphorylation by Glc7 
(Pinsky et al., 2006a; Pinsky et al., 2006b; Westermann et al., 2007).  Ipl1 is an aurora 
kinase that ensures proper kinetochore attachment and chromosome segregation by 
resolving incorrect attachments of microtubules to the kinetochore.  Ipl1 phosphorylation 
of multiple targets causes improperly attached microtubules to detach from the 
kinetochore, allowing for a second attempt to properly attach to the kinetochore.  This is 
part of the spindle checkpoint will continue until proper attachment occurs and 
chromosome segregation can proceed (Pinsky et al., 2006b).   
Ipl1 phosphorylates Dam1 in response to improperly attached microtubules 
(Cheeseman et al., 2002), while Set1 methylates Dam1 in response to properly attached 
microtubules, blocking phosphorylation by Ipl1 (Zhang et al., 2005).  In other words, 
Set1 methylation antagonizes Ipl1 phosphorylation.  Dam1 is dimethylated by Set1 at an 
internal lysine residue (K233) flanked by serine residues that are sites of 
phosphorylation by Ipl1.  Methylation of Dam1 at K233 by Set1 physically blocks the 
phosphorylation by Ipl1 of those neighboring serine residues (Zhang et al., 2005).  This 
new role for Set1 methylation was discovered using an ipl1-2 temperature sensitive (ts) 
yeast strain.  At a restrictive temperature of 30°C ipl1-2 is inactive and cell growth is 
inhibited, while in yeast strains combining ipl1-2 and set1Δ, normal cell growth is 
restored meaning deletion of SET1 suppresses the growth defect of ipl1-2 and therefore 
Set1 has some role in Ipl1 function (Zhang et al., 2005).  Methylation of Dam1 by Set1 
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inhibits continued phosphorylation by Ipl1, allowing segregation of chromosomes during 
anaphase.   
 
HETEROCHROMATIN REGIONS IN Saccharomyces cerevisiae  
Silencing of transcription is an essential part of any organism‟s ability to control 
gene expression.  In our model system Saccharomyces cerevisiae, commonly referred to 
as baker‟s yeast, transcriptional silencing occurs in three regions: telomeres located at 
the end of chromosomes, the ribosomal DNA array located on chromosome XII, and the 
silent mating-type loci located on chromosome III.  Chromosome III consists of two 
silenced loci HML and HMR on either side of the centromere, near the telomeres of 
chromosome III with a mating type locus (MAT) in between.  Yeast can function as 
haploids or diploids, with haploids occurring in one of two mating types: α and a.  The 
mating type is determined by the genetic information expressed at the MAT locus, either 
MATα or MATa (Klar et al., 1981; Nasmyth et al., 1981).  HML and HMR carry extra 
silenced copies of α and a, with α at HML and a at HMR.  Chromatin within the silent 
mating type loci HML and HMR represses transcription, ensuring that only the 
information present at the MAT locus is expressed (Rusche et al., 2003).  The genetic 
information expressed at the MAT locus can change due to HO endonuclease, which cuts 
within the MAT locus causing a double-stranded break that is repaired through 
homologous recombination between one of the silenced HML or HMR loci and identical 
sequences within the MAT locus (Rusche et al., 2003).  The gene encoding HO 
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endonuclease is deleted in lab strains to maintain cells as one mating type and strains are 
unable to switch between the two.   
Though each region utilizes many different proteins to restrict gene expression, 
members of the Silent Information Regulators, or SIR proteins can be found at each of 
these silent regions (Perrod and Gasser, 2003; Rusche et al., 2003).  The histone 
deacetylase (HDAC) Sir2 is required for transcriptional silencing of gene expression at 
all three regions and specifically targets lysine 9, 14, and 56 of histone H3 and lysine 16 
of histone H4 (Imai et al., 2000a; Imai et al., 2000b; Xu et al., 2007).  In S. cerevisiae, 
silent chromatin is characterized by low levels of acetylated and methylated histones 
while actively transcribed chromatin is characterized by high levels of acetylated and 
methylated histones (Braunstein et al., 1993; Hecht et al., 1995; Braunstein et al., 1996; 
Suka et al., 2001; Bryk et al., 2002; Li et al., 2006a). 
The recruitment and spreading of SIR proteins along chromatin differs between 
each of the three regions of heterochromatin in S. cerevisiae.  At both telomeres and the 
silent mating type loci Sir2, Sir3, and Sir4 interact and spread along both regions to form 
heterochromatin (Aparicio et al., 1991; Gotta et al., 1997; Hoppe et al., 2002); however, 
at the rDNA only Sir2 is required for silencing of transcription (Smith and Boeke, 1997; 
Straight et al., 1999; Hoppe et al., 2002).  A cycle of recruitment and deacetylation of 
histones facilitates spreading along chromatin in just a few steps.  At the telomeres, 
formation of silent chromatin is initiated by the binding of a telomere binding protein 
called Rap1 (Repressor/Activator Protein 1) to specific sites (Klein et al., 1992; Kyrion 
et al., 1992; Moretti et al., 1994; Luo et al., 2002).  Rap1 and Ku70/80 work together to 
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specifically recruit Sir4 to telomeres (Mishra and Shore, 1999) followed by the HDAC 
Sir2 which deacetylates H3 and H4 (Imai et al., 2000a), recruiting Sir3 followed by Sir4, 
etc.  Hypoacetylated H3 and H4 N-terminal tails are the preferred binding site for Sir4 
and Sir3, and thus a Sir2-Sir3-Sir4 complex spreads along telomeres forming a silenced, 
compact chromatin structure (Braunstein et al., 1993; Hecht et al., 1995; Suka et al., 
2001; Sperling and Grunstein, 2009).  As mentioned above, Dot1 methylates lysine 79 of 
histone H3 which is important for silencing at telomeres and is believed to specifically 
target and restrict SIR proteins to heterochromatin regions.  With a loss of methylation at 
lysine 79 of histone H3, SIR proteins spread further along chromatin depleting SIR 
proteins from heterochromatin and leading to a loss of silencing (van Leeuwen et al., 
2002; Verzijlbergen et al., 2009).   
The heterochromatin structure of telomeres is stabilized by folding back on itself 
(de Bruin et al., 2000) upon associating with specific foci along the nuclear periphery 
containing high levels of silencing proteins (Maillet et al., 1996; Andrulis et al., 1998).  
Association of telomeres with the nuclear periphery is believed to be important for 
interaction with specific foci containing the silencing proteins Rap1, Sir2, Sir3, Sir4 and 
both Ku proteins (Klein et al., 1992; Palladino et al., 1993; Gotta et al., 1996; Maillet et 
al., 1996; Laroche et al., 1998; Mondoux et al., 2007).  Ku70 and Ku80 are believed to 
function as important anchors of telomeres to these foci at the nuclear periphery 
(Boulton and Jackson, 1998; Laroche et al., 1998; Andrulis et al., 2002).  Deletion of 
any of the five proteins listed above can result in loss of silencing at telomeres, 
chromosome instability, and loss of formation of the silencing foci.  The current model 
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suggests that localization of telomeres at the periphery is not required for silencing but is 
required for interaction with silencing proteins leading to the initiation and thus 
maintenance of silencing (Mondoux et al., 2007).  In other words, once silencing is 
initiated telomeres can travel away from the periphery and be silent but association with 
the nuclear periphery is required for interaction with a pool of SIR proteins and others to 
initiate silencing of gene expression.    
 The recruitment and deacetylation cycle described above is similar to the 
spreading of Sir2-Sir3-Sir4 in the silent mating type loci (Moazed, 2001; Rusche et al., 
2003).  Both of the HM loci are flanked by silencer regions that recruit Rap1, the origin 
recognition complex (ORC) and Abf1.  Unlike the other heterochromatin regions, HM 
loci rely on Sir1 to initiate the recruitment of other SIR proteins followed by spreading 
as described above (Rine and Herskowitz, 1987; Aparicio et al., 1991; Bose et al., 
2004).  Localization of the HM loci to the nuclear periphery has also been found to be 
important in silencing (Maillet et al., 1996; Andrulis et al., 1998; Andrulis et al., 2002), 
and as with telomeres it is believed that association with the periphery is important in 
initiating silencing but is not required for maintaining silencing once established 
(Gartenberg et al., 2004).    
 Ribosomal DNA locus 
 The ribosomal DNA locus consists of a 1-2 Mb rDNA tandem array containing 
~150 to 200 copies of a 9.1 kb ribosomal DNA repeat on chromosome XII forming 10% 
of the genome in S. cerevisiae (Petes et al., 1978b; Skryabin et al., 1978; Petes, 1979; 
Warner, 1999).  A single rDNA repeat consists of two transcribed regions, the 35S 
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rRNA gene and the 5S rRNA gene.  The 35S rRNA gene is transcribed by RNA 
Polymerase I (RNA Pol I) and is the precursor of 25S, 5.8S and 18S rRNAs.  The 5S 
rRNA gene is transcribed by RNA Polymerase III (RNA Pol III).  RNA Pol I accounts 
for up to 60% of the total transcription in S. cerevisiae (Warner, 1999).  Two 
nontranscribed spacer regions NTS1 and NTS2 surround the 5S gene (Figure 2a) 
(Skryabin et al., 1984).  The rDNA array compacts along the interior of the nucleus 
forming a „cap‟ structure called the nucleolus.  While telomeres serve as a classic 
example of heterochromatin, the ribosomal DNA locus is best described as facultative 
heterochromatin; a region that is contains high levels of transcription as well as regions 
of silenced transcription.     
Of the SIR proteins mentioned above, only Sir2 is required for silencing at the 
rDNA (Gotta et al., 1997; Smith and Boeke, 1997; Straight et al., 1999; Hoppe et al., 
2002).  Gene silencing was demonstrated at the rDNA by silencing of Ty1 elements as 
well as other RNA Pol II transcribed genes (Bryk et al., 1997; Smith and Boeke, 1997).  
Ty1 elements are retrotransposons transcribed by RNA Polymerase II (RNA Pol II) that 
inserts themselves upstream of tRNA genes, and insertion is dependent upon 
transcription by RNA Pol III at that tRNA gene (Devine and Boeke, 1996).  Silencing at 
the rDNA is not absolute, instead silencing results in a large decrease but not a complete 
loss in RNA Pol II transcription.  Silencing at the rDNA is a result of a specialized 
chromatin structure that depends upon Sir2 to prevent transcription by RNA Pol II.  Sir2 
has a larger effect on the NTS regions than on the transcribed regions of the rDNA (Bryk 
et al., 1997; Smith and Boeke, 1997).  In cells lacking Sir2, there is an increase in 
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trimethylated H3K4 within NTS2 (Li et al., 2006a).  Sir2 also silences small transcripts 
that naturally occur within the NTS by RNA Pol II transcription (Li et al., 2006a).  
These transcripts are associated with disrupting the association of cohesin at the rDNA 
(Kobayashi and Ganley, 2005).  The role of cohesin is discussed in further detail below.    
Role of NTS1 and NTS2 in DNA replication 
Both NTS1 and NTS2 regions play important roles in DNA replication at the 
rDNA.  Autonomous replicating sequence (ARS) elements within NTS2 consist of three 
10-11bp sequences that are conserved among rDNA repeats (Miller and Kowalski, 1993) 
(Figure 2b).  DNA replication at the rDNA initiates bidirectionally within NTS2 at 
conserved ARS elements that function as origins of replication (Skryabin et al., 1984; 
Brewer and Fangman, 1987; Linskens and Huberman, 1988).  Electron microscopy was 
used to visualize replication bubbles in the NTS opening in a concerted manner in early 
S-phase downstream of actively transcribed 35S repeats (Saffer and Miller, 1986).  Only 
the replication forks traveling towards NTS1 are halted by a replication fork barrier 
(RFB) preventing RNA Pol I transcriptional machinery on actively transcribed 35S 
rRNA genes and DNA replication machinery from colliding (Linskens and Huberman, 
1988; Kobayashi and Horiuchi, 1996; Kobayashi, 2003).  Replication forks travelling in 
the same direction as RNA Pol I transcription are allowed to pass through the RFB site.  
The arrest of replication is independent of transcription by RNA Pol I and RNA Pol II 
and depends solely on proteins associating with the RFB (Brewer et al., 1992).  Fob1 



























































































































































































































































































































































































































































































































































































































































































































































































halt DNA replication and RNA Pol I transcriptional machinery (Kobayashi et al., 1992; 
Kobayashi and Horiuchi, 1996).  Once the fork is arrested within NTS1, DNA  
replication machinery continues traveling in the same direction as RNA Pol I (Brewer 
and Fangman, 1988; Linskens and Huberman, 1988).        
Although each of the ~150 to 200 copies of the rDNA contains an ARS sequence 
only ~ 20% of those sequences are used to initiate DNA replication (Linskens and 
Huberman, 1988; Muller et al., 2000; Pasero et al., 2002).  Active origins are only 
initiated downstream of actively transcribed RNA Pol I genes (Muller et al., 2000).  In 
general, ARS elements that are closely spaced (~7.5 kb apart) interfere with each other 
(Brewer and Fangman, 1994).  Single molecule analysis of the rDNA repeat shows 
active origins cluster within the rDNA and are separated by large gaps of inactive origins 
greater than 60 kb, and that the majority of all origins that do initiate replication do so in 
early S phase (Pasero et al., 2002).  Origins were directly visualized by stretching 
strands of the rDNA across slides in a technique called molecular combing in 
combination with BrdU incorporation at actively replicated regions and specific 
fluorescent probes.  In addition to the role of Sir2 in transcriptional silencing, it also 
performs a role in repression of origin initiation.  Sir2 is known to associate within 
NTS2 at the ARS element (Gotta et al., 1997; Hoppe et al., 2002).  In cells lacking Sir2, 
origin initiation increases between 60-80% and these newly activated origins originate 




RNA Polymerase I transcriptional machinery 
 NTS2 is also home to the promoter region of the 35S rRNA gene transcribed by 
RNA Pol I.  The 5S rRNA gene contains an internal promoter within the gene that 
contains internal control regions (ICRs) which bind the RNA Pol III transcriptional 
machinery (Lee et al., 1995; Paule and White, 2000).  These regions are shown in Figure 
2 and are discussed in Chapter II.  In vitro transcription assays with the rDNA was first 
performed with extracts from mouse cells, showing that RNA Pol I initiates at the 5‟ end 
of the large rRNA gene (Grummt, 1981).  RNA Pol I activity was more robust in 
extracts from actively dividing cells than from cells that have reached senescence.  Up to 
this point nothing was known about the proteins required for RNA Pol I initiation and 
transcription.  To identify factors important for RNA Pol I transcription in S. cerevisiae, 
synthesis of rRNA genes must be maintained.  Thus, a system was created in which an 
RNA Pol II promoter GAL7 was fused at the 5‟ end of the 35S rRNA gene.  In this 
system, 35S rRNA transcription is maintained by RNA Pol II allowing researchers to 
screen for mutants that affect RNA Pol I and still preserve cell viability (Nogi et al., 
1991a; Nogi et al., 1991b).  From this initial study three transcription factors were 
discovered: UAF (upstream activation factor), CF (core factor), and Rrn3p (Figure 2c). 
The RNA Pol I promoter region within NTS2 contains two domains, an upstream 
element that stretches from -155 to -60 and a core promoter that stretches from -38 to +5 
(Musters et al., 1989; Kulkens et al., 1991; Choe et al., 1992) (Figure 2c).  Using an in 
vitro system, transcription is detected from the core promoter but is increased ten-fold 
when the upstream element is included.  Thus, the upstream element is required for a 
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higher level of transcription and the core promoter is required at minimum for RNA Pol 
I transcription (Kulkens et al., 1991; Choe et al., 1992).  UAF, CF, Rrn3, TBP and RNA 
Pol I are known to bind within the upstream element and core factor regions forming the 
RNA Pol I promoter region (Figure 2c).  The binding and formation of the RNA Pol I 
transcriptional machinery leads to an actively transcribed 35S rRNA gene.   
 The Upstream Activation Factor (UAF) is comprised of Rrn5, Rrn9, Rrn10 (Keys 
et al., 1996), Uaf30 (Siddiqi et al., 2001b), and histones H3 and H4 (Keener et al., 1997) 
and binds specifically to the upstream element in NTS2 (Keys et al., 1996) (Figure 2c).  
Without the upstream element or without UAF, transcription by RNA Pol I does occur 
however only at basal levels.  Cells lacking Rrn5, Rrn9, Rrn10, and Uaf30 are extremely 
sick but are viable, and the level of RNA Pol I transcription is reduced.  This suggests 
that UAF is not essential for RNA Pol I transcription but is required for the high levels 
of RNA Pol I transcription needed for normal growth.  In cells lacking the Uaf30 subunit 
RNA Pol I transcription at the rDNA is decreased by ~70% (Hontz et al., 2008).  The 
amount of RNA Pol I transcriptional machinery more than doubles on actively 
transcribed rDNA to compensate for this decrease.  The Uaf30 subunit is also required 
for the UAF complex to bind to the Upstream Element within the RNA Pol I promoter 
(Hontz et al., 2008).  UAF initiates the formation of a pre-initiation complex bound at 
the upstream element (Keys et al., 1996).  UAF is also comprised of histones H3 and 
H4; accounting for the ability of UAF to bind strongly to the upstream element region in 
such a way that it rarely binds a second template (Keener et al., 1997).  In cells lacking 
H3 or H4 ~90% of rRNA synthesis is inhibited resulting from a three-fold decrease in 
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the association of UAF with RNA Pol I promoter region (Tongaonkar et al., 2005).  
UAF is tightly bound at the RNA Pol I promoter region through its interactions with H3 
and H4 whether or not active transcription by RNA Pol I takes place (Keener et al., 
1997; Claypool et al., 2004).  UAF remains bound to the 35S promoter through multiple 
rounds of transcription by RNA Pol I (Keys et al., 1996; Aprikian et al., 2001; Claypool 
et al., 2004).      
Core factor (CF) is composed of Rrn6, Rrn7, and Rrn11 proteins (Keys et al., 
1994; Lalo et al., 1996; Lin et al., 1996).  All three subunits are essential for RNA Pol I 
transcription and cell viability, and interact with the TATA-binding protein (TBP) (Lalo 
et al., 1996; Lin et al., 1996).  The name core factor comes from the requirement of the 
complex of Rrn6, 7 and 11 in directing RNA Pol I transcription from the core promoter 
region (Lin et al., 1996) (Figure 2c).  Without Rrn11 RNA Pol I is unable to initiate 
transcription from neither the full promoter region nor from the core promoter only.  A 
complete complex of CF in addition to, at minimum, the core promoter region is 
required for RNA Pol I transcription (Lin et al., 1996).           
Rrn3 is a protein that physically interacts with RNA Pol I to initiate transcription 
and then dissociates during elongation (Yamamoto et al., 1996; Milkereit and 
Tschochner, 1998).  The bulk of Rrn3 exists as a free protein while a smaller portion 
forms an association with RNA Pol I to initiate transcription (Milkereit et al., 1997).  
Rrn3 interacts not only with RNA Pol I through its A43 subunit but also with Rrn6, a 
subunit of CF.  In an in vitro assay RNA Pol I is able bind to the promoter without Rrn3, 
however the complex is transcriptionally inactive (Aprikian et al., 2001). Rrn3 is 
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believed to bridge the interaction between RNA Pol I and CF to stimulate binding of 
RNA Pol I and CF to the promoter to initiate transcription (Peyroche et al., 2000) 
(Figure 2c).   
The TATA-binding protein (TBP) is a transcription factor that is required for 
initiation of transcription by all three RNA Polymerases in eukaryotic cells.  The role of 
TBP in RNA Pol II transcription is well documented.  Briefly, TBP is known for binding 
directly to a conserved TATA box sequence within the promoter regions to further 
recruit additional transcription factors.  Conversely, the RNA Pol I promoter region 
lacks a TATA box sequence and is instead recruited through protein interactions.  TBP 
specifically interacts with Rrn6 of CF and Rrn9 of UAF to stimulate transcription, and 
UAF utilizes its interaction with TBP to recruit CF (Steffan et al., 1996) (Figure 2c).  
Basal levels of transcription only require RNA Pol I, Rrn3, and CF.  It is the association 
of TBP and UAF at the Upstream Element that elevates the level of RNA Pol I 
transcription (Keener et al., 1998).   
In summary, RNA Pol I utilizes UAF, CF, Rrn3, and TBP to form an initiating 
complex.  UAF binds to the Upstream Element to begin assembly of the RNA Pol I 
initiation complex (Keys et al., 1996; Steffan et al., 1996).  UAF can bind the Upstream 
Element in the absence of CF and RNA Pol I (Aprikian et al., 2001).  Next, Core Factor 
and RNA Pol I bound with Rrn3 are recruited to the promoter region.  This recruitment 
requires TBP and is dependent upon UAF bound to the Upstream Element, however it is 
unknown whether TBP is recruited by UAF or enters with CF and RNA Pol I with Rrn3 
(Aprikian et al., 2001; Siddiqi et al., 2001a).  The promoter region contains poised 
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transcriptional machinery that allows the cell to rapidly respond to a demand for 
increased ribosome synthesis.  Once the pre-initiation complex is formed transcription 
begins and enters elongation.  RNA Pol I begins transcribing the 35S rRNA gene while 
TBP, CF, and UAF remain bound to the promoter region (Aprikian et al., 2001; Bier et 
al., 2004; Claypool et al., 2004).   
The relationship between RNA Pol I and Pol II transcription  
The rDNA contains a specialized chromatin structure that allows transcription by 
RNA Pol I and III but silences RNA Pol II in regions that undergo high levels of RNA 
Pol I and Pol III transcription.  Silencing spreads along the rDNA array in one direction 
towards the centromere (Figure 2a).  This spreading of silenced chromatin towards the 
centromere is dependent upon Sir2 and RNA Pol I transcription (Buck et al., 2002).  
Deletion of the 35S rRNA core promoter abolishes silencing of RNA Pol II transcription 
(Buck et al., 2002; Cioci et al., 2003), and if the orientation of the 35S rRNA gene is 
flipped silencing spreads to the right, toward the centromere (Buck et al., 2002).  
Silencing of an RNA Pol II gene specifically takes place in actively transcribed 35S 
rRNA repeats only and silencing of RNA Pol II does not occur in inactive 35S rRNA 
repeats (Cioci et al., 2003).  In a yeast strain with 25 copies of the rDNA repeat, where 
all 35S rRNA genes are actively transcribed by RNA Pol I, silencing of RNA Pol II 
transcription is stronger than in wild-type cells with 150 to 200 copies of the rDNA 
repeat.  To summarize, silencing of RNA Pol II transcription requires high levels of 
RNA Pol I transcription found in active repeats (Buck et al., 2002; Cioci et al., 2003).  
This is referred to as the reciprocal silencing model.        
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Chromatin structure and nucleosome positioning 
There are three techniques commonly used to study chromatin structure and nucleosome 
positioning at the rDNA: in vitro footprinting techniques such as micrococcal nuclease 
(MNase) accessibility, in vitro psoralen crosslinking, and in vivo DNA methyltransferase 
accessibility (Figure 3).  These techniques can each provide data on where factors such 
as nucleosomes or other DNA binding factors associate with chromatin, and whether 
chromatin is in an open or closed conformation.  Micrococcal nuclease (MNase) is a 
non-specific endo-exonuclease that is ~17kDa.  MNase assays use purified nuclei or 
permeabilized cells in vitro with low levels of enzyme to create partial digestion of the 
chromatin.  These chromatin fragments are then separated by size and probed for an area 
of interest to reveal a footprint of where factors bind along a specific region (Figure 3a).  
Psoralen is a three-ring compound produced in plants that when incubated with 
chromatin will intercalate with increased frequency within open areas of chromatin 
rather than closed areas of chromatin.  Once treated with UV light, psoralen covalently 
bonds with the DNA in these regions.  DNA is purified, cut with restriction 
endonucleases, and fragments are separated by size.  Chromatin that was in an open 
conformation by active transcription will contain more psoralen and thus migrate slower 
than chromatin in a closed conformation containing a low amount of psoralen.  This 
technique was used successfully in studying open and closed chromatin at the rDNA, 
showing that 50% of rDNA repeats contain open and actively transcribed chromatin 
while the other 50% contain closed and silent chromatin (Dammann et al., 1993)(Figure 





Figure 3. Overview of commonly used techniques in chromatin structure and nucleosome 
positioning.  (A) A Micrococcal nuclease assay.  These experiments have typically been used to study 
nucleosome positioning.  In this experiment MNase will cut DNA at areas that are accessible.  Areas 
protected by nucleosomes or other DNA binding proteins are not as accessible and are therefore protected.  
A partial digestion of the DNA will create fragments of different lengths.  By probing for an area of 
interest, nucleosomes and other DNA binding factors are seen as a footprint.  (B) Psoralen crosslinking 
assay.  These experiments have been used in the past to study active and inactive repeats of the rDNA 
(Dammann et al., 1993).  In these experiments, actively transcribed repeats that have an open chromatin 
structure will associate with more psoralen.  Thus when probing specifically for the rDNA, two fragments 
are formed.  A slow moving fragment contains more psoralen and thus represents open and actively 
transcribed repeats while a fast moving fragment contains less psoralen and thus represents closed and 
silent repeats.  (C) In vivo induction of M.CviPI.  In these experiments as referenced in the text, the 
methyltransferase is expressed in vivo and recognizes accessible 5‟-GpC-3‟ sites in open chromatin 
structure.  Sites that are accessible are methylated and protected from conversion to uracil.  This 
methylated 5‟-GpCM-3‟ sequence becomes a mark of open, accessible chromatin and can be analyzed by 
sequence analysis in an area of interest.  A common way of displaying data is with a „dot diagram‟ as 
explained in the text. 
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DNA methyltransferase accessibility is based on experiments that show 
positioned nucleosomes can inhibit methylation of DNA (Kladde and Simpson, 1994) 
and this technique can be adapted to map nucleosome positioning and thus chromatin 
structure in vivo (Kladde and Simpson, 1996).  Various DNA methyltransferases have 
been adapted for this procedure, either those expressed endogenously in human cells (Li 
et al., 2006b) or those artificially inserted into the genome in Saccharomyces cerevisiae 
(Kladde et al., 1996).  In human systems, DNA methylation occurs naturally, while in 
yeast a DNA methyltransferase can be artificially inserted into the genome to study 
nucleosome positioning and chromatin structure.  M.CviPI is a methyltransferase that 
has been utilized in our lab and others to study chromatin structure.  M.CviPI recognizes 
5‟-GpC-3‟ sites (GpC sites), methylating the cytosine residue in open chromatin 
structure.  This specificity by M.CviPI provides a recognition site approximately every 
27 bp, providing good coverage of a region of interest (Carvin et al., 2003).  DNA 
methylation can be analyzed using a chemical treatment called bisulfite deamination, 
during which cytosine residues that are unmethylated are converted to uracil while those 
that are methylated (and thus were accessible in an area of open chromatin) remain 
unchanged.  We and others (Pardo et al., 2009) have developed a single molecule 
technique by expressing M.CviPI in vivo and cloning areas of interest into plasmids.  
Using this technique we can study changes in nucleosome positioning as an indicator of 
active transcription by RNA Pol I and as a result of the loss of Sir2.  Using this 
technique we can differentiate between open and closed chromatin structure by the 
presence of bound factors within the 35S rRNA gene promoter region and changes in 
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nucleosome positions within NTS2.  A common way of displaying data is through a „dot 
diagram‟ where methylation sites are drawn to scale.  A black dot represents a 
methylated site, and therefore an area of open chromatin, and a white dot represents an 
unmethylated site and therefore an area of closed chromatin (Figure 3c).   
Transcriptionally active and inactive regions of chromatin can be described by 
the sort of chromatin structure present at those regions.  Active and inactive regions of 
the rDNA have been distinguished using psoralen to show that at any one time 
approximately half of all rDNA genes are actively transcribed and the other half are 
silent.  These two populations can be distinguished by focusing on the entire non-
transcribed spacer region (Dammann et al., 1993) and depend upon elongating RNA Pol 
I to establish an open chromatin structure (Dammann et al., 1995).  Within the rDNA 
actively transcribed genes are randomly distributed along the array, although in the 
nucleus these active genes may cluster together due to folding of the chromatin forming 
points of active transcription within the nucleolus (Dammann et al., 1995).  Open and 
active repeats are not maintained from one cell cycle to the next, meaning that there 
seems to be no preference for one repeat or another (Dammann et al., 1995; Lucchini 
and Sogo, 1995).   
 Footprinting techniques were used to define the chromatin structure of the NTS 
regions including the 35S rRNA gene promoter region.  In general it is believed that 
silent areas of chromatin contain a strict nucleosome positioning, compacted to keep 
DNA binding factors from disrupting positioning and opening chromatin, while actively 
transcribed regions may contain few to no nucleosomes that lack a strict position.  
 31 
Actively transcribed rDNA genes contain approximately 50 complexes of RNA Pol I 
(French et al., 2003) and have an open chromatin structure are characterized by a lack of 
nucleosomes while inactive rDNA regions contain strictly positioned nucleosomes 
(Dammann et al., 1993, 1995).  Within NTS2 there are five well-positioned nucleosomes 
while in NTS1 nucleosome positions are not well defined and cannot be detected 
(Vogelauer et al., 1998; Lucchini et al., 2001) (Figure 2b).  The passage of DNA 
replication machinery also affects nucleosome positioning.  Positioned nucleosomes are 
temporarily displaced but once the machinery has passed, positioned nucleosomes 
rapidly reform within NTS2 (Lucchini et al., 2001).  When replication machinery enters 
an actively transcribed gene, positioned nucleosomes reform on the resulting daughter 
strands.  Our lab has utilized M.CviPI to study nucleosome positioning within NTS2 as 
an indicator of actively transcribed genes.   
The histone deacetylase Sir2 regulates chromatin structure and nucleosome 
positioning within individual rDNA repeats.  Previous experiments analyzing the 
chromatin structure of the rDNA have used micrococcal nuclease (Fritze et al., 1997; 
Cioci et al., 2002; Li et al., 2006a) or psoralen (Smith and Boeke, 1997) to show that in 
strains lacking Sir2 there is a change in chromatin accessibility.  In other words, in cells 
lacking Sir2 chromatin forms a more open structure that allows increased accessibility to 
MNase or psoralen.  Sir2 affects silencing at the NTS region more than at the transcribed 
regions and the loss of Sir2 increases the number of actively transcribed genes at the 
rDNA (Smith and Boeke, 1997).  Studies focusing specifically on NTS2 show the 
positioning of five nucleosomes changed in cells lacking Sir2 that result in increased 
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MNase accessibility.  In these strains, increased MNase accessibility is found at the areas 
between specific nucleosomes (Cioci et al., 2002) at linker regions downstream of 
nucleosome 1, between nucleosome 2 and 3, and upstream of nucleosome 5 (Li et al., 
2006a) (Figure 2b). 
Hmo1 is part of the high-mobility group B (HMGB) protein family and contains 
a DNA-binding motif.  Hmo1 associates with the active transcribed 35S rRNA genes.  
The discovery of Hmo1 is an important one because of its similarity to human UBF, a 
homolog of yeast UAF (Schnapp et al., 1994).  In many ways human UBF and yeast 
UAF are similar however yeast UAF lacks the conserved HMG-box characteristic of 
human UBF.  A HMG-box domain allows binding to DNA and is a characteristic of 
HMG proteins (Stros et al., 2007).  UAF lacks this domain however there is no question 
it associates within the promoter region of RNA Pol I.  Hmo1 contains such a domain 
and may allow direct binding of RNA Pol I to chromatin.  Hmo1 associates throughout 
the entire actively transcribed 35S rRNA gene and is especially enriched at the RNA Pol 
I promoter region.  A technique called ChEC for Chromatin Endogenous Cleavage was 
used to study chromatin structure in vivo (Merz et al., 2008).  Using this technique, a 
protein of interest (i.e. Hmo1) is fused to MNase and expressed in vivo to determine 
where the protein of interest associates with chromatin.  By analyzing cut sites in 
genomic DNA generated from this technique, the chromatin present at the promoter 
region of RNA Pol I was found to loop around UAF.  MNase connected to histones in a 
yeast strain with an all actively transcribed array suffered less cleavage in the rDNA 
(and thus has fewer histones) than an array containing 50% active and 50% inactive 35S 
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rRNA genes.  ChEC and psoralen can be combined to show that Hmo1 associates with 
transcriptionally active genes.  Hmo1 is specific to active repeats only and remains 
bound to the RNA Pol I promoter region once RNA Pol I leaves the promoter region and 
enters elongation (Merz et al., 2008).  Remember that TBP, CF, and UAF also remain 
bound to the promoter region when RNA Pol I enters elongation (Aprikian et al., 2001; 
Bier et al., 2004; Claypool et al., 2004).  To summarize, the promoter region of actively 
transcribed genes contain TBP, CF, UAF, and Hmo1.   
The data generated above from MNase and psoralen experiments about active 
and inactive repeats are based on a population of rDNA repeats in a population of cells.  
Research has been branching out into single molecule and single cell experiments.  By 
using fluorescence in situ hybridization (FISH) in individual yeast cells, data was 
collected on the kinetics of rDNA transcription by RNA Pol I at the 35S rRNA gene 
(Tan and van Oudenaarden, 2010).  Using FISH, the rate of the 35S rRNA gene 
switching from inactive to actively transcribed by RNA Pol I, or activation rate, and the 
average number of transcripts produced from a single activation event, or „burst size‟ 
were measured.  By measuring RNA expression from single rDNA repeats over time 
from a single cell the activation rate is ~5 minutes before the 35S rRNA gene becomes 
inactive again (Tan and van Oudenaarden, 2010).  For each active repeat, approximately 
190 transcripts are produced during those 5 minutes (Tan and van Oudenaarden, 2010).  
These results shows that reinitiation of RNA Pol I takes ~1.6 seconds, which agrees with 
previous data from electron microscopy experiments that estimated between 1.2 and 2.2 
seconds (French et al., 2003).  Data from these experiments support the idea that at any 
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one time 50% of repeats are active and 50% are inactive (Dammann et al., 1993) and 
that the state of transcription within individual repeats is not inherited between cell 
cycles (Lucchini and Sogo, 1995).  Using FISH researchers were able to go a step further 
to analyze a single cell with a single rDNA repeat.  They propose through mathematical 
modeling that throughout an entire cell cycle all repeats will eventually become actively 
transcribed by RNA Pol I with the proportion of active and inactive repeats (50/50) 
staying constant at any one time (Tan and van Oudenaarden, 2010).  These results would 
be impossible to replicate with our single molecule technique with M.CviPI.  Our 
experiments with M.CviPI were based on the idea that the proportion of active repeats 
within a cell remain active throughout the entire cell cycle and that inactive repeats 
remain silent through the entire cell cycle.  As mentioned above, there is only a 5 minute 
window when the 35S rRNA is actively transcribed and accordingly the nucleosome 
positioning within NTS2 is in an open conformation.  Our induction times of 60 and 120 
minutes for M.CviPI are much too long to properly characterize a 35S rRNA gene that is 
only actively transcribed for 5 minutes, but these induction times are necessary for this 
technique.  This is discussed in greater detail in Chapter II.   
Regulator of nucleolar silencing and telophase exit  
The rDNA forms a distinct structure within the nucleus called the nucleolus that 
is positioned on one side of the periphery of the nucleus forming a dark nuclear cap 
structure (Santoro, 2005).  Nucleolar structure can change from a compact cap seen on 
the edge of the nucleus to an amorphous blob due to factors that damage nucleolar 
structure.  Silencing of RNA Pol II transcription at the rDNA occurs through the RENT 
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complex for Regulator of Nucleolar silencing and Telophase exit and is comprised of 
Sir2, Net1, and Cdc14 (Shou et al., 1999; Straight et al., 1999).  RENT is recruited to 
two regions of the rDNA: by Fob1 in NTS1 and by RNA Pol I at the 35S promoter 
region in NTS2 (Huang and Moazed, 2003).  Net1 (Nucleolar silencing Establishing 
factor and Telophase regulator) is known to promote RNA Pol I mediated transcription 
at the rDNA and is believed to tether RNA Pol I specifically to the nucleolus by a 
physical interaction with RENT (Shou et al., 2001; Huang and Moazed, 2003).  Data has 
shown that deletion of Net1 leads to loss of a specific subunit of RNA Pol I causing 
decrease in rDNA transcription (Shou et al., 2001).  Net1 is specifically required for 
silencing at the rDNA and recruits Sir2 (Straight et al., 1999) and Cdc14 (Shou et al., 
1999) to the nucleolus silencing transcription.  Deletion of Net1 causes a loss of gene 
silencing at the rDNA and instability in nucleolar structure resulting in the distinct cap-
like structure of the nucleolus to disperse (Straight et al., 1999; Shou et al., 2001).   
In addition to silencing of RNA Pol II transcription at the rDNA, RENT also 
plays a role in exit from mitosis.  Exit from mitosis in yeast requires two signaling 
cascades: Cdc fourteen early anaphase release (FEAR) and mitotic exit network (MEN).  
FEAR functions to release Cdc14 during early stages of anaphase which stimulates 
MEN to maintain release of Cdc14 during later stages of anaphase leading to exit from 
mitosis (Stegmeier et al., 2002).  Net1‟s recruitment of Cdc14 to the nucleolus inhibits 
Cdc14 activity and results in inhibiting exit from mitosis (Shou et al., 1999; Traverso et 
al., 2001), however once Net1 is phosphorylated at the beginning of anaphase by the 
protein kinase Cdk1, Cdc14 (Azzam et al., 2004) and Sir2 are released, while Net1 
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remains associated at the rDNA throughout the cell cycle.  The release of Cdc14 allows 
phosphorylation of its substrates and exit from mitosis (Shou et al., 1999; Straight et al., 
1999).   
RENT also plays a role in repressing recombination between repetitive rDNA 
repeats.  There are two key proteins that control recombination at the rDNA array in 
yeast: Sir2 (Gottlieb and Esposito, 1989) and Fob1 (Kobayashi and Horiuchi, 1996).  As 
mentioned above, RENT binds within NTS1 and the 35S promoter region of RNA Pol I 
in NTS2 (Huang and Moazed, 2003).  While bound to NTS1, RENT associates with 
Fob1 at the RFB site.  This association of RENT to Fob1 is required for silencing of 
RNA Pol II transcription in NTS1 (Huang and Moazed, 2003).  Fob1 is known to 
enhance recombination but its activity is repressed through its recruitment of RENT to 
NTS1 (Kobayashi and Horiuchi, 1996; Huang and Moazed, 2003).  With Fob1 bound at 
the RFB site (Kobayashi et al., 1992), replication forks traveling left from the ARS in 
NTS2 are blocked from colliding with RNA Pol I transcriptional machinery (Kobayashi 
and Horiuchi, 1996; Kobayashi, 2003).  Thus, NTS1 is a region that has a role in 
repressing recombination and in halting replication forks (Kobayashi and Horiuchi, 
1996; Kobayashi et al., 1998).   
 In cells lacking Sir2, recombination increases between 10-15% and this increase 
is specific to the rDNA (Gottlieb and Esposito, 1989).  Sir2 represses unequal sister-
chromatid recombination occurring in NTS1 (Kobayashi et al., 2004).  With a loss of 
Sir2, two paired alleles of the rDNA recombine between each other leading to the two 
copies of the rDNA, the sister chromatids, to misalign and the copy number of the rDNA 
 37 
to increase in one daughter cell and to decrease in the other daughter cell.  When a 
double strand break occurs between sister chromatids, Sir2 uses an association with 
cohesin to repress recombination between sister chromatids during mitosis (Kobayashi et 
al., 2004).  Cohesin is a multi-subunit ring-like complex that associates within NTS1 at 
the replication fork to keep sister chromatids together by encircling the DNA until the 
cell reaches anaphase and chromatids separate (Lengronne et al., 2006).  Cohesin is 
cleaved by separase once sister chromatids have properly aligned in metaphase.  
Cleavage of cohesin leads to anaphase and segregation of sister chromatids (Haering et 
al., 2008).     
Cohesin and condensin at the rDNA 
In 2006 Huang et al. proposed the existence of a “protein bridge” containing 
RENT, Fob1, and other proteins that span between NTS1 regions and functions to 
repress recombination at the rDNA between sister chromatids during replication (Huang 
et al., 2006a).  By purifying proteins known to function in rDNA silencing (Sir2, Net1, 
and Fob1) a series of proteins were identified that included nuclear envelope proteins, 
Tof2, Lrs4, and Csm1.  Tof2 was originally discovered to co-purify with the RENT 
complex in a study focusing on identifying additional Sir2 interacting factors (Tanny et 
al., 2004).  Tof2 and a heterodimer of Lrs4 and Csm1 specifically associate with Fob1 
and RENT at NTS1 to silence an RNA Pol II gene artificially inserted into NTS1.  The 
Huang et al. 2006 article in combination with other articles that detail the association of 
Lrs4 and Csm1 with cohesin through screens (Graumann et al., 2004) and one that 
showed the association of Sir2 with cohesin at the rDNA in NTS1 (Kobayashi et al., 
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2004; Kobayashi and Ganley, 2005) proposed a model that cohesin forms a ring 
specifically at NTS1 and associates with RENT, Fob1, Tof2, Lrs4, and Csm1 to clamp 
sister chromatids together.  The purpose of this clamp is to prevent recombination 
between sister chromatids that could result in a change in the number of repeats present 
at the rDNA array. 
An important step to cell division is the ability to properly compact and segregate 
the ~1-2 Mb rDNA array during mitosis.  During anaphase of mitosis, many steps are 
involved in controlling segregation of chromosomes.  Tof2, Lrs4, Csm1, Fob1 and 
Cdc14 all function in segregation of the rDNA during the cell cycle, and associate with 
condensin, another large ring complex of proteins that functions to compact 
chromosomes for segregation during mitosis (Geil et al., 2008; Waples et al., 2009).  
Both cohesin (Graumann et al., 2004; Kobayashi et al., 2004; Kobayashi and Ganley, 
2005) and condensin (Johzuka et al., 2006; Machin et al., 2006) have been shown to 
associate at NTS1 in the rDNA.  During anaphase, RNA Pol I transcription is inhibited 
by Cdc14 by preventing the association of Pol I with the rDNA.  This inhibition of 
transcription is required for association of condensin (Clemente-Blanco et al., 2009).   
Deletion of Tof2, Lrs4, Csm1, or Fob1 abolishes the compacted structure of the rDNA 
created by association of condensin and therefore affects segregation during the cell 
cycle, suggesting a role of these four proteins in recruitment of condensin and 
compaction of the rDNA (Geil et al., 2008; Waples et al., 2009).   
A model can be proposed to explain how the association of condensin and 
cohesin is coordinated at the rDNA (Figure 4).  At NTS1, RENT (Sir2, Net1, and 
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Cdc14) interacts with Tof2 and Fob1.  Prior to anaphase, cohesin functions to restrict 
recombination at the rDNA through the formation of a protein bridge formed around 
sister chromatids as discussed above (Huang et al., 2006a; Haering et al., 2008).  
Cohesin is lost by the time the cell reaches anaphase due to cleavage by separase.  At the 
beginning of anaphase, Net1 is phosphorylated by Cdk1 and a partial release of Cdc14 
occurs (Azzam et al., 2004).  This partial release of Cdc14 inhibits RNA Pol I 
transcription (Clemente-Blanco et al., 2009) and causes a late association of condensin 
to the rDNA (Sullivan et al., 2004; Geil et al., 2008; Waples et al., 2009).  Condensin is 
known to associate with chromatin throughout the cell cycle at relatively even levels 
(D'Ambrosio et al., 2008), but once there is a partial release of Cdc14 a portion of 
condensin is siphoned off and relocated to the rDNA.  This early release of Cdc14 by 
FEAR not only initiates exit from mitosis but also leads to chromosome segregation 
(D'Amours et al., 2004).  The remaining Cdc14 is retained by Tof2, either directly or by 
preventing full release of Cdc14 from Net1.  This retention of Cdc14 at the rDNA is 
required for the rDNA to compact and segregate in late anaphase.  Once late anaphase is 
reached (MEN pathway) the rest of Cdc14 is released, chromosomes segregate and cells 
exit mitosis to begin the cell cycle again (Shaw and Doonan, 2005; Waples et al., 2009).  





Figure 4.  Cohesin and Condensin at the rDNA.  Within NTS1, RENT (a heterotrimer in yellow) 
associates with Fob1 (blue) and Lrs4 (green), Csm1 (purple), and Tof2 (pink).  These proteins associate 
with cohesin as shown in the image.  Association of these proteins represses recombination at the rDNA 
between sister chromatids during replication.  A partial release of Cdc14 marks early anaphase leading to 
association of condensin in preparation for chromosome segregation.  Late anaphase requires the full 
release of Cdc14 and leads to chromosome segregation and exit from mitosis.   
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Chromosome linkage inner nuclear membrane proteins 
As with the other heterochromatin regions in yeast, the rDNA is known to 
associate with the nuclear periphery.  The rDNA forms a distinct structure called the 
nucleolus.  During the purification of Lrs4 and Csm1 by Huang et al. 2006 nuclear 
proteins were found to associate with the protein clamp described above.  Further 
research showed that the “protein bridge” of Lrs4 and Csm1 associates with the nuclear 
periphery through chromosome linkage inner nuclear membrane proteins (CLIP) 
composed of Heh1 and Nur1 (Mekhail et al., 2008).  CLIP is required for repressing 
recombination between rDNA repeats, but on its own CLIP is not required for silencing 
of RNA Pol II genes at the rDNA.  Localization to the nuclear periphery is required to 
repress recombination since losing either CLIP or Lrs4/Csm1 causes the structure of the 
nucleolus to destabilize and an increase in recombination.  Together, the association of 
CLIP with RENT and Lrs4/Csm1 at NTS1 functions to tether the rDNA to the nuclear 
periphery, stabilizes nucleolar structure, and prevents recombination between rDNA 
repeats (Mekhail et al., 2008). 
In human and mouse cells, recruitment to the nuclear periphery alters gene 
expression by silencing transcription of an artificially inserted gene and HDACs play 
some role in silencing transcription (Finlan et al., 2008; Reddy et al., 2008).  Early 
research in human and mouse model systems showed that euchromatin and 
heterochromatin regions localize to the nucleoplasm and nuclear periphery, respectively 
(Ferreira and Carmo-Fonseca, 1997; Ferreira et al., 1997; Sadoni et al., 1999).  Histones 
located near the nuclear periphery are hypoacetylated and those located away from the 
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periphery are hyperacetylated (Sadoni et al., 1999).  In other words, localization to the 
nuclear periphery is associated with silenced transcription and contains histone 
modifications characteristic of silent chromatin (Reddy et al., 2008).  Although a 
correlation has been shown between association with the nuclear periphery, H4 
deacetylation, and decreased transcription (Sadoni et al., 1999; Finlan et al., 2008; 
Reddy et al., 2008), evidence pointing to a specific HDAC has not been found (Ruault et 
al., 2008).      
 Summary 
 Heterochromatin is described as a closed chromatin structure silent for 
transcription.  The previous description of telomeres in S. cerevisiae provides a classic 
example of heterochromatin.  The rDNA contradicts the classic definition of 
heterochromatin because it contains high levels of transcription by RNA Pol I and RNA 
Pol III.  Silencing of transcription at the rDNA is specific to RNA Pol II transcription 
and unlike telomeres requires only Sir2 of the SIR family proteins.  The rDNA is further 
complicated by results showing that only half of the 35S rRNA genes are actively 
transcribed in five minute intervals while to other half are silent.  This fast switching 
between active and inactive 35S rRNA genes is discussed in greater detail in Chapter II.  
Hmo1 has been shown using a technique called ChEC to specifically associate with 
actively transcribed genes only.  Our data shown in Chapter II might represent the 




STRUCTURE AND MECHANISM OF HUMAN SET DOMAIN PROTEINS 
 Post-translational modifications of histones is a field that encompasses many 
types of modifications, most commonly histone methylation, acetylation and 
ubiquitylation.  Histone methylation is a modification that has been linked to both 
euchromatin and heterochromatin regions.  In Saccharomyces cerevisiae, H3K4 
methylation is associated with high levels of histone methylation in euchromatin regions 
and low levels in heterochromatin regions.  By studying the crystal structures of Set7/9 
and MLL1, we can further our understanding of lysine methylation and pinpoint 
important residues in SET domain proteins.  Only two human H3K4 methyltransferases 
have been crystallized: Set7/9 and MLL1.  This discussion will focus on Set7/9 and 
MLL1, and later on in Chapter III their relevance to yeast Set1.  To help understand 
these comparisons, Table 2 shows the conserved amino acids discussed among these 
three proteins as well as mutants made in yeast Set1 discussed in Chapter III.  SET 
domain methyltransferases exhibit many similarities: the presence of a pseudoknot, 
conserved tyrosines and phenylalanines, and a water channel to deprotonate lysine 4 of 
histone H3.  SET domain proteins contain conserved motifs of GXG (I), YXG (II), 
RXXNHS/C (III), EELXY/FXY (IV) and CXCXXXXC (V) (Figure 5).  Each motif has 
a specific role in SET domain proteins.  GXG (I) motifs are known for their role in 
binding the cofactor S-adenosyl methionine in methyltransferase enzymes (Shields et al., 
2003).  RXXNHS/C (III) and EELXY/FXY (IV) along with YXG (II) form the active 
site within a substrate specific channel for the target lysine residue and interact with 
lysine 4 of histone H3 and SAM (Kwon et al., 2003; Xiao et al., 2003).  CXCXXXXC 
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(V) coordinates a zinc ion that aides SET domain proteins in properly folding the c-
terminus (Zhang et al., 2003; Southall et al., 2009).  Those that lack these conserved 
cysteines rely on a c-terminal α helix to properly associate with the larger protein 
structure and form the lysine substrate specific channel.   
 
Table 2. Comparison of conserved amino acids between yeast and human SET domain 
proteins. 
Set1-COMPASS Set1 mutants Set7/9 MLL1 
Saccharomyces cerevisiae Human Human 
G951 G951A G229 G3842 
Y967 Y967F/A Y245 Y3858 
I972 I972A I250 I3863 
I989 I989A L267 I3880 
Y993 Y993A E271 Y3883 
R1013 R1013H H293 R3903 
N1016 N1016A N296 N3906 
H1017 H1017A/R/L H297 H3907 
T1024 T1024Y/A Y305 Y3914 
R1042 R1042H/A R323 R3932 
E1048 E1048A E329 E3938 
E1049 E1049A/G E330 E3939 
L1050 L1050A L331 L3940 
Y1052 Y1052F/A V333 Y3942 
Y1054 Y1054F/A Y335 Y3944 
F1056 F1056Y/A Y337 F3946 
C1068 C1068A -- C3957 
C1070 C1070A -- C3959 





























































































































































































































































































 SET domain proteins contain a unique structure called a pseudoknot formed from 
one strand threading through the loop of another.  This knotted structure is characteristic 
of SET domain proteins and brings into contact two conserved motifs RXXNHS/C (III) 
and EELXY/FXY (IV) that together form the active site for the majority of all SET 
domain proteins.  This structure was first identified in Set7/9 but can also be seen in 
MLL1 as well (Jacobs et al., 2002) (Figure 6).  Structural studies of Set7/9 and MLL1 
have provided information on key amino acids and their role in interacting with 
substrates and their role in the methylation mechanism.  Set7/9 has been extensively 
studied through crystal structures combined with theoretical studies utilizing computer 
simulations to gain information on the methyltransferase mechanism at the active site.  
Computer simulations allowed researchers to use a previously crystallized structure of 
Set7/9 (Xiao et al., 2003) to simulate certain amino acid mutations and the role of water 
in the catalytic mechanism (Hu and Zhang, 2006; Wang et al., 2007b; Zhang and Bruice, 
2007; Hu et al., 2008).  From these crystal structures and computer simulations, general 





























































































































































































































































































































































































































































































































































































































































































































































Tyrosine residues control active site structure and product specificity 
Set7/9 is characterized by a substrate specific channel that runs through the 
protein, with S-adenosyl methionine (SAM) and lysine 4 of histone H3 (H3K4) 
associating through opposite sides of the protein through this channel (Kwon et al., 
2003; Xiao et al., 2003).  This substrate specific channel is lined with conserved amino 
acids that make contact with both SAM and lysine 4 and form the structure of the 
channel: Tyr245, Leu267, Tyr305, Tyr335, and Tyr337.  The hydroxyl side chains of 
Tyr245, Tyr305, and Tyr335 are directed toward the methyl group of SAM and lysine 4 
of histone H3 (Kwon et al., 2003; Xiao et al., 2003).  Figure 7 contains high resolution 
images of the crystal structure of Set7/9 showing the core amino acids that form the 
structure of the substrate specific channel (Figure 7a) along with other conserved amino 
acids present in motifs within SET domain proteins (Figure 7b,c).  Of the tyrosine 
residues listed Tyr335 is a key residue that forms the active site and its positioning is 
stabilized by His297.  His293 and His297 are conserved residues that serve a structural 
role.  In the crystal structure of Set7/9 both histidines are positioned away from the 
active site making it unlikely that these residues serve any catalytic role.  His293 and 
His297 may assist Tyr245 and Tyr335, respectively, with catalysis by properly 
positioning these tyrosine residues in the active site (Kwon et al., 2003; Xiao et al., 
2003).   
The majority of what is known about the catalytic mechanism of Set7/9 comes 
from theoretical studies using computer simulations.  These simulations have focused on 
studying Tyr245 and Tyr305, and have concentrated on the formation of a water channel 
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important in deprotonation of the amine group of lysine 4 of histone H3.  In SET domain 
proteins there is a phenomenon that exists called a phenylalanine/tyrosine switch that 
controls product specificity.  The presence of the hydroxyl group of a tyrosine residue 
blocks the rotation of methylated lysine 4 of histone H3 and prevents higher levels of 
methylation (Collins et al., 2005).  SET domain proteins are rich in tyrosine residues, 
any one of which could control product specificity.  Set7/9 is a human H3K4 
methyltransferase that is only able to add a single methyl group to lysine 4 (Wilson et 
al., 2002; Kwon et al., 2003; Xiao et al., 2003).  In Set7/9, Tyr245 and Tyr305 are 
believed to serve this function, while in other SET domain proteins other tyrosine 
residues may fulfill this role.  These two amino acids were studied by artificially 
simulating Y245A and Y305F mutants and studying the effect of these mutants through 
computer modeling (Hu and Zhang, 2006; Zhang and Bruice, 2007; Hu et al., 2008).  
These mutants were also studied by crystallizing Set7/9 with these mutations along with 
an alternative substrate TAF10 peptide to further analyze their effect on histone 
methylation (Del Rizzo et al., 2010).  These results are discussed in Appendix C.   
 Through these computer simulations Set7/9 is a mono methyltransferase only, 
due to steric hindrance by Tyr245.  Tyr245 interacts with lysine 4 of histone H3 through 
its ring.  Removing this ring by simulating the mutant Y245A through computer 
modeling removes steric hindrance within the active site and allows Set7/9 to 
trimethylate H3K4 where normally it only monomethylates (Xiao et al., 2003; Hu and 
Zhang, 2006).  This mutation formed the model that the presence of a tyrosine can 



































































































































































































































































































































































hydroxyl group on Tyr245 prevents monomethylated H3K4 from rotating and aligning 
with a new SAM molecule for further methylation (Hu and Zhang, 2006).  This 
misalignment of the amine group of lysine 4 causes a decrease in the amount of product 
produced over time (Del Rizzo et al., 2010).   
 Tyr305 is also studied for its role in product specificity.  The active site contains 
several water molecules, one of which is close to the amine group of lysine 4 of histone 
H3 and forms a hydrogen bond with Tyr305 (Kwon et al., 2003; Xiao et al., 2003; Wang 
et al., 2007b).  The mutation Y305F causes Set7/9 to mono- and dimethylate H3K4 (Hu 
et al., 2008).  With Y305F, the loss of the hydroxyl group disrupts hydrogen bonds 
within the active site, specifically with a single water molecule (Kwon et al., 2003).  
Within the active site, hydrogen bonds formed between monomethylated H3K4, Tyr245, 
and Tyr305 work together to prevent rotation of the methylated H3K4 and prevent 
further methylation (Zhang and Bruice, 2007).   
 Formation of a water channel is critical for the deprotonation of lysine 4 
 Hydrogen bonding between amino acids within the active site of Set7/9 can align 
both substrates lysine 4 of histone H3 and SAM properly for monomethylation to occur, 
along with positioning methylated lysine 4 into a suitable position for higher levels of 
methylation (Couture et al., 2006c).  As mentioned above, further methylation by 
hydrogen bonds forming between Tyr245 and Tyr305 with monomethylated lysine 4 can 
prevent the alignment of SAM for further methylation (Zhang and Bruice, 2007).  The 
role of hydrogen bonding within the active site became increasingly important by the 
discovery of a string of water molecules that hydrogen bond within the active site, 
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termed a water channel (Zhang and Bruice, 2007).  The formation of this water channel 
is critical for the deprotonation of the amine group of lysine 4 of histone H3 to occur, the 
first step in the mechanism for methylation of H3K4.  Through computer simulations 
with Set7/9, Y245A and Y305F allow an additional water channel to form following 
monomethylation of H3K4 by disrupting the structure of the active site and/or by 
disrupting the strict hydrogen bonds formed within the active site.  This additional water 
channel allows further methylation of H3K4 to occur (Zhang and Bruice, 2007; Hu et 
al., 2008; Zhang and Bruice, 2008a).   
 The mechanism of Set7/9 relies on the formation of a water channel to 
deprotonate the amine group of lysine 4 of histone H3 through an SN2 reaction (Dirk et 
al., 2007; Zhang and Bruice, 2007) (Figure 8).  The water channel functions as a proton 
acceptor from the amine group of lysine 4 to allow deprotonation of lysine 4.  A 
conflicting model has been proposed that Tyr335 acts as a base to deprotonate the amine 
group of lysine 4 of histone H3 (Guo and Guo, 2007).  Using computer simulations, the 
pKa of amino acids within the active site can be calculated in different environments.  
When Set7/9 is bound with SAM, the pKa of the amine group of lysine 4 is 8.5, meaning 
that when both substrates are bound deprotonation can occur.  However, the pKa of 
Tyr335 in Set7/9 with both bound substrates is 18.7, making it unlikely to function as a 
base to deprotonate lysine 4 (Zhang and Bruice, 2007).  Once deprotonation occurs the 
reaction follows through to methylate H3K4.  Binding of lysine 4 of histone H3 or SAM 
is either a random or ordered event, but once bound deprotonation of lysine 4 occurs 





Figure 8.  SN2 reaction catalyzed by SET domain proteins
2
.  Water molecules within 
the active site function to deprotonate lysine 4 and allow a nucleophilic attack of a 




                                                 
2
 Reprinted with permission from “Chemical mechanisms of histone lysine and arginine modifications” by 
Brian C. Smith and John M. Denu, (2009), Biochim Biophys Acta, 1789, 45-57, Copyright 2009 by 
Elsevier.  
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The model for SET domain proteins is that monomethylation is distributive while di- and 
trimethylation are successive.  Unmodified H3K4 is methylated and released as 
monomethylated H3K4, suggesting a distributive model shown through the 
accumulation of monomethylated H3K4 throughout the course of an assay.  Di- and 
trimethylation are successive; there is no accumulation of an intermediate suggesting 
that monomethylated H3K4 is carried straight on to trimethylated H3K4 without being 
released (Dirk et al., 2007). 
 MLL1 is a superior model for understanding yeast Set1  
 MLL1 has also been studied structurally and is a better model for understanding 
yeast COMPASS than Set7/9 for two reasons.  First, MLL1 forms a complex with 
subunits homologous to COMPASS unlike Set7/9 that functions as a monomer.  
Secondly, MLL1 retains key residues found in yeast COMPASS that are not conserved 
in Set7/9 such as Tyr3883, Tyr3942, and three conserved cysteines within motif V 
CXCXXXXC (Table 2).  An important point about the crystal structure of MLL1 is that 
it is crystallized on its own without additional complex members.  Because of this, 
proper folding or positioning of amino acids must be taken with a degree of uncertainty.  
For instance, there are great differences in the positioning of key active site residues 
between Set7/9 (Figure 7) and MLL1 (Figure 9).  Tyr305 in Set7/9 is conserved as 
Tyr3914 in MLL1, and these residues are positioned in complete opposite directions in 
the structures of these two methyltransferases.  His293 is thought to help properly 
























































































































































































































































































































































































Tyr3858 does not seem to be in close proximity to Arg3903 suggesting that this arginine 
serves no role in positioning Tyr3858.  
The crystal structure of Set7/9 (Figure 7) shows a closed, substrate specific 
channel.  However, the crystal structure of MLL1 shows an open channel that allows 
flexibility in the positioning of the histone H3 tail (Figure 9), but this open channel is 
thought to close upon binding of additional MLL1 complex members and shift the 
histone H3 tail into a single position that is found in other SET domain proteins 
(Southall et al., 2009).  The c-terminus of MLL1 contains motif V CXCXXXXC 
coordinates a zinc ion that assists in properly folding and forming a substrate specific 
channel for histone H3.  The zinc ion is positioned by four cysteines; the three shown in 
Figure 9c along with a fourth cysteine Cys3909 within motif III RXXNHS/C that 
involves the c-terminus in the formation of the substrate specific channel (Southall et al., 
2009).   
 Without additional complex members bound, MLL1 alone is a 
monomethyltransferase that utilizes positioning of Tyr3942, which is not conserved in 
Set7/9, to prevent di- and trimethylation (Patel et al., 2009).  However, when bound with 
additional factors such as RBBP5, WDR5, and Ash2L, MLL1 is able to dimethylate 
H3K4.  This contrasts with in vivo data that shows MLL1 mono-, di-, and trimethylates 
H3K4.  Again, not all subunits of the MLL1 complex were included in these in vitro 
studies, and association additional factors may further alter the conformation of MLL1 
and allow trimethylation (Patel et al., 2009).  In MLL1 Tyr3942 is considered the 
Phe/Tyr switch for this protein, and a Y3942F mutant in an in vitro system with MLL1, 
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RBBP5, WDR5, and Ash2L is able to trimethylate H3K4 (Patel et al., 2009).  The main 
active site resides are Phe3885, Tyr3942, Tyr3944, and Phe3946 (Figure 9).  The 
substrate specific channel within MLL1 contains hydrogen bonds between Asn3906 and 
His3907 to the adenine ring of SAM and Tyr3883.  Tyr3883 and Phe3885 are part of a 
YXF motif that has not been previously characterized.  The orientation of Tyr3942 
depends upon whether or not MLL1 binds a histone H3 peptide (Figure 9).  Upon 
binding of a histone H3 peptide, the position of Tyr3942 orients and points towards 
Tyr3858; otherwise, Tyr3942 is positioned ~90° away pointing towards Tyr3914.  The 
orientation of Tyr3942 shown in Figure 9 is the position it obtains when bound with a 
histone H3 peptide (Southall et al., 2009).     
 
DISSERTATION OVERVIEW AND SIGNIFICANCE 
The scope of my research attempts to understand how histone methylation and 
chromatin structure affect gene silencing at the ribosomal DNA locus in Saccharomyces 
cerevisiae.  Chapter II of this dissertation analyzes the chromatin structure of the NTS2 
region within individual rDNA repeats by expressing a DNA methyltransferase M.CviPI 
in vivo, followed by bisulfite deamination, and cloning areas of interest.  By expressing 
M.CviPI in vivo, we are able to study chromatin structure at the rDNA and visualize 
differences in chromatin structure between active and inactive repeats through 
differences in nucleosome positioning in NTS2.  Actively transcribed repeats with an 
open chromatin structure would obtain high levels of methylation from M.CviPI, while 
inactive repeats with a closed chromatin structure would obtain low levels of 
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methylation.  We based our experiments on the assumption that rDNA repeats that are 
actively transcribed remain in that state for the duration of a single cell cycle.  Two 
approaches were taken in analyzing the chromatin structure of individual rDNA repeats.  
First, we focused on comparing wild type cells with cells lacking Sir2, searching for 
changes in nucleosome positioning similar to previously published results from out lab 
using MNase accessibility: downstream of nucleosome 1, between nucleosome 2 and 3, 
and upstream of nucleosome 5 (Li et al., 2006a).  Secondly, we attempted to 
differentiate repeats that are actively transcribed by RNA Pol I from repeats that are 
silent through nucleosome positioning within NTS2.  Using this technique, we hope to 
create a new way of analyzing open and closed repeats at the rDNA and to better 
understand differences between euchromatin and heterochromatin.   
Chapter III of this dissertation describes a mutagenesis of yeast Set1.  Human 
H3K4 methyltransferases are a complex group in a complex system, with roles in many 
types of cancers and diseases.  Studying Set1 in yeast provides a simpler system without 
sacrificing the relevance to higher eukaryotes.  Mutants of Set1 were chosen by using a 
sequence alignment of other SET domain proteins, by studying the crystal structures of 
Set7/9, and through a random mutagenesis of the catalytic SET domain.  Conserved 
tyrosine residues play a role in the majority of SET domain proteins, as well as motifs 
RXXNHS/C and EELXY/FXY that together form the active site of the majority of SET 
domain proteins.  Mutants of Set1 were analyzed for their effect on silencing of a RNA 
Pol II-transcribed gene within the rDNA locus through northern analysis, histone 
methylation through quantitative Westerns, suppression of ipl1-2 by plate assay, 
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association with COMPASS through TAP tag purifications, and an in vitro activity assay 
with full length H3 by Western analysis.  This analysis of yeast Set1 mutants will 
increase our understanding of the importance of certain residues in the H3K4 
methylation and cellular function of yeast Set1 and provide insight into Set1-like 





ANALYSIS OF CHROMATIN STRUCTURE AT NTS2 WITHIN INDIVIDUAL 
RDNA REPEATS USING IN VIVO EXPRESSION OF M.CviPI 
 
 The chromatin structure of the rDNA has been mapped by two ex vivo 
techniques: psoralen crosslinking and MNase accessibility.  Both of these techniques 
provide results from a population of cells, each with a population of repeats.  In order to 
understand the chromatin structure within individual repeats, the DNA methyltransferase 
M.CviPI was expressed in vivo, followed by bisulfite deamination, and cloning of the 
NTS2 region into plasmids.  We have used this technique to study changes in 
nucleosome positioning as a result of a silencing defect caused by the loss of Sir2, and as 
an indicator of active transcription by RNA Pol I.  Using this technique we can 
differentiate between open and closed chromatin structure by changes in nucleosome 
positions within NTS2 and by the presence of bound factors at the 35S rRNA gene 
promoter.  From our results we see changes in nucleosome positions by comparing wild 
type and sir2Δ cells in S288c and W303 strain backgrounds, specifically in nucleosomes 
5, 4, and 3.  In addition, we used a 25 copy rDNA strain to compare an rDNA array that 
is all actively transcribed by RNA Pol I with a wild type strain containing an rDNA 
array with half of the repeats actively transcribed and the other half silent.  From these 
experiments we show reduced GpC accessibility suggesting the presence of a bound 




In Saccharomyces cerevisiae the ribosomal DNA (rDNA) locus is ~1-2 Mb 
tandem array comprised of ~150 to 200 copies of a 9.1 kb repeat on chromosome XII 
(Petes et al., 1978a; Petes, 1979).  A single rDNA repeat consists of two transcribed 
regions, the 35S rRNA gene transcribed by RNA Pol I and the 5S rRNA gene 
transcribed by RNA Pol III.  Two nontranscribed spacer regions NTS1 and NTS2 
surround the 5S rRNA gene (Figure 2a) (Skryabin et al., 1984).  RNA Pol I binds the 
35S rRNA gene promoter that is formed from an upstream element that stretches from  
-155 to -60 and a core promoter that stretches from -38 to +5 (Musters et al., 1989; 
Kulkens et al., 1991; Choe et al., 1992) (Figure 2c).  The transcriptional machinery of 
RNA Pol I consists of Upstream Activation Factor (UAF) (Keys et al., 1996; Siddiqi et 
al., 2001b) with histones H3 and H4 (Keener et al., 1997), Core Factor (CF) (Keys et al., 
1994; Lalo et al., 1996; Lin et al., 1996), Rrn3 (Yamamoto et al., 1996; Milkereit and 
Tschochner, 1998), and the TATA-binding protein (TBP) (Steffan et al., 1996)(Figure 
2c).  RNA Pol I utilizes these proteins to form an initiating complex at the 35S rRNA 
gene promoter.   
The promoter contains poised transcriptional machinery that will allow the cell to 
respond rapidly to a demand for increased ribosome synthesis (Figure 2c).  UAF binds to 
the upstream element to begin assembly of the RNA Pol I initiating complex.  Next, core 
factor and a RNA Pol I-Rrn3 complex are recruited to the promoter.  This recruitment 
requires TBP and is dependent upon UAF bound to the upstream element (Aprikian et 
al., 2001).  Once the pre-initiation complex is formed transcription begins and enters 
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elongation, TBP, CF, and UAF remain bound to the promoter while RNA Pol I 
transcribes the 35S rRNA gene (Aprikian et al., 2001; Bier et al., 2004).  Rrn3 
dissociates from RNA Pol I during elongation, returning to initiate transcription at the 
35S rRNA gene promoter by binding RNA Pol I and bridging the interaction between 
RNA Pol I and CF (Yamamoto et al., 1996; Milkereit and Tschochner, 1998; Peyroche 
et al., 2000).      
Within the rDNA, individual rDNA repeats can exist in two states, either actively 
transcribed by RNA Pol I with an open chromatin structure characterized by a lack of 
nucleosomes, or as inactive repeats not transcribed by RNA Pol I with a closed 
chromatin structure that contains strictly positioned nucleosomes (Dammann et al., 
1993, 1995).  Active and inactive rDNA repeats have been distinguished using psoralen 
crosslinking to show that at any one time in an actively dividing cell, approximately half 
of the 35S rRNA genes are actively transcribed and the other half are silent.  Evidence 
suggests that the transcription state of a 35S rRNA gene is not maintained or inherited 
from one cell cycle to the next (Dammann et al., 1995; Lucchini and Sogo, 1995).  
Footprinting assays showed the localization of five well-positioned nucleosomes within 
NTS2 (Vogelauer et al., 1998) (Figure 2b).  Our lab and others have used micrococcal 
nuclease (MNase) mapping experiments to compare the positions of nucleosomes in the 
NTS2 region of the rDNA repeats in wild type cells and in cells with a silencing defect 
caused by deletion of SIR2 (Fritze et al., 1997; Cioci et al., 2002; Li et al., 2006a).  In 
these studies, changes in positions of nucleosomes in NTS2 were observed in cells 
lacking the Sir2 protein, a histone deacetylase that is required for silencing of RNA Pol 
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II transcription (Bryk et al., 1997; Smith and Boeke, 1997) and homologous 
recombination at the rDNA (Gottlieb and Esposito, 1989).  These previous MNase 
mapping studies within repeated sequences like the rDNA provide the average position 
of each nucleosome in all of the rDNA repeats.  In my research, I sought to determine if 
a new technique can be utilized to evaluate the accessibility in a single rDNA repeat.  
To study the chromatin structure at the single molecule level in the rDNA, a 41 
kDa DNA methyltransferase M.CviPI is expressed within yeast cells from an estrogen-
inducible promoter (Jessen et al., 2004; Hoose and Kladde, 2006).  M.CviPI originates 
from a virus that infects Chlorella-like algae, and recognizes GpC sites, methylating the 
cytosine residue at the C5 position (Xu et al., 1998) (Figure 3c).  In chromatin, the 
methylation of cytosine residues by M.CviPI occurs at GpC sites that are located in 
accessible regions of the genome.  Cytosine residues within inaccessible regions of 
chromatin remain unmethylated (Xu et al., 1998).  After purifying genomic DNA, a 
chemical treatment called bisulfite deamination converts unmethylated cytosines to 
uracil (Shapiro and Weisgras, 1970; Shapiro et al., 1973; Shapiro et al., 1974) while 
methylated cytosines remain unchanged, acting as a mark of open, accessible chromatin.  
After treatment, regions of interest are amplified, cloned into a plasmid and transformed 
into bacterial cells.  Single clones are sequenced and analyzed to distinguish regions of 
accessible chromatin by GpC sites that retain cytosine from regions of inaccessible 
chromatin where GpC sites are converted to GT (Jessen et al., 2004; Hoose and Kladde, 
2006).  Previously published results have shown the value of this single molecule 
technique in studying changes in positioned nucleosomes from the PHO5 locus in yeast 
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cells (Pardo et al., 2009).  Using this technique, I analyzed the chromatin structure of 
individual rDNA repeats to differentiate between open chromatin structures with high 
levels of GpC methylation from closed chromatin structure with low levels of GpC 
methylation.   
In this study, we used in vivo expression of M.CviPI to examine changes in 
chromatin structure at the rDNA NTS2 region due to a silencing defect caused by 
deletion of SIR2 and due to RNA Pol I transcription.  In wild type cells (MBY1944), we 
detected high levels of accessibility in three regions: between nucleosome 2 and 3 at the 
three conserved ARS regions, at a highly methylated region (blue box), and at +4 and 
+10 within the 35S rRNA gene (Figure 2b).  We observed changes in positioning of 
nucleosome 5, 4, and 3 in NTS2 in sir2Δ cells and in cells with a shortened rDNA array 
(25 rDNA repeats), leading to increased accessibility and GpC methylation.  In the 25 
copy rDNA array where all 35S rRNA genes are actively transcribed by RNA Pol I, we 
detected reduced GpC site accessibility suggesting the presence of a bound factor within 
the upstream element of the 35S rRNA gene promoter.  Taken together, our results shed 
light on how the chromatin structure of NTS2 within the rDNA changes in response to 





METHODS AND MATERIALS 
Yeast media and strains 
Standard yeast media used in these experiments are described elsewhere (Rose, 
1990).  YPAD consists of YPD media with 40 mg/l of adenine sulfate.  All 
Saccharomyces cerevisiae strains are listed in Table 3.  Both S288c and W303 yeast 
strain backgrounds were utilized in this study.  Plasmid pSH1052 (aka pSH006a), 
containing the GpC methyltransferase M.CviPI (Xu et al., 1998; Jessen et al., 2004), as 
well as strains MBY1944 (SHY1860) and its parent strain MBY2076 (Y880/CCY113a) 
are described elsewhere (Hoose and Kladde, 2006).  MBY2076 was used to create 
MBY2203 by using PCR-mediated gene disruption with a sir2Δ::KANMX fragment 
forming MBY2188, followed by integration of pSH1052 to form MBY2203. 
The yeast strain MBY2078 (NOY408-1b MATa ade2-1 ura3-1 his3-11 trp1-1 
leu2-3,112 can1-100) is described elsewhere (Nogi et al., 1991b).  PCR-mediated gene 
disruption was used to introduce lys2Δ::KANMX4 into strain MBY2078 to create 
MBY2276, and integration of pSH1052 into MBY2276 generated MBY2291.  The yeast 
strain NOY1071 (MATa ade2-1 ura3-1 trp1-1 leu2-3, 112 his3-11 can1-100 
fob1Δ::HIS3 ~25 rDNA copies) is described elsewhere (Cioci et al., 2003).  MBY2279 
was formed by PCR-mediated gene disruption with lys2Δ::KANMX4, followed by 
integration of pSH1052 into MBY2279 to form MBY2293.  PCR-mediated gene 




Table 3. S. cerevisiae strains used in this M.CviPI study. 
Name Background Genotype 
MBY1944 S288c MATa leu2Δ0 lys2Δ0 ura3Δ0 pho3Δ::Rho::pSH006a 
(ho/L-lexO.pGAL1M.CviPI.ADH1term - LYS2-pADH1-
LexADBD.ERHBD.VP16AD.ADH1term-hoR) 
MBY2076 S288c MATa leu2Δ0 lys2Δ0 ura3Δ0 pho3Δ::R 
 
MBY2078 W303 MATa ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112 can1-100 
MBY2188 S288c MATa leu2Δ0 lys2Δ0 ura3Δ0 pho3Δ::R sir2Δ::KANMX4 
#1 
MBY2203 S288c MATa leu2Δ0 lys2Δ0 ura3Δ0 pho3Δ::R sir2Δ::KANMX4 
HO::pSH1052 (ho/L-lexO.pGAL1-M.CviPI-ADH1term – 
LYS2-pADH1-LexADBD-ERHBD-VP16AD-ADH1term-hoR 
MBY2276 W303 MATa ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112 can1-100 
lys2Δ::KANMX4 #2 
MBY2279 W303 MATa ade2-1 ura3-1 trp1-1 leu2-3, 112 his3-11 can1-100 
fob1Δ::HIS3 lys2Δ::KANMX4  ~25 rDNA copies 
MBY2291 W303 MATa ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112 can1-100 
lys2 Δ::KANMX4 #2 ho::pSH1052 (ho/L-lexO. 
GAL1M.CviPI.ADH1term-LYS2-pADH1-
LexADBD.ERHBD.VP16AD.ADH1term-hoR)  
MBY2293 W303 MATa ade2-1 ura3-1 trp1-1 leu2-3, 112 his3-11 can1-100 
fob1Δ::HIS3 lys2Δ::KANMX4 ho::pSH1052 (ho/L-lexO. 
pGAL1M.CviPI.ADH1term-LYS2-pADH1-
LexADBD.ERHBD.VP16AD.ADH1term-hoR) ~25 rDNA copies  
MBY2321 W303 MATa ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112 can1-100 





Isolation of yeast genomic DNA and bisulfite deamination 
 Isolation of yeast genomic DNA and bisulfite deamination was carried out as 
described elsewhere (Jessen et al., 2004; Hoose and Kladde, 2006).  For all PCR 
amplifications using deaminated DNA as a template reaction conditions were optimized, 
including the annealing temperature against untreated genomic DNA, and carried out as 
discussed elsewhere (Warnecke et al., 2002; Shen et al., 2007).  Oligonucleotides 
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OM773 and OM774 (Table 4) were used to amplify a ~1,300 bp fragment from NTS2.  
PCR reactions were extracted with phenol:chloroform:isoamyl alcohol (25:24:1), 
precipitated in ethanol, resuspended in water, digested with BamHI and PstI and then 
ligated into similarly cut pBluescript plasmid (pBST).  Ligations were transformed into 
chemically competent XL-1 Blue cells, and grown for a maximum of 30 min at 37°C in 
Luria broth to prevent duplication of individual bacterial clones.  Transformations were 
plated onto Luria broth/agarose plates containing 50 mg/L ampicillin, with a final 
concentration of 0.25 mM IPTG and 0.05 mg/ml X-Gal (Zymo Research) for blue/white 
screening.  Individual colonies were screened for single ligation events by PCR with 
oligonucleotide primers OM781 and OM782 (Table 4) in order to verify that each 
plasmid contained one NTS2 fragment.  Cultures from verified clones were stored at -
70°C in 96-well deep dishes in 25% glycerol.  
Sequencing and data analysis 
 Initial results were obtained using dideoxy sequencing with the SequiTherm 
Cycle Sequencing Kit using dideoxy CTP (Epicenter Biotechnologies, Madison, WI).  A 
20 µL colony PCR reaction was used to amplify each NTS2 fragment separately.  
Reactions were treated with ExoSAP-IT (USB Corporation, Cleveland, OH) to remove 
unincorporated primers and nucleotides from PCR reactions leaving only the amplified 
DNA.  Sequencing primers (OM448, OM781, OM782, OM807, OM808, OM810, and 
OM816) were labeled with γ-32P-ATP using T4 Polynucleotide Kinase as described by 
the SequiTherm Cycle Sequencing Kit protocol (Table 4).  In order for the sequencing 
reaction to proceed, the concentration of dGTP was increased to a final concentration of 
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4uM.  Reactions were carried out as described by the SequiTherm Cycle Sequencing Kit 
with dideoxy CTP (Epicenter Biotechnologies, Madison, WI) and were separated by gel 
electrophoresis as described elsewhere (Hoose and Kladde, 2006).  Additional data were 
collected by sending 96-well plates of individual E. coli clones in 8% glycerol for 
sequencing by the University of Florida Interdisciplinary Center for Biotechnology 
Research (ICBR).  Sequences obtained from ICBR were assessed for quality of 
sequencing and for percent deamination of all lone cytosines, maintaining no less than 
97% complete deamination for each clone (Figure 3c).   
Data were generated from the NTS2 region of the rDNA from both S288c and 
W303 S. cerevisiae strain backgrounds (Table 5).  The number of clones produced 
indicates the number of NTS2 fragments cloned into the pBST vector, sequenced, and 
analyzed.  Following sequencing, the DNA sequences were aligned against a wild type 
strand for ease of identifying GpC sites.  Alignments were made using the ClustalW 
program from European Bioinformatics Institute (EBI) (Larkin et al., 2007).  Microsoft 
Excel was used to calculate percent methylation at each possible GpC methylation site.  
If a site is methylated, the result was recorded as „1‟ while an unmethylated site where 

























MBY1944 WT S288c 30 min 7 
  60 min 27 
  90 min 19 
  120 min 144 
MBY2203 sir2Δ S288c 120 min 111 
MBY2293 25 copy array W303 120 min 119 
MBY2291 WT W303 60 min 114 
  90 min NA 
  120 min 101 
MBY2321 sir2Δ W303 60 min 100 
  90 min NA 
  120 min NA 








RESULTS AND DISCUSSION  
Two approaches were taken to analyze the chromatin structure of individual 
rDNA repeats.  Strains were analyzed for changes in nucleosome positioning due to a 
silencing defect by the loss of Sir2 and due to RNA Pol I transcription.  Results were 
evaluated in two ways, through plotting the percent methylation of each GpC site within 
NTS2 to visualize the level of methylation between sites and to visualize nucleosome 
positioning, and, secondly, by using a correlation analysis.  This correlation analysis is a 
statistical method that was used to assess how closely related two sites within a single 
repeat are to each other with respect to GpC methylation (Figure 10).  In these analyses, 
green refers to anti-correlation, or when one site is methylated the other is not; black 
indicates no correlation, meaning there is a lack of sufficient variation to provide a 
statistically significant result; while red indicates a positive correlation, meaning either 
both sites are methylated or both sites are not methylated.  Thus, red represents either 
open or closed chromatin and can be used to visually represent a change in 
methyltransferase accessibility, i.e. a change in nucleosome positioning or a change in 
association of a DNA binding factor.  The correlation analyses were performed by Hugh 
Patterton of the Department of Microbial, Biochemical, and Food Biotechnology, at the 
University of the Free State, South Africa.  
In vitro methylation experiment for site specificity of M.CviPI  
An initial control experiment was performed to determine if M.CviPI had any 




Figure 10. Description of graphical representation of the correlation analyses.  Above is an example 
of the scale of colors produced in these analyses.  Green represents anti-correlation, or when one GpC site 
is methylated the other GpC site is not.  Black represents no correlation resulting from a lack of data in 
this region.  In black regions there is not enough data to produce a statistical result.  Red represents 
positive correlation, or when both sites are in agreement.  Both are either methylated (and accessible in 
open chromatin regions) or both are unmethylated (and inaccessible in closed chromatin regions).  Thus, 
red can represent changes in in chromatin structure when comparing two different data sets, for example 
wild type and sir2Δ.  Below is a mock representation of the correlation analyses showing an analysis of 
five GpC sites.  On the X and Y axis the sites are aligned for comparison.  A black diagonal line forms in 
the correlation analysis from comparing a site to itself.     
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would be skewed toward these sites.  Purified naked genomic DNA from the S288c 
yeast strain MBY1944 was treated in vitro with 0.5U of purified M.CviPI.  DNA was 
processed and cloned as described in the methods.  Thirty-two clones were sequenced to 
determine if M.CviPI favored certain GpC sites in the NTS2 region of the rDNA repeat.  
Figure 11 shows an almost even level of percent methylation across the NTS2 region, 
with values ranging between ~15-30%.  In this and subsequent graphs, the percent of 
methylation for each possible GpC site to the total number of clones was calculated.  
These graphs convert single molecule data into average accessibility data like that 
obtained with MNase experiments in order to give a simple representation of the data 
and to easily visualize positioned nucleosomes to scale within NTS2.  Methylation peaks 
at GpC site -725 but subsequent experiments showed that site -725 is not overly favored 
by M.CviPI perhaps because it is occluded from M.CviPI by nucleosome 3.  In addition, 
the graph does not show protection patterns that would be expected if the DNA was 
contaminated with positioned nucleosomes meaning that the DNA was truly „naked‟ and 
thus there was no interference from DNA bound factors.  To further analyze these 
results, a correlation analysis was performed (Figure 12).  There seems to be two regions 
that differ in the intensity of the correlation within NTS2; however, this is likely due to 
the two separate sequencing reactions that were needed to span the NTS2 region in each 
clone.  With that in mind, the correlation analysis on the naked DNA samples shows a 
relatively even accessibility between all sites, indicating that M.CviPI has little to no site 




Figure 11. In vitro methylation of naked DNA from S288c background MBY1944 treated with 0.5U 
of M.CviPI.  In vitro methylation was performed to determine site specificity of M.CviPI in NTS2 on 
naked DNA.  Total percent methylation out of the total number of sites available was calculated.  (Top) 
This graph shows nucleosome positioning and GpC sites to scale.  The five positioned nucleosomes shown 
as numbered circles outlined in black are based upon MNase mapping (Vogelauer et al., 1998; Li et al., 
2006a).  Circles outlined in red show nucleosome positioning from M.CviPI accessibility.  Each GpC is 
numbered on the x-axis relative to the transcriptional start site (+1) of the 35S rRNA gene.  The 5S and 
35S rRNA genes are indicated with arrows and white boxes to the left and right, respectively.  Yellow 
boxes represent conserved ARS sequences 1, 2, and 3.  A blue box represents a highly methylated region.  





Figure 12. Correlation analysis of in vitro methylation of naked DNA from S288c background 
MBY1944 treated with 0.5U of M.CviPI.  On the X and Y axis lie the 5‟-GpC-3‟ sites within the NTS2 
region.  A red box and green box represent the 5S and 35S rRNA genes, respectively.  A yellow circle 
encompasses the conserved ARS sequences.  A blue box represents the highly methylated region.  Note 
that the image is not to scale.  In these analyses, green refers to anti-correlation, or when one site is 
methylated the other is not; black indicates no correlation, meaning there is a lack of sufficient variation to 
provide a statistically significant result; while red indicates a positive correlation, meaning either both sites 
are methylated or both sites are not methylated.  Black and red lines above the representation of the NTS2 
region represent the GpC sites where nucleosomes 1-5 lie within NTS2.  Black represents the nucleosome 
positions from previous data (Li et al., 2006a) while red lines represent nucleosome positioning from the 




Time course of M.CviPI induction in S288c yeast strain MBY1944 
 Initial experiments focused on optimizing the induction time of M.CviPI.  
Inducing for too short or too long of a time may result in under or over methylation of 
the DNA, respectively.  A time course of 30, 60, 90, and 120 minutes was performed 
using a wild type S288c yeast strain MBY1944 (Figure 13).  From this induction trial, 
120 minutes was deemed optimal for DNA methylation.  The 30 and 60 minute 
induction of M.CviPI DNA methylation was too short to obtain complete data on all 
positioned nucleosomes.  This is evident when looking at the correlation analysis in 
Figure 14.  In these experiments only a short region of NTS2 was analyzed.  For the 30, 
60, and 90 minute correlation analyses there is insufficient variation to provide 
statistically significant correlation, i.e. the copious amount of black regions.  Only in the 
clones from the 120-minute induction do we see clear positioning of all five 
nucleosomes (Figure 13) and a finer scale of correlation between sites (Figure 14).   
When choosing a technique to study nucleosome positioning, the size of the 
probe can affect the accuracy of how well the location of DNA-bound factors associated 
with chromatin is mapped.  Smaller probes are able to get closer to DNA-bound factors 
than probes that are larger; therefore, smaller probes have the potential to provide a 
higher resolution map.  M.CviPI is a 41 kDa protein while MNase is 17 kDa and 
psoralen is the smallest with a three-ringed furocoumarin structure with the molecular 
formula C11H6O3.  Of the three, M.CviPI is the largest and admittedly not the best probe 
in terms of size; however, with each probe there are pros and cons.  By expressing 
M.CviPI in vivo, it can be utilized for single molecule accessibility to study chromatin 
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structure within a living cell, while both MNase and psoralen are ex vivo probes that 
provide average accessibility data.  From our experiments with M.CviPI, we see 
differences in positioned nucleosomes in NTS2 similar to previously published results 
obtained using MNase (Li et al., 2006a).  In Figure 13, nucleosomes outlined in black 
represent the previously published MNase mapping data, while nucleosomes outlined in 
red represent approximate positions determined from the data generated with M.CviPI.  
The differences in the positions are likely due to the size of the probe.  These data do not 
disprove previous positioning data (Vogelauer et al., 1998; Li et al., 2006a).  These 
differences are simply a caveat of using M.CviPI.  The data presented here are also 
relevant and conclusions can be made about changes in nucleosome positioning and 
open/inactive repeats by analysis of single molecules.   
 Recent experiments using FISH have theorized that during an entire cell cycle a 
single repeat in a single cell is active for five minutes before turning off and that during 
that one cycle every repeat will eventually switch on (Tan and van Oudenaarden, 2010).  
Our experiments were based on the idea that an actively transcribed repeat remains in an 
active state throughout the cell cycle.  Using our technique, a 5-minute induction time 
would be too short to produce enough methylation in NTS2.  The induction times of 60 
and 120 minutes of M.CviPI are necessary for this technique based on the correlation 







Figure 13. Percent methylation in time course induction of M.CviPI in S288c yeast strain MBY1944.  
An induction of M.CviPI with estrogen for 30, 60, 90, and 120 minutes is shown with the total number of 






































































































Methylation in wild type and sir2Δ S288c strains after 120 min induction  
 Our lab previously showed changes in nucleosome positioning within NTS2 by 
performing MNase mapping experiments in cells with a silencing defect due to deletion 
of SIR2 (Li et al., 2006a).  In cells lacking Sir2, increased MNase accessibility was seen 
between each nucleosome at linker regions downstream of nucleosome 1, between 
nucleosome 2 and 3 representing the ARS region, and upstream of nucleosome 5 (Cioci 
et al., 2002; Li et al., 2006a).  We sought to utilize expression of M.CviPI in vivo for 
single molecule analysis of nucleosome positioning in wild type and sir2Δ cells.  Using 
this single molecule approach we hoped to discover new characteristics of the chromatin 
structure within NTS2 that could not be seen with MNase, in addition to visualizing 
results similar to what has been previously observed using MNase.  The classic way of 
presenting single-molecule methylation data is with a dot diagram (Figure 15).  A dot 
diagram was created with a random selection of 50 NTS2 clones from S288c wild type 
yeast cells (MBY1944) after a 120-minute induction of M.CviPI.  In dot diagrams, black 
dots represent a GpC site that was methylated by M.CviPI while white dots represent a 
GpC site that was not methylated by M.CviPI.  We observed three regions with high 
levels of accessibility in wild type cells: at -668 and -667 between nucleosome 2 and 3 
near ARS1 and ARS2 conserved sequences, downstream of nucleosome 1 at a region 
designated by a blue box, and within +4 and +10 of the 35S rRNA gene.  These data 
from wild type cells are compared to sir2Δ data in Figure 16, revealing few differences 



























































































































































































































































Figure 16. Percent methylation in wild type (MBY1944) and sir2Δ (MBY2203) in S288c background 
after 120 minute induction.  The total number of clones are listed at the top right of the figure.  Refer to 
Figure 11 for a description of this figure.   
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In the correlation analysis for these data, there is an overall increase in 
positive/red correlation suggesting a change in chromatin structure has occurred in sir2Δ 
cells (Figure 17).  Remember that this correlation analysis is a statistical method that 
assesses how closely related two sites within a single repeat are to each other with 
respect to GpC methylation.  Positive/red correlation can indicate that either both sites 
are methylated or both sites are not methylated, meaning either open (accessible) or 
closed (inaccessible) sites.  This can be interpreted as a change in the positioning of a 
DNA bound factor.  In comparing the region of nucleosome 5 and 4 between wild type 
and sir2Δ data, we see a region of negative/black correlation in wild type cells is 
changed to positive/red correlation in sir2Δ cells.  This suggests that in sir2Δ cells there 
is an increase in accessibility to M.CviPI and thus a change in the positions of these 
nucleosomes.  Differences are also seen within the highly methylated region, though no 
factor is known to bind in this region.  Also, changes can be seen within the 35S rRNA 
gene promoter region at GpC site -106, an area within the upstream element (Figure 2c).  
We expected to see differences in accessibility within the ARS region.  In cells lacking 
Sir2 there is an increase in DNA replication and ARS firing at the rDNA locus (Pasero et 
al., 2002), but from this analysis we cannot detect any obvious changes in 
methyltransferase accessibility in sir2Δ cells.  It could be that increased origin activity in 
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 Methylation of wild type and sir2Δ in W303 strains after 60 min induction 
 M.CviPI was induced in wild type (MBY2291) and sir2Δ (MBY2321) W303 
strains for 60 minutes.  As discussed above, a 60-minute induction time was not optimal; 
however, with a decreased induction time we aimed to obtain a clearer correlation 
analysis.  When graphed, our ability to visualize positioned nucleosomes is decreased, 
but we can see changes between wild type and sir2Δ cells (Figure 18).  Downstream of 
nucleosome 1 there are clear changes in percent methylation between wild type and 
sir2Δ cells within the highly methylated region.  We see the opposite of what is 
expected, with decreased accessibility (decreased methylation) in sir2Δ cells compared 
to wild type.   
Changes in nucleosome positioning can be seen clearly in the correlation analysis 
(Figure 19).  The correlation graph from the wild type clones clearly shows 
negative/black correlation at regions within nucleosome 5, 4, and 3.  In sir2Δ clones, 
positions of nucleosome 5, 4, and 3 have shifted.  There is an increase in negative/black 
correlation around the region of nucleosome 5 and 4, and nucleosome 3 has shifted 
downstream.  These nucleosomes occupy a larger area in sir2Δ cells, suggesting less 
well defined nucleosome positioning.  In addition, analysis of the wild type clones 
revealed a large amount of positive/red correlation at the highly methylated region and 
the 35S rRNA gene promoter region, which is decreased in sir2Δ cells to an overall 
negative/green correlation.  Differences in these regions are visible in the percent 





Figure 18. Percent methylation in wild type (MBY2291) and sir2Δ (MBY2321) in W303 background 
after 60 minute induction.  The total number of clones are listed at the top right of the figure.  Refer to 
























































































































wild type and sir2 cells to M.CviPI indicate a change in chromatin structure at the 
highly methylated region and the 35S rRNA gene promoter region. 
 By combining a graph of percent methylation and correlation analysis we detect 
changes in nucleosome positioning in sir2Δ cells similar to previously published data 
obtained using MNase (Cioci et al., 2002; Li et al., 2006a).  Overall, nucleosomes 5, 4, 
and 3 exhibit changes in positioning in sir2Δ cells, characterized by an increase in 
black/negative correlation at 60 minute induction in Figure 19 and an increase in positive 
correlation at 120 minutes in Figure 17.  This difference in data is due to the different 
induction times of M.CviPI used in these experiments.  With longer induction times, 
there will be less black/negative correlation due to a lack of variation in the methylation 
data and thus by looking at both 60 and 120 minute inductions we can see changes in 
nucleosome positioning in sir2Δ cells.  Unlike with MNase data, we did not see changes 
between nucleosome 2 and 3, and downstream of nucleosome 1 in sir2Δ cells.  
 Methylation of 150-200 rDNA repeats and 25 rDNA repeats in W303 strains 
after 120 min induction  
 Our second approach to studying the chromatin structure of individual rDNA 
repeats was to analyze for different populations of rDNA repeats based on RNA Pol I 
transcription.  In wild type cells that contain ~150-200 rDNA repeats, approximately half 
of the 35S rRNA genes are transcribed by RNA Pol I (Dammann et al., 1993).  We 
expected actively transcribed repeats to be more accessible to M.CviPI because RNA Pol 
I-transcribed genes have been shown to be free of nucleosomes or non-nucleosomal 
(Dammann et al., 1993, 1995).  To facilitate identification of actively transcribed 
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repeats, we analyzed M.CviPI accessibility in a strain that carries a 25 rDNA copy array 
(MBY2293) with all twenty five 35S rRNA genes transcribed by RNA Pol I and 
compared the results to those from wild type cells (MBY2291).  Our experiments were 
based on the hypothesis that an actively transcribed 35S rRNA gene remains active 
throughout a single cell cycle.   
 Within the 35S rRNA gene promoter region, we detected reduced methylation, 
representing the binding of RNA Pol I transcriptional machinery (Figure 20).  The 
region surrounding -94 GpC site represents binding of RNA Pol I transcriptional 
machinery at the upstream element in the 35S rRNA gene promoter region (Figure 2c).  
The correlation analysis has a predominance of black or no correlation, meaning a lack 
of variation among the rDNA repeats analyzed.  Again, this suggests the binding of a 
DNA binding factor that blocks M.CviPI accessibility
 
(Figure 21).  UAF is bound at the 
upstream element of the 35S rRNA promoter at all times, regardless of whether or not 
the gene is transcribed by RNA Pol I (Claypool et al., 2004).  However, Hmo1, a HMG-
box protein, associates exclusively with actively transcribed 35S rRNA genes within the 
promoter region (Kasahara et al., 2007; Merz et al., 2008).  Our data suggests that we 
are able to detect the association of Hmo1 with actively transcribed 35S rRNA genes.  
Hmo1 is an interesting factor because of its similarity to human UBF (Schnapp et al., 
1994).  In mammalian cells, UBF binds to the upstream control region of the 45S rRNA 
promoter through its HMG boxes forcing ~140 bp into a 360° loop (Bazett-Jones et al., 
1994; Stefanovsky et al., 2001).    Hmo1 contains two HMG box domains, however it  
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Figure 20. Percent methylation in wild type (MBY2291) and 25 copy array (MBY2293) in W303 
background after 120 minute induction.  The total number of clones are listed at the top right of the 






























































































































uses its C-terminus to bind and bend the DNA but no evidence of looping has been 
observed (Xiao et al., 2010).     
 In the data from the wild type clones, much of the black correlation can be 
attributed to strict nucleosome positioning, in particular nucleosomes 5, 4, and 3.  Much 
of the negative correlation observed in the data from wild type clones is replaced with 
color in the data from the 25 copy cells, suggesting that in a 25 copy rDNA array 
nucleosomes are less well positioned or not present, which would account for greater 
variation in the level of methylation that was observed.  Actively transcribed regions of 
the rDNA may contain either unstable nucleosomes or none at all due to being 
constantly displaced by RNA Pol I transcriptional machinery (Dammann et al., 1993, 
1995; Jones et al., 2007; Merz et al., 2008).  The correlation analysis in Figure 21 
represents the analysis of only a portion of the total data produced in these experiments: 
18 clones from the wild type 200 copy array cells and 37 clones from the 25 copy array 
cells.  The lack of correlation in the highly methylated region (blue box, Figure 21) is 
unique to this strain background.  In other analyses using the S288c background, we did 
not detect a lack of correlation at this highly methylated region.  This difference could be 
due to the sample size analyzed or to the binding of an unknown factor.     
 We used a single molecule technique to analyze changes in nucleosome 
positioning within NTS2 of the rDNA due to a silencing defect caused by deletion of 
Sir2 and due to active transcription by RNA Pol I.  In wild type and sir2Δ experiments, 
we observed changes in the positioning of nucleosomes 5, 4, and 3, but did not detect 
differences in accessibility either between nucleosome 2 and 3 or downstream of 
 92 
nucleosome 1 that has been observed previously in MNase experiments (Figure 17, 19) 
(Cioci et al., 2002; Li et al., 2006a).  In order to further analyze specific nucleosomes, 
analysis of M.CviPI accessibility should be carried out on smaller regions of NTS2 
rather than the whole fragment at once.  These windows of data could focus on smaller 
areas of specific nucleosomes, on the ARS region, the highly methylated region, and on 
the 35S rRNA promoter region to visualize changes in accessibility.  With wild type and 
25 copy experiments, our data suggests the presence of a bound factor within the 35S 
rRNA promoter that associates exclusively with actively transcribed 35S rRNA genes 
within the upstream element (Figure 20, 21).  Based on published articles it is likely that 
this factor is Hmo1 discussed in Chapter I (Merz et al., 2008).  Future work should focus 
on identifying factors bound within active repeats, whether it is Hmo1 or any other 
factors present at the promoter region of actively transcribed 35S rRNA genes.  These 
correlation analyses are an unproven technique and although conclusions have been 
made about the 25 copy clones containing a bound factor unique to actively transcribed 
repeats, these conclusions should be verified with a more traditional technique.  ChIP 
could easily be used to verify the presence of a bound factor that is enriched within the 
RNA Pol I promoter region in actively transcribed genes.   
 Taken together, this work has analyzed changes in chromatin structure using the 
DNA methyltransferase M.CviPI as a probe.  We measured M.CviPI accessibility 
comparing wild type cells to those with a silencing defect due to deletion of SIR2 and to 
cells with fewer rDNA repeats.  We detected changes in nucleosome positioning in 
NTS2 and changes at the 35S rRNA promoter, likely due to the association of RNA Pol I 
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factors.  Our results show that alterations in silent chromatin structure at the rDNA can 





CHARACTERIZATION OF CONSERVED AMINO ACIDS IN THE  




 In S. cerevisiae, the protein methyltransferase Set1 is part of a larger complex 
called COMPASS (Complex associated with Set1) that associates with RNA Polymerase 
II.  Set1 contains a conserved SET domain with an active site where substrates are 
methylated using the methyl group from S-adenosyl methionine (SAM).  Mutants of 
Set1 were made within the SET domain to learn more about the catalytic mechanism of 
Set1.  The crystal structures of human SET domain proteins, as well as sequence 
alignments and a random mutagenesis of yeast Set1 were used to identify conserved 
amino acids in the SET domain of Set1.  Here we present Set1 mutants characterized 
with quantitative Western blots to measure the levels of the different forms of K4-
methylated H3, and with quantitative Northern blots to evaluate gene silencing at the 
ribosomal DNA locus.  Set1 has also recently been found to perform a role in 
chromosome segregation through methylation of Dam1.  Set1 mutants have been 
characterized for their ability to suppress an ipl1-2 temperature sensitive phenotype.  
Set1 mutants R1013H and Y967F have been tested for their ability to form the 
COMPASS complex in vivo using tandem affinity purification (TAP) from yeast cell 
extracts.  TAP purification of Set1 with R1013H and Y967F mutations has been used in 
                                                 
3
 John Mueller contributed to quantitative Westerns measuring the level of mono-, di-, and trimethylated 
H3K4 relative to either Pgk1 or total histone H3 (Figure 21, Table 8).  Victoria Schneider contributed the 
ipl1-2 plate assays (Table 9). 
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in vitro assays for their ability to methylate lysine 4 of histone H3.  This analysis will 
increase understanding of the catalytic mechanism and cellular function of S. cerevisiae 
Set1 and provide insight into Set1-like proteins in higher eukaryotes.    
 
INTRODUCTION 
 Histone methylation of lysine residues has long been studied for its role in both 
euchromatin and heterochromatin regions, specifically in RNA Pol II transcription, 
heterochromatin formation, gene silencing, and chromosome segregation.  The majority 
of histone methylation is carried out by proteins that contain a highly conserved SET 
domain, its origins from Drosophila genes Suvar 3-9, Enhancer of zeste, and Trithorax 
(Jones and Gelbart, 1993; Tschiersch et al., 1994).  SET domain proteins have been 
found in a wide range of organisms from simple model systems all the way to mouse and 
human systems.  With each step up on the evolutionary ladder, SET domain proteins and 
their roles within those systems become increasingly complex.  In humans, SET domain 
proteins have been linked to a multitude of diseases such as leukemia, breast cancer and 
colon cancer (Ziemin-van der Poel et al., 1991; Prasad et al., 1997; Natarajan et al., 
2010).     
 SET domain proteins can modify lysine residues of histone H3 up to three times 
using S-adenosyl methionine (SAM) as the methyl donor.  Mono-, di-, and 
trimethylation of lysine 4 of histone H3 by Set1 has been linked to high levels of gene 
expression as well as silencing of genes (Nislow et al., 1997; Briggs et al., 2001; Roguev 
et al., 2001; Bryk et al., 2002; Krogan et al., 2002; Santos-Rosa et al., 2002).  Our lab 
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has focused on studying methylation of H3K4 at the ribosomal DNA locus in S. 
cerevisiae, one of three heterochromatin regions.  Set1 is part of a multi subunit complex 
called COMPASS (Complex associated with Set1) that associates with RNA Pol II 
through the Paf1 complex (Briggs et al., 2001; Miller et al., 2001; Roguev et al., 2001).  
The subunits of COMPASS contain counterparts in human H3K4 methyltransferase 
complexes, like the MLL complexes and Set1A and Set1B complexes.  Although yeast 
Set1 is predominantly studied for its role in actively transcribed genes, it was first 
discovered for its role in silencing transcription at telomeres, mating type loci, and the 
rDNA (Nislow et al., 1997; Briggs et al., 2001; Bryk et al., 2002; Krogan et al., 2002).  
At the rDNA, RNA Pol II transcription is silenced despite high levels of RNA Pol I and 
RNA Pol III transcription.  With deletion of SET1, there is a loss of silencing of RNA 
Pol II transcription, suggesting a model where Set1 is required for silencing of 
transcription at the rDNA (Bryk et al., 2002).  In sir2Δ cells there is loss of silencing of 
RNA Pol II transcription and an increase in di- and trimethylated H3K4 within NTS2 (Li 
et al., 2006a).  It is not yet clear what form(s) of H3K4 methylation (mono-, di-, or 
trimethylated) is required for gene silencing in S. cerevisiae or how the low levels of 
H3K4 methylation found at the rDNA alter silent chromatin function.  In addition to 
methylated H3K4, Set1 also methylates Dam1, a protein involved in chromosome 
segregation during the cell cycle.  Methylation of Dam1 at K233 leads to proper 
chromosome segregation by blocking phosphorylation of a neighboring serine residue by 
Ipl1 aurora kinase.  Phosphorylation halts chromosome segregation when microtubules 
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improperly attach to the kinetochore and is part of the anaphase checkpoint during the 
cell cycle (Zhang et al., 2005; Westermann et al., 2007).   
 In humans, there are six known groups of histone methyltransferases that 
methylate H3K4: MLL complexes 1-5, Set1A and Set1B complexes, Set7/9, Ash1, 
Smyd3, and Meisetz (Malik and Bhaumik, 2010) (Appendix A).  Each of these 
complexes are involved in specific and complex roles within human cells.  Set7/9 forms 
the majority of our understanding of the catalytic mechanism of SET domain proteins 
due to its small size and because it functions without any additional subunits (Wilson et 
al., 2002; Kwon et al., 2003; Xiao et al., 2003).  Recent crystal and in vitro analysis of 
MLL1 have also provided insight into the catalytic mechanism of SET domain proteins, 
especially yeast Set1 as it is more similar to MLL1 than Set7/9 (Patel et al., 2009; 
Southall et al., 2009).  Computer simulations with the crystal structure of Set7/9 have 
focused on the importance of tyrosine residues within the catalytic SET domain to 
maintain an ordered hydrogen bonding with water molecules present inside a substrate 
specific channel with lysine 4 of histone H3 that is critical for deprotonation of SAM and 
thus methylation of lysine 4 (Zhang and Bruice, 2007, 2008a).  Because of the multiple 
H3K4 methyltransferases available in humans, study of these complexes is incredibly 
difficult.  This chapter describes a mutational analysis of yeast Set1 that was performed 
to identify and characterize amino acid residues in the SET domain of Set1 that are 
required for the methylation of histone H3 at K4 and transcriptional silencing in the 
rDNA.  In our model system S. cerevisiae, Set1 is the sole H3K4 methyltransferase 
 98 
allowing a straightforward characterization in vivo, easily providing information about 
other SET domain proteins in eukaryotes.   
 Specific amino acids within the catalytic SET domain of SET1 were chosen from 
an alignment of SET domain proteins and by studying the crystal structures of Set7/9 
and MLL1.  Set1 mutants were created by site-directed mutagenesis as well as random 
mutagenesis, and were characterized using quantitative Westerns for H3K4 methylation 
in vivo and Northerns for transcriptional silencing of a RNA Pol II-transcribed gene at 
the rDNA.  Furthermore, methylation of Dam1 was analyzed using ipl1-2 temperature 
sensitive strains.  Mutants were also assessed for their effect on COMPASS formation 
using Tandem affinity purification followed by in vitro assays with increasing 
concentrations of SAM.  Overall, we have identified residues in three categories of 
mutants: mutants with wild type activity, partially active mutants, and null mutants.     
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MATERIALS AND METHODS 
Media 
 Standard yeast media used in these experiments are described elsewhere (Rose, 
1990).  YPADT consists of YPD media with 40 mg/l of adenine sulfate and 20 mg/l of l-
tryptophan.   
Plasmids and mutagenesis 
Plasmid MBB251 contains the SET1 gene flanked by a Xho1 site and 436 bp 
upstream and a SacII site and 347 bp downstream of the SET1 ORF.  MBB251 was 
modified by the addition of a Cla1 site 9 bp downstream of the SET1 stop codon to 
make MBB484.  The Xho1-SacII fragment of MBB484 was ligated into pRS406 to 
create MBB491 to create a vector for integration of SET1 sequences into ura3-52 (see 
below).  The Bluescript plasmid was modified by cloning a linker containing a Mun1 
restriction site into the unique EcoR1 site to create plasmid MBB479.  For mutagenesis, 
the Mun1-Cla1 fragment of SET1 from MBB484 was ligated into MBB479 to make 
MBB487.  Set1 mutants were generated by site-directed mutagenesis with Phusion 
polymerase (New England Biolabs, Ipswich, MA) and specific primers (Table 6).  
Mutagenized sequences were verified by DNA sequence analysis (Gentech lab and 
Interdisciplinary Center for Biotechnology Research, University of Florida).  For each 
mutant, the Mun1-Cla1 fragment was ligated into the Mun1-Cla1 interval of MBB491 to 




Table 6. Oligonucleotides used in Set1 experiments. 
Primer Description Sequence 
OM336 TAP primer TGGGATATAATCGATGAGTTGGAGCAAATTGCC
CTACAGCAATCCATGGAAAAGAGAAG 
OM337 TAP primer ACACTTTCAGTGTGTTTTAATTATTCTTCTTTGA
ATGCTGCTTACGACTCACTATAGGG 
OM486 N1016A sense GGTGGTATAGCCCGTTTCATTGCTCATTGTTGTG
ATCCAAATTGTACGGC 
OM487 N1016A antisense GCCGTACAATTTGGATCACAACAATGAGCAATG
AAACGGGCTATACCACC 
OM504 G951A sense CGTTCAGCAATTCACAACTGGGCTTTATATGCT
CTAGACTCTATCGC 
OM505 G951A antisense GCGATAGAGTCTAGAGCATATAAAGCCCAGTTG
TGAATTGCTGAACG 
OM506 Y967A sense GCAAAGGAAATGATTATCGAGGCCGTTGGTGA
AAGGATCAGGC 
OM507 Y967A antisense GCCTGATCCTTTCACCAACGGCCTCGATAATCA
TTTCCTTTGC 
OM508 I972A sense CGAGTACGTTGGTGAAAGGGCCAGGCAACCTG
TAGCAG 
OM509 I972A antisense CTGCTACAGGTTGCCTGGCCCTTTCACCAACGT
ACTCG 
OM510 Y993A sense GGGATTGGATCCAGTGCCCTTTTTAGGGTTGAT
GAAAACACGG 
OM511 Y993A antisense CCGTGTTTTCATCAACCCTAAAAAGGGCACTGG
ATCCAATCCC 
OM512 H1017L sense GGTATAGCCCGTTTCATTAATCTTTGTTGTGATC
CAAATTGTACGGC 
OM513 H1017L antisense GCCGTACAATTTGGATCACAACAAAGATTAATG
AAACGGGCTATACC 
OM636 T1024Y sense CATTAATCATTGTTGTGATCCAAATTGTTATGCA
AAGATTATAAAGGTTGGCGGGAG 
OM637 T1024Y antisense CTCCCGCCAACCTTTATAATCTTTGCATAACAAT
TTGGATCACAACAATGTAAAATG 
OM638 R1013H sense GCCACCAAGAAAGGTGGTATAGCCCATTTCATT
AATCATTGTTGTGATCCA 
OM639 R1013H antisense TGGATCACAACAATGATTAATGAAATGGGCTAT
ACCACCTTTCTTGGTGGC 
OM708 Cla1 primer GGTTTCTTGAACTGACGATGATACATCGATTTG
TTTGGAGCTTCCTG 
OM709 Cla1 primer CAGGAAGCTCCAAACAAATCGATGTATCATCGT
CAGTTCAAGAAACC 
OM712 SET1_FWD CCTGAACTTTGTCAAAGAGAAGAATCCTCG 
OM713 SET1_RVS GAATGCTGTCGGTAGCCTAAAGAAATGCTTC 
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Table 6. continued. 
Primer Description Sequence 
OM749 Y967F sense GGAAATGATTATCGAGTTCGTTGGTGAAAGGAT
CAGG 
OM750 Y967F antisense CCTGATCCTTTCACCAACGAACTCGATAATCAT
TTCC 
OM751 Y1054F sense GCGAAGAGTTGACATATGATTTCAAATTTGAGA
GAGAAAAGG 
OM752 Y1054F antisense CCTTTTCTCTCTCAAATTTGAAATCATATGTCAA
CTCTTCGC 
OM753 T1024A sense CATTGTTGTGATCCAAATTGTGCGGCAAAGATT
ATAAAGG 
OM754 T1024A antisense CCTTTATAATCTTTGCCGCACAATTTGGATCACA
ACAATG 
OM755 Y1054A sense GAAGAGTTGACATATGATGCCAAATTTGAGAG
AGAAAAG 
OM756 Y1054A antisense CTTTTCTCTCTCAAATTTGGCATCATATGTCAAC
TCTTC 
OM757 F1056Y sense GACATATGATTACAAATATGAGAGAGAAAAGG
ATGACGAG 
OM758 F1056Y antisense CTCGTCATCCTTTTCTCTCTCATATTTGTAATCA
TATGTC 
OM851 Mun1 linker TGATGCCATGAATTCGTAGCAATTGGAATTCTA
GGTGCAT 
OM852 Mun1 linker ATGCACCTAGAATTCCAATTGCTACGAATTCAT
GGCATCA 
OM947 F1056A sense GAAGAGTTGACATATGATTACAAAGCTGAGAG
AGAAAAGGATGACGAG 
OM948 F1056A antisense CTTCTCAACTGTATACTAATGTTTCGACTCTCTC
TTTTCCTACTGCTC 
OM949 I989A sense GAGAAAAGATATCTGAAAAATGGGGCTGGATC
CAGTTACCTTTTTAGG 
OM950 I989A antisense CCTAAAAAGGTAACTGGATCCAGCCCCATTTTT
CAGATATCTTTTCTC 
OM951 H1017A sense GCCCGTTTCATTAATGCTTGTTGTGATCCAAATT
GTACG 
OM952 H1017A antisense CGTACAATTTGGATCACAACAAGCATTAATGAA
ACGGGC 
OM953 H1017R sense GCCCGTTTCATTAATCGTTGTTGTGATCCAAATT
GTACG 
OM954 H1017R antisense CGTACAATTTGGATCACAACAACGATTAATGAA
ACGGGC 
OM955 Y1052F sense GCGGCAAGCGAAGAGTTGACATTTGATTACAA
ATTTGAGAGAG 
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Table 6. continued. 
Primer Description Sequence 
OM956 Y1052F antisense CTCTCTCAAATTTGTAATCAAATGTCAACTCTTC
GCTTGCCGC 
OM957 Y1052A sense GCGGCAAGCGAAGAGTTGACAGCTGATTACAA
ATTTGAGAG 
OM958 Y1052A antisense CTCTCAAATTTGTAATCAGCTGTCAACTCTTCGC
TTGCCGC 
OM959 Y1052V sense GCGGCAAGCGAAGAGTTGACAGTTGATTACAA
ATTTGAGAG 
OM960 Y1052V antisense CTCTCAAATTTGTAATCAACTGTCAACTCTTCGC
TTGCCGC 
OM961 E1048A sense CTGCGTGATATCGCGGCAAGCGCTGAGTTGACA
TATGATTAC 
OM962 E1048A antisense GTAATCATATGTCAACTCAGCGCTTGCCGCGAT
ATCACGCAG 
OM963 E1049A sense CTGCGTGATATCGCGGCAAGCGAAGCTTTGACA
TATGATTAC 
OM964 E1049A antisense GTAATCATATGTCAAAGCTTCGCTTGCCGCGAT
ATCACGCAG 
OM965 L1050A sense GATATCGCGGCAAGCGAAGAGGCTACATATGA
TTACAAATTTGAG 
OM966 L1050A antisense CTCAAATTTGTAATCATATGTAGCCTCTTCGCTT
GCCGCGATATC 
OM967 R1042H sense AGAATTGTTATCTATGCACTGCATGATATCGCG
GCAAGCG 
OM968 R1042H antisense CGCTTGCCGCGATATCATGCAGTGCATAGATAA
CAATTCT 
OM969 R1042A sense AGAATTGTTATCTATGCACTGGCTGATATCGCG
GCAAGCG 
OM970 R1042A antisense CGCTTGCCGCGATATCAGCCAGTGCATAGATAA
CAATTCT 
OM971 C1068A sense GACGAGGAAAGACTTCCTGCTTTATGTGGAGCA
CCTAATTGT 
OM972 C1068A antisense ACAATTAGGTGCTCCACATAAAGCAGGAAGTCT
TTCCTCGTC 
OM973 C1070A sense GAGGAAAGACTTCCTTGTTTAGCTGGAGCACCT
AATTGTAAAGG 
OM974 C1070A antisense CCTTTACAATTAGGTGCTCCAGCTAAACAAGGA
AGTCTTTCCTC 
OM975 C1075A sense TGTTTATGTGGAGCACCTAATGCTAAAGGTTTC
TTGAACTGACG 
OM976 C1075A antisense CGTCAGTTCAAGAAACCTTTAGCATTAGGTGCT
CCACATAAACA 
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 Set1 mutants generated by random mutagenesis were created by PCR from wild 
type SET1 gene in MBY1198, described previously (Bryk et al., 2002), using primers 
OM712 and OM713 (Table 5) to amplify the SET domain through two rounds of PCR 
(Hirschhorn et al., 1995).  The SET domain fragment was digested with Cla1 and Mfe1 
and inserted in to a similarly cut MBB484 containing full length SET1 using gap repair 
into MBY2269.  Mutants were screened based on transcription of a RNA Pol II-
transcribed gene Ty1his3AI.  Set1 mutants that resulted in a loss of silencing at the 
rDNA will become HIS
+
.  Mutants were analyzed by plating aliquots of 5mL YPADT 
cultures of each mutant grown at 20°C for four days onto SC-Ura agarose plates for total 
number of cells compared to cells plated on SC-Ura-His plates.  The ratio to a wild type 
SET1 strain and a set1Δ strain was calculated and used as a basis for judging randomly 
generated Set1 mutants.  Random mutants were selected for a partial loss of silencing 











Table 7. Summary of Set1 mutants generated by random mutagenesis of the SET 
catalytic domain. 
Random mutant Description 
RM 2 F995Y 
RM 6 A959T, I1003Y 
RM 8 E1049G 
RM 13 S945L 
RM 14 I958T, E1049G 
RM 26 I1015Y, T1051A 
RM 29 N1016D 
RM 44 L1066P 
RM 46 E924G 
RM 47 G990E 
RM 56 K982R, F995L 
RM 62 I972T 
RM 72 D1053G 
RM 74 R1065K 
RM 80 Y967C 
RM 98 I964F, D1004G 
RM 118 Y1039C 
RM 122 C1075Y 
RM 141 G969C 
RM 142 Y993H, F1056L 













 Yeast strains 
 All Saccharomyces cerevisiae strains are listed in Table 8.  Yeast strains were 
made by using standard genetic crosses and transformation techniques.  Wild type and 
mutant alleles of SET1 in the integrating vector were digested with Stu1 and transformed 
into MBY2269 and ZK2 Δset1.  Integration of a single copy of MBB491 with wild-type 
SET1 or derivatives containing mutant alleles of SET1 into the ura3-52 locus were 
verified by PCR and Southern blot analysis.  All yeast strains containing Set1 mutants 
were verified to be a single copy integrated into ura3-52 by PCR by southern blot 
analysis.     
 Yeast strain MBY2269 was generated from a cross between MBY1206 (MATa 
ura3Δ0 leu2Δ0 his3Δ200 ade2Δ::hisG trp1Δ63 met15Δ0 Ty1his3AI-236 Ty1ade2AI-
515) and MBY2046 (MATα ade2Δ::hisG his3Δ200 leu2-(Δ0orΔ1) met15Δ0 trp1Δ63 
ura3-52 set Δ::TRP1 Ty1his3AI-236 ADE2::TELVR) and verified by marker checks and 
PCR.  Strains made using MBY2269 were used in quantitative Western analysis and 
northern analysis.  Strains used in the ipl1-2 plate assays were made with MBY2450 and 
have been described elsewhere as ZK2 Δset1 (Zhang et al., 2005).  Set1 mutants were 
integrated into ipl1-2 strains and were verified to be a single copy integrated into ura3-
52 by PCR and southern blot analysis.  Strains used in tandem affinity purification 
(TAP) were made with MBY2469, with the originating strain SF10 (BJ5459 MATa 
ura3-52 trp1Δ lys2-801 leu2Δ1 pep4::HIS3 prb1Δ1 can1-) described elsewhere (Li et 
al., 2002).  The addition of sequences encoding the TAP tag to the C-terminus of the 
yeast BRE2 gene was performed as described in Puig et al. (1998) Yeast 14, 1139-1146.  
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Oligonucleotides OM336 and OM337 were used to amplify a fragment containing 
sequences encoding the TAP tag and K. lactis TRP1 gene flanked by sequences with 
homology to the carboxy terminus of the BRE2 coding region.  The fragment was 
transformed into yeast strain BJ5459 (MBY1212) and Trp+ transformants were selected.  
After identification of strains with the correct integration of TAP sequences at the C-
terminus of the BRE2 gene, the SET1 gene was replaced by a set1::KANMX4 fragment 
as described (Bryk et al., 2002) to create yeast strain MBY2469.  Strains used in tandem 
affinity purification (TAP) were made with MBY2469, with the originating strain 
described elsewhere (Li et al., 2002). 
 
Table 8. S. cerevisiae strains used in this Set1 study. 
Name Genotype 
BJ5459 MATa ura3-52 trp1Δ lys2-801 leu2Δ1 pep4::HIS3 prb1Δ1 can1- 
MBY2269 MATa ade2∆::hisG his3∆200 leu2- (∆0 or ∆1) met15∆0 trp1∆63 ura3-
52 set1∆::TRP1 Ty1his3AI-236 ADE2::TELVR 
MBY2313 MBY2269 ura3-52:: URA3-pRS406-SET1 
MBY2315 MBY2269 ura3-52::URA3-pRS406 
MBY2317 MBY2269 ura3-52::URA3-pRS406-SET1-T1024Y 
MBY2318 MBY2269 ura3-52::URA3-pRS406-SET1-R1013H 
MBY2337 MBY2269 ura3-52::URA3-pRS406-SET1-Y1054F 
MBY2338 MBY2269 ura3-52::URA3-pRS406-SET1-Y1054A 
MBY2339 MBY2269 ura3-52::URA3-pRS406-SET1-F1056Y 
MBY2341 MBY2269 ura3-52::URA3-pRS406-SET1-N1016A 
MBY2342 MBY2269 ura3-52::URA3-pRS406-SET1-T1024A 
MBY2382 MBY2269 ura3-52::URA3-pRS406-SET1-Y976A 
MBY2383 MBY2269 ura3-52::URA3-pRS406-SET1-I972A 
MBY2384 MBY2269 ura3-52::URA3-pRS406-SET1-Y993A 
MBY2385 MBY2269 ura3-52::URA3-pRS406-SET1-H1017L 
MBY2386 MBY2269 ura3-52::URA3-pRS406-SET1-Y967F 
MBY2387 MBY2269 ura3-52::URA3-pRS406-SET1-G951A 
MBY2395 MBY2269 ura3-52::URA3-pRS406-SET1-I989A 
MBY2396 MBY2269 ura3-52::URA3-pRS406-SET1-H1017A 
MBY2397 MBY2269 ura3-52::URA3-pRS406-SET1-Y1052F 
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Table 8. continued. 
Name Genotype 
MBY2398 MBY2269 ura3-52::URA3-pRS406-SET1-Y1052A 
MBY2399 MBY2269 ura3-52::URA3-pRS406-SET1-Y1052V 
MBY2400 MBY2269 ura3-52::URA3-pRS406-SET1-E1048A 
MBY2401 MBY2269 ura3-52::URA3-pRS406-SET1-E1049A 
MBY2402 MBY2269 ura3-52::URA3-pRS406-SET1-L1050A 
MBY2403 MBY2269 ura3-52::URA3-pRS406-SET1-R1042H 
MBY2404 MBY2269 ura3-52::URA3-pRS406-SET1-R1042A 
MBY2405 MBY2269 ura3-52::URA3-pRS406-SET1-C1068A 
MBY2406 MBY2269 ura3-52::URA3-pRS406-SET1-C1070A 
MBY2407 MBY2269 ura3-52::URA3-pRS406-SET1-C1075A 
MBY2408 MBY2269 ura3-52::URA3-pRS406-SET1-F1056A 
MBY2409 MBY2269 ura3-52::URA3-pRS406-SET1-E1049G 
MBY2412 MBY2269 ura3-52::URA3-pRS406-SET1-C1075Y 
MBY2413 MBY2269 ura3-52::URA3-pRS406-SET1-H1017R 
MBY2450 MATa ade2- his3∆200 ura3-52 ipl1-2 set1∆::KANMX4  
MBY2469 MATa ura3-52 trp1- lys2-801 leu2∆1 his3∆200 pep4::HIS3 prb1∆1 
can1- GAL BRE2::TAP tag::TRP1#11 set1∆::KANMX4 #1 
MBY2494 MBY2469 ura3-52::URA3-pRS406-SET1 
MBY2496 MBY2469 ura3-52::URA3-pRS406-SET1-R1013H 
MBY2511 MBY2450 ura3-52::URA3-pRS406-SET1 
MBY2512 MBY2450 ura3-52::URA3-pRS406 
MBY2513 MBY2450 ura3-52::URA3-pRS406-SET1-G951A 
MBY2514 MBY2450 ura3-52::URA3-pRS406-SET1-Y967A 
MBY2515 MBY2450 ura3-52::URA3-pRS406-SET1-I989A 
MBY2516 MBY2450 ura3-52::URA3-pRS406-SET1-R1013H 
MBY2517 MBY2450 ura3-52::URA3-pRS406-SET1-N1016A 
MBY2518 MBY2450 ura3-52::URA3-pRS406-SET1-H1017L 
MBY2519 MBY2450 ura3-52::URA3-pRS406-SET1-H1017R 
MBY2520 MBY2450 ura3-52::URA3-pRS406-SET1-C1068A 
MBY2521 MBY2450 ura3-52::URA3-pRS406-SET1-C1075Y 
MBY2522 MBY2450 ura3-52::URA3-pRS406-SET1-Y993A 
MBY2523 MBY2450 ura3-52::URA3-pRS406-SET1-Y1054A 
MBY2524 MBY2450 ura3-52::URA3-pRS406-SET1-T1024A 
MBY2525 MBY2450 ura3-52::URA3-pRS406-SET1-T1024Y 
MBY2526 MBY2450 ura3-52::URA3-pRS406-SET1-R1042A 
MBY2527 MBY2450 ura3-52::URA3-pRS406-SET1-E1048A 
MBY2528 MBY2450 ura3-52::URA3-pRS406-SET1-Y1052V 
MBY2529 MBY2450 ura3-52::URA3-pRS406-SET1-F1056A 
MBY2530 MBY2450 ura3-52::URA3-pRS406-SET1-F1056Y 
MBY2531 MBY2450 ura3-52::URA3-pRS406-SET1-C1070A 
MBY2532 MBY2450 ura3-52::URA3-pRS406-SET1-C1075A 
MBY2540 MBY2469 ura3-52::URA3-pRS406-SET1-Y993A 
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Table 8. continued. 
Name Genotype 
MBY2541 MBY2469 ura3-52::URA3-pRS406-SET1-I972A 
MBY2542 MBY2469 ura3-52::URA3-pRS406-SET1-G951A 
MBY2543 MBY2469 ura3-52::URA3-pRS406-SET1-E1049G 
MBY2544 MBY2469 ura3-52::URA3-pRS406-SET1-E1049A 
MBY2546 MBY2469 ura3-52::URA3-pRS406-SET1-H1017R 
MBY2547 MBY2469 ura3-52::URA3-pRS406-SET1-L1050A 
MBY2548 MBY2469 ura3-52::URA3-pRS406-SET1-Y1054F 
MBY2549 MBY2469 ura3-52::URA3-pRS406-SET1-Y976F 
MBY2550 MBY2469 ura3-52::URA3-pRS406-SET1-R1042H 
MBY2551 MBY2450 ura3-52::URA3-pRS406-SET1-Y967F 
MBY2552 MBY2450 ura3-52::URA3-pRS406-SET1-I972A 
MBY2554 MBY2450 ura3-52::URA3-pRS406-SET1-H1017A 
MBY2556 MBY2450 ura3-52::URA3-pRS406-SET1-R1042H 
MBY2557 MBY2450 ura3-52::URA3-pRS406-SET1-E1049A 
MBY2558 MBY2450 ura3-52::URA3-pRS406-SET1-L1050A 
MBY2559 MBY2450 ura3-52::URA3-pRS406-SET1-Y1052A 
MBY2560 MBY2450 ura3-52::URA3-pRS406-SET1-Y1052F 
MBY2561 MBY2450 ura3-52::URA3-pRS406-SET1-Y1054F 
MBY2563 MBY2450 ura3-52::URA3-pRS406-SET1-E1049G 
MBY2595 MBY2469 ura3-52::URA3-pRS406-SET1-H1017A 
 
 Whole cell protein extracts  
 Cells were grown to ~1-2 X 10
7
 cells/ml in 50mL YPADT, harvested and 
washed with sterile reverse osmosis water.  Cells were resuspended in 0.2ml RIPA with 
1% SDS and protease inhibitors (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 
50 mM Tris–HCl pH 8.0, 1% SDS, 1 mM phenylmethylsulfonyl fluoride, 1.67 µg/ml 
aprotonin, 1.67 µg/ml pepstatin, 0.33 µg/ml leupeptin, and 0.40 µg/ml bestatin).  Cells 
were disrupted at 4°C with acid washed glass beads using a Mini-BeadBeater 16 Cell 
Disrupter (Biospec Products, Bartlesville, OK).  Cell lysate was collected and incubated 
on ice for 30 min, then clarified by centrifugation for 30 min 4°C at 12,000 rpm. Total 
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protein concentration was determined by a Bradford colorimetric assays using dye 
reagent concentrate (Bio-Rad, Hercules, CA).  
Western blot analysis 
All quantitative histone methylation Westerns for Set1 mutant strains in the 
MBY2269 background were performed by Dr. John Mueller unless otherwise stated.  
Westerns were carried out as described elsewhere (Mueller et al., 2006) with few 
modifications.  For quantitative histone methylation Westerns, between 8-80 µg of 
whole cell extract was resolved on 4-20 % Pierce gradient gels (Thermo Fisher 
Scientific, Rockford, IL) and transferred to polyvinylidene fluoride (PVDF) membranes.  
Blots were probed with α-K4-monomethyl H3 (07-436, Upstate Cell Signaling or 
ab8895, Abcam; 1:500), α-K4-dimethyl (07-030, Upstate Cell Signaling; 1:5000), α-K4-
trimethyl (ab8580, Abcam; 1:5000), α-histone H3 (ab1791, Abcam; 1:1000), and α-
phosphoglycerate kinase (A6457, Molecular Probes: 1:1000).  Blots were then probed 
with either HRP-conjugated α-rabbit or α-mouse secondary antibodies (Promega; 
1:2000-1:5000 and 1:2000, respectively), followed by developing with Immuno-Star 
HRP substrate kit (Bio-Rad, Hercules, CA).  Western blots were imaged and quantified 
using the Molecular Imager ChemiDoc XRS with Quantity One software (Bio-Rad, 
Hercules, CA).    
To measure steady state levels of Set1 protein, ~150 µg of whole cell extract 
were resolved on 7% SDS-PAGE gels and transferred to PVDF membrane.  Blots were 
probed with α-Set1 antibody (25945, Santa Cruz Biotechnology; 1:1000) and then 
probed with HRP-conjugated α-goat secondary antibody (2020, Santa Cruz 
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Biotechnology; 1:1000).  Blots were developed and imaged as described above, and then 
stained with Ponceau S stain to serve as a loading control.    
 Northern blot analysis 
 Isolation of total RNA and Northern blotting were performed, as described 
previously (Bryk et al., 1997; Bryk et al. 2002).  Northern blots were imaged with a 
Pharos FX Plus Molecular Imager and quantified using Quantity One software (Bio-Rad, 
Hercules, CA). 
 Nickel purification of His-tagged TEV protease 
 His tagged Tobacco Etch Virus (TEV) protease was purified using nickel NTA 
beads (Qiagen, Chatsworth, CA) as described previously (Parks et al., 1995).  Following 
elution from nickel beads, eluate was dialyzed at 4°C for a minimum of 12 hours in 
10mM Tris HCl pH 8.0, 0.3M NaCl, and 10% glycerol using a Slide-A-Lyzer Dialysis 
Cassette (Thermo Fisher Scientific, Rockford, IL). 
 Tandem affinity purification  
 Cells were grown to ~5 X 10
7
 cells/ml in 6 or 12L of YPADT, harvested and 
washed with sterile milliQ water.  Cell pellet was weighed and resuspended in 1/3 
volume of lysis buffer with protease inhibitors (LBpi) forming a cell slurry (40 mM 
Hepes KOH, 350 mM NaCl, 10% glycerol, 0.1% Tween-20, 1 mM 
phenylmethylsulfonyl fluoride, 1.67 µg/ml aprotonin, 1.67 µg/ml pepstatin, 0.33 µg/ml 
leupeptin, and 0.40 µg/ml bestatin).  The cell slurry was dripped slowly into liquid N2.to 
make yeast popcorn.  A prechilled mortar and pestle was used to grind ~10-15g of frozen 
yeast popcorn into a fine powder, checking the lysis under a microscope (Schultz, 1999; 
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Wong et al., 1999).  Lysed yeast cells were stored at -80°C until needed.  For Tandem 
Affinity Purification (TAP), cell lysate was thawed slowly on ice then purified as 
previously described (Puig et al., 2001) using 500 µl of Rabbit IgG Agarose beads 
(Sigma, St. Louis, MO), cleaved with ~100µg of purified His tagged TEV protease, then 
purified with 500µl of Calmodulin Sepharose 4B beads (GE Healthcare, Pittsburgh, PA).  
TAP purified COMPASS was eluted from calmodulin beads by incubating for 1 hr at 
4°C with a standard elution buffer containing fresh 10 mM EGTA.  Eluate was 
concentrated to ~1-2 µg/µl using Amicon Ultra Centrifugal filters 100K MWCO 
(Millipore, Billerica, MA). 
 Plate assay using ipl1-2 ts strains  
 Plate assays were performed by Victoria Schneider.  Strains containing ipl1-2 
were grown in 5mL of YPADT and grown to saturation.  Ten-fold serial dilutions were 
made in sterile milliQ water and 5-10 µl of each dilution was spotted onto YPADT 




 The goal of this study was to design, synthesize, and characterize several 
mutations in the SET1 gene that affect histone methylation and silencing at the rDNA.  
Amino acids were identified using an amino acid alignment of SET domain proteins 
(Figure 5) as well as the crystal structures of Set7/9 and MLL1.  There are five 
conserved motifs in SET domain proteins: GXG (I), YXG (II), RXXNHS/C (III), 
EELXY/FXY (IV) and CXCXXXXC (V).  Each motif has a specific role in SET domain 
proteins.  GXG (I) motifs are known for their role in binding the cofactor S-adenosyl 
methionine (SAM) in methyltransferase enzymes (Shields et al., 2003).  RXXNHS/C 
(III) and EELXY/FXY (IV) along with YXG (II) form the active site within a substrate 
specific channel for the target lysine residue and interact with lysine 4 of histone H3 and 
SAM (Wilson et al., 2002; Kwon et al., 2003; Xiao et al., 2003).  CXCXXXXC (V) 
coordinates a zinc ion that aides some SET domain proteins in properly folding the c-
terminus (Zhang et al., 2003; Southall et al., 2009).  Many of the mutants created in 
yeast Set1 are from these motifs, and are conserved in human Set7/9 and Mll1 as 
discussed above (Table 2).   
 Steady-state levels of Set1 and methylated histones in vivo  
 Figure 5 along with Table 2 details the SET domain mutants created in yeast 
Set1, focusing on these motifs as well as conserved amino acids.  To verify that cells 
with the wild type or a mutant SET1 gene integrated at ura3-52 express Set1 protein, 
Western blotting assays were performed using whole cell extracts (WCEs) and 




Figure 22.  Western blot analysis of Set1 protein in wild type and mutant strains.  Whole cell extracts 
(150 µg) were separated by SDS-PAGE and transferred to PVDF membranes.  The results of three 
Western blotting experiments are shown.  For each of the three experiments shown, the top panel is an 
immunoblot showing the level of Set1 protein detected after incubation with anti-Set1 primary antibodies 
and HRP-conjugated secondary antibodies; the bottom panel is the same membrane shown in the top panel 
stained with Ponceau S to verify equal loading.   
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Set1 protein is similar in protein extracts from wild type cells and each of the Set1 
mutants.  Little or no signal was detected at the position corresponding to Set1 in control 
extracts from cells that lack Set1 proteins (set1Δ). 
 After verifying that S. cerevisiae cells carrying mutations in the SET1 gene 
express the Set1 protein at levels similar to those in cells with the wild type SET1 gene, 
in vivo phenotypes associated with Set1 function were tested.  Mutants were evaluated 
for their ability to methylate H3K4 using Western blots with antibodies specific for each 
of the three levels of methylated H3K4 with either Pgk1 or total histone H3 protein 
serving as a loading control (Figure 23, Table 9).  By comparing the levels of methylated 
H3K4 between wild type and mutant WCEs, we were able to separate the Set1 mutants 
into three classes: mutants with wild type activity, partially active mutants, and null 
mutants.  Mutants similar to or greater than wild type maintained the ability to methylate 
lysine 4 of histone H3 with levels greater than 50% of wild type.  For some of these 
mutants, levels of methylated H3K4 exceeded the levels detected in wild type cells.  The 
mutants with wild type activity were: I972A, I989A, H1017A, T1024A, T1024Y, 
R1042H, R1042A, E1048A, L1050A, Y1052F, Y1052V, and F1056Y. 
 The second class of mutants maintained partial in vivo histone H3 methylation 
activity where the levels of methylated H3K4 were less than 50% of wild type levels.  
This class of mutants can be further subdivided based on the reduced levels of one or 
two forms of methylated H3K4.  In one subclass of partial H3 methylation mutants 
containing G951A, Y967F and Y993A, monomethylated H3K4 was detected at a level 
of 50-70% of wild type, but di- and trimethylated H3K4 were either absent or present at 
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Figure 23.  Quantitative Western blots measuring the level of methylated H3K4 in cells expressing 
wild type and mutant SET1.  Nine Western blotting experiments are shown.  Dilutions of protein extracts 
(µg loaded is indicated below each loading control panel) from Set1
+
, set1Δ and set1 mutant cells were 
analyzed by Western blotting with antibodies to measure the in vivo steady-state levels of K4-
monomethylated H3 (α-mono), K4-dimethylated H3 (α-di), and K4-trimethylated H3 (α-tri).  The level of 
histone H3 (α-H3) or Pgk1 (α-Pgk1) protein was used to normalize the amount of protein loaded in each 
lane.  The average ratio of normalized K4-methylated H3 detected in set1 mutant extracts relative to wild 
type extracts is shown below each blot (n=2 or 3).  Results were quantitated using Quantity One software 
from BioRad.  Panels of this figure were generated by John Mueller, with the exception of the EEL 











α-monoH3K4 α-diH3K4 α-triH3K4 
Pgk1/H3  H3 Pgk1/H3 H3 Pgk1/H3 H3 
G951A 0.57 0.84 0.01 0.03 0.00 0.00 
Y967F 0.45 0.56 0.01 0.01 0.11 0.01 
Y967A 0.00 0.00 0.00 0.00 0.00 0.00 
I972A 1.08 0.83 0.69 0.99 0.70 0.84 
I989A 0.76 0.72 0.70 0.42 0.63 0.63 
Y993A 0.55 0.43 0.10 0.02 0.00 0.00 
R1013H 1.31 1.35 0.59 0.59 0.03 0.00 
N1016A 0.00 0.00 0.00 0.00 0.00 0.00 
H1017A 1.65 1.38 1.67 2.28 1.71 4.64 
H1017R 0.01 0.04 0.02 0.00 0.00 0.00 
H1017L 0.02 0.00 0.00 0.00 0.00 0.00 
T1024Y 2.39 4.04 1.42 1.61 1.08 1.14 
T1024A 4.24 5.09 1.09 2.39 0.60 1.04 
R1042H 0.56* 0.92 0.77* 0.71 0.65* 0.78 
R1042A 1.79* 2.09 1.40* 1.24 1.61* 1.34 
E1048A --  -- 1.41* -- 1.3* -- 
E1049A -- -- 0* -- 0* -- 
E1049G -- -- 0.28* -- 0* -- 
L1050A -- -- 1.08* -- 1.92* -- 
Y1052F 0.54 0.59 0.68 1.00 1.16 1.83 
Y1052A 0.19 0.07 0.71 0.48 1.28 0.81 
Y1052V 0.83 0.42 1.54 0.93 3.44 1.95 
Y1054F 0.38 0.51 0.24 0.32 0.04 0.01 
Y1054A 0.00 0.00 0.00 0.00 0.00 0.00 
F1056Y 1.02* 0.91 1.09* 0.75 0.41* 0.70 
F1056A 0.00 0.00 0.00 0.00 0.00 0.00 
C1068A 0 0 0 0 0 0 
C1070A 0 0 0 0 0 0 
C1075A 0 0 0 0 0 0 
C1075Y 0 0 0 0 0 0 
a
The loading control use was either total H3 or Pgk1.  “Pgk1/H3” indicates that for those experiments, red 
values were determined using total H3 as a loading control, while those in black were determined from 
total Pgk1.  Data marked by an asterisk (*) was generated by Kelly M. Williamson, while the rest of the 




levels that were less than 7% of wild type.  In extracts from members of a second 
subgroup of partial activity mutants (R1013H, E1049G and Y1054F), trimethylated 
H3K4 was either absent or present at levels less than 5% of wild type.  The last subclass 
of partial activity mutants includes Y1052A that has reduced levels of monomethylated 
H3K4 but wild type levels of di- and trimethylated H3K4.     
The third class, the null mutants, includes mutants that were unable to methylate 
H3K4 in vivo.  The null mutants were: Y967A, N1016A, H1017R, H1017L, E1049A, 
Y1054A, F1056A, C1068A, C1070A, C1075A and C1075Y (Figure 23, Table 9).  Set1 
protein is expressed at similar levels to wild type in these cells (Figure 22).  Therefore, 
the mutations in each null mutant abolishes methyl transfer activity in vivo without 
affecting the level of expression of the Set1 protein.  Table 10 and Figure 24 summarizes 
these three classes along with additional data discussed below.  Further interpretation of 
the in vivo effects of mutations in Set1 will be presented in the discussion and will take 
into account the results of two additional in vivo functions of Set1, Pol II gene silencing 
at the rDNA (Bryk et al., 2002) and methylation of a Dam1, a kinetochore-associated 


















I972A wild type proficient No 
I989A wild type proficient No 
H1017A wild type proficient No 
T1024A wild type proficient No 
T1024Y wild type proficient No 
R1042A wild type proficient No 
R1042H wild type defective No 
E1048A wild type proficient No 
L1050A wild type proficient No 
Y1052F wild type proficient No 
Y1052V wild type proficient No 
F1056Y wild type proficient No 
        
G951A partial  defective partial 
Y967F partial  partial defect No 
Y993A partial  defective Yes 
        
R1013H partial  partial defect partial 
E1049G partial  defective partial 
Y1054F partial  defective partial 
        
Y1052A partial  proficient No  
    
Y967A null defective Yes 
N1016A null defective Yes 
H1017L null defective Yes 
H1017R null defective Yes 
E1049A null defective Yes 
Y1054A null defective Yes 
F1056A null defective Yes 
C1068A null defective Yes 
C1070A null defective Yes 
C1075A null defective Yes 
C1075Y null defective Yes 
a
Classification based on the levels of K4-methylated H3 detected in whole cell extracts.   
b
Score based on ability to silence Pol II-transcribed gene in rDNA. Lack of rDNA silencing, defective; 
wild-type level of rDNA silencing, proficient; incomplete rDNA silencing, partial defect. 
c
Ability to suppress ipl1-2 growth defect at 30°C.  Yes, growth at 30°C; no, poor growth at 30°C; partial, 




































































































































































































































































































































































Silencing of RNA Pol II transcription at the rDNA 
Previous work has shown that Set1 is required for silencing of RNA Pol II 
transcription at the ribosomal DNA locus (Briggs et al., 2001; Bryk et al., 2002) and at 
telomeres (Nislow et al., 1997; Krogan et al., 2002).  Substitution of lysine 4 of histone 
H3 with arginine causes a loss of silencing of a RNA Pol II-transcribed gene at the 
rDNA indicating that methylated H3K4 is required for RNA Pol II gene silencing in S. 
cerevisiae (Briggs et al., 2001; Bryk et al., 2002).  Northern blots were performed to 
determine if mutants of Set1 affected RNA Pol II gene silencing at the rDNA (Figure 
22).  With the range of H3K4 methylation phenotypes represented in the partial activity 
Set1 mutants, it was expected that the specific order of methylated H3K4 (mono, di or 
tri) required for silencing of Pol II genes at the rDNA could be determined.  The function 
of the Set1 mutants in silencing of RNA Pol II transcription was tested using RNA 
isolated from yeast cells harboring one of the thirty SET1 mutant alleles and a RNA Pol 
II-transcribed reporter gene, Ty1his3AI, integrated into the rDNA locus (Figure 25).  
Table 11 reports the average values of n=3-4 Northern blotting experiments and the 
standard deviation.   
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Figure 25.  Northern blot analysis to evaluate gene silencing at the rDNA.  Seven representative 
Northern blotting experiments are shown.  The sample loaded in each lane is indicated above the top panel 
of each set of blots.  A RNA Pol II-transcribed gene inserted in the rDNA locus, Ty1his3AI, was used to 
assess gene silencing at the rDNA.  Total Ty1 mRNA was measured to verify that the effect of the Set1 
mutation was specific to the Ty1his3AI gene in the rDNA.  PYK1 mRNA was used to normalize the 
amount of RNA loaded in each lane.  The values representing the average ratio of Ty1his3AI/PYK1 
mRNA are shown below each Ty1his3AI panel, and the values of the average ratio of total Ty1/PYK1 









Set1 mutant HIS3/PYK1 STD Total Ty1/PYK1 STD 
WT 1.00 0.00 1.00 0.00 
set1Δ 3.50 0.38 1.51 0.64 
G951A 9.19 0.79 1.44 0.62 
Y967F 1.53 0.63 1.15 0.69 
Y967A 8.92 2.43 2.20 1.14 
Y993A 5.09 1.34 2.37 1.01 
N1016A 4.26 0.40 1.96 0.92 
H1017L 4.37 0.68 1.71 1.14 
     
WT 1.00 0.00 1.00 0.00 
set1Δ 4.89 1.81 1.46 0.52 
F1056Y 0.84 0.12 0.96 0.28 
Y1054A 3.31 0.66 1.09 0.21 
     
WT 1.00 0.00 1.00 0.00 
set1Δ 4.86 0.44 1.03 0.42 
R1013H 3.10 0.30 1.03 0.10 
     
WT 1.00 0.00 1.00 0.00 
set1Δ 5.78 1.60 1.82 0.48 
Y1054F 6.24 1.07 1.41 0.15 
F1056A 5.35 1.14 1.59 0.49 
C1068A 9.67 1.57 1.29 0.26 
C1070A 5.28 1.77 1.47 0.56 
C1075A 4.88 1.29 1.29 0.26 
C1075Y 4.22 1.20 1.23 0.37 
     
WT 1.00 0.00 1.00 0.00 
set1Δ 5.62 1.11 1.21 0.07 
I972A 1.38 0.51 1.03 0.45 
I989A 1.31 0.27 1.03 0.22 
     
WT 1.00 0.00 1.00 0.00 
set1Δ 7.28 0.54 1.50 0.11 
T1024Y 1.48 0.26 1.06 0.15 
T1024A 1.22 0.14 0.99 0.19 
R1042H 6.19 0.59 1.14 0.11 
E1049A 7.29 1.19 1.56 0.25 
Y1052F 1.05 0.01 1.05 0.15 
Y1052A 0.77 0.17 1.05 0.08 
Y1052V 0.81 0.35 0.99 0.31 
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Table 11. continued. 
Set1 mutant HIS3/PYK1 STD Total Ty1/PYK1 STD 
WT 1.00 0.00 1.00 0.00 
set1Δ 4.50 1.38 1.00 0.38 
H1017A 1.10 0.29 1.00 0.34 
H1017R 5.00 1.49 1.40 0.51 
R1042A 0.60 0.07 1.10 0.20 
E1048A 1.00 0.37 1.50 0.89 
E1049G 2.80 0.66 1.40 0.73 
L1050A 0.70 0.15 1.10 0.38 
a
Data was calculated as a ratio of Ty1his3AI to either total Ty1 or PYK1.  STD = standard deviation.  All 
Northerns are based on three separate experiments, except for the last set which was repeated four times. 
 
The results of Northern blotting experiments presented in Figure 24 revealed that 
in most cases the ability of a mutant Set1 protein to maintain silent chromatin at the 
rDNA correlated directly with its ability to methylate histone H3 in vivo (Figure 23).  All 
of the null mutants exhibited a defect in silencing of RNA Pol II transcription consistent 
with methylated H3K4 being required for the function of silent chromatin at the rDNA.  
With the exception of R1042H, each mutant with in vivo levels of methylated H3K4 that 
were similar to or greater than wild type retained the ability to silence the Ty1his3AI 
gene in the rDNA.  The data largely support the existing model that the requirement for 
Set1 in gene silencing reflects its role in methylation of H3K4 (Table 10). 
 The partial activity mutants had the most diverse rDNA-silencing phenotypes 
and provided insight into the specific form of K4-methylated H3 required for gene 
silencing at the rDNA.  The G951A, Y967F and Y993A mutants share similar defects in 
methylation of H3 in vivo, with moderate levels of monomethylated H3K4 and no di- 
and trimethylated H3K4 detected in cell extracts.  The Y967F mutant exhibited a partial 
defect while G951A and Y993A each exhibited a complete defect in silencing of the 
 125 
RNA Pol II reporter gene located in the rDNA.  These results suggest that silent 
chromatin does not function in the presence of moderate levels of monomethylated 
H3K4 if di- and trimethylated H3K4 are absent.  Two other partial activity mutants, 
Y1052F and Y1052V, with reduced in vivo levels of monomethylated H3K4, behaved 
like wild type cells retaining the ability to silence RNA Pol II gene expression at the 
rDNA.  These results indicate that silent chromatin is maintained in the presence of 
reduced levels of monomethylated H3K4 when di- and trimethylated H3K4 are present, 
thereby pointing to a requirement for higher order methylated forms of H3 in the 
function of silent chromatin in S. cerevisiae.  Three other partial activity mutants 
(R1013H, Y1054F and E1049G) with moderate to wild type levels of mono- and 
dimethylated H3K4, but severely reduced trimethylated H3K4, exhibited defects in gene 
silencing at the rDNA.  Taken together, the results from the partial activity mutants 
strongly suggest that trimethylated H3K4 is required to silence RNA Pol II transcription 
at the rDNA.  Some of the Set1 mutants produced defects in rDNA silencing greater than 
set1Δ: G951A, Y967A, Y993A, N1016A, H1017L, Y1054F, and C1068A.  These 
mutants may be affecting additional factors that function in silencing at the rDNA 
although any factors are unknown.   
Suppression of ipl1-2 allele growth defects  
In addition to methylating H3K4, Set1 also dimethylates the non-histone protein 
Dam1 at K233 as part of the anaphase checkpoint (Zhang et al., 2005).  Dam1 is part of 
a large ten subunit complex called the Dam1 complex.  Approximately 16-20 Dam1 
complexes associate to form a single Dam1 ring which encircles microtubules, sliding 
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along the microtubule surface creating energy that is used to power chromosome 
movement and thus segregation of chromosomes during anaphase (Westermann et al., 
2007).  Repositioning of incorrectly attached microtubules requires the phosphorylation 
of Dam1 by the S. cerevisiae Aurora kinase, Ipl1.  Methylation of Dam1 by Set1 
prevents phosphorylation of nearby serine residues by Ipl1, a situation that can lead to 
chromosome loss and growth defects due to missegregation of chromosomes during 
mitosis.  Cells with a point mutation in IPL1, ipl1-2, have reduced kinase activity and 
exhibit growth defects due to chromosome loss.  Growth defects associated with ipl1-2 
can be suppressed by deletion of Set1, creating a situation where phosphorylation of 
Dam1 occurs in a manner that not antagonized by Set1, thereby allowing repositioning 
of incorrectly attached spindle fibers.  Because Dam1 and histone H3 are different 
substrates we expected that the ability to methylate Dam1 would provide an additional 
means to further separate the Set1 mutants into functional classes.   
Cells carrying an ipl1-2 allele and lacking the endogenous SET1 gene were 
transformed with the individual set1 mutations to evaluate the ability of the Set1 mutants 
to methylate Dam1 (Materials and Methods).  Plate growth assays were performed to 
evaluate the ability of the Set1 mutants to methylate Dam1 and are summarized in Table 
10.  The controls, cells with a wild type copy of the SET1 gene (ipl1-2 SET1) and cells 
lacking SET1 (ipl1-2 set1), grew equally well at the permissive temperature (22°C).  
However, the ipl1-2 SET1 cells exhibited growth defects at 30°C, a condition that is 
permissive for the growth of ipl1-2 set1cells.  As has been shown previously, growth 
at 30°C occurs in set1 cells that lack the ability to methylate Dam1 (Zhang et al., 
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2005).  Overall, each of the null mutants suppressed the growth defect of ipl1-2 allele at 
30°C, indicating that methylation of Dam1 does not occur in these mutants.  In contrast, 
none of the mutants with wild type activity were able to suppress the ipl1-2 growth 
defect at 30°C suggesting that these Set1 mutant proteins have retained the ability to 
methylate Dam1. 
 Purification of COMPASS and in vitro analysis 
 Both Human MLL complexes and Set1A/Set1B complexes contain subunits that 
are homologues to those found in yeast COMPASS.  The MLL family forms multi-
subunit complexes characterized by three core subunits of WDR5, RBBP5, and Ash2L 
forming a core platform to which other MLL proteins can associate (Dou et al., 2006).  
These subunits have counterparts in the yeast Set1 COMPASS complex through 
conserved domains: WDR5 is similar to Swd3, RBBP5 is similar to Swd1, and Ash2L is 
similar to both Bre2 and Spp1.  The most studied, WDR5 for WD repeat domain 5, is a 
doughnut shaped structure with propeller-like domains containing a substrate specific 
channel through the middle that interacts with dimethylated lysine 4 histone H3 
(Wysocka et al., 2005b; Dou et al., 2006).  WDR5 is a promiscuous subunit of SET 
domain methyltransferases and interacts with many methyltransferase complexes like the 
MLL family and human Set1A/Set1B complex, forming an initial complex of RBBP5 
and Ash2L and then recruits MLL1 for methylation (Steward et al., 2006).   
 Set1A and Set1B associate with the same set of subunits: Ash2L (homolog of 
Bre2 in yeast), WDR5 (as Swd3 in yeast), RBBP5 (as Swd1 in yeast), CFP1 (as Spp1 in 
yeast), WDR82/Swd2 (as Swd2 in yeast), and DPY-30 (as Sdc1 in yeast).  These 
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subunits share conserved domains and are thought to act accordingly with similar 
functions and roles in histone methylation.  Both Set1A and Set1B form distinct and 
separate complexes that each bind to a separate regions of euchromatin, shown by 
confocal microscopy experiments with differential staining between localization of 
Set1A and Set1B in human nuclei (Lee et al., 2007).  It is believed that human 
Set1A/Set1B complexes are responsible for ~95% of all methylation, with MLL 
complexes contributing the remaining 5% of total methylation to specifically targeted 
HOX genes.  Wdr82 is one of the more well studied subunits of human Set1A/Set1B 
complexes.  Wdr82 is a WD40 domain protein similar to WDR5 and a homolog of Swd2 
in yeast COMPASS.   
 Tandem affinity purification (TAP) can be used to evaluate the ability of Set1 
mutants to associate with the other subunits of COMPASS as well as using these extracts 
in in vitro assays to investigate the effect these Set1 mutants have on interacting with 
both SAM and histone H3 through measuring kinetic constants.  COMPASS contains 
eight subunits including Set1, Bre2, Swd1, Spp1, Swd2, Swd3, Sdc1, and Shg1.  
Previous work from our lab has shown that all subunits, with the exception of Shg1, are 
required for silencing of RNA Pol II transcription at the rDNA and at telomeres.  
Deletion of individual subunits of COMPASS results in decreased levels of H3K4 
methylation (Mueller et al., 2006).  In order to explain Set1 mutants with partial 
function, TAP was used to investigate whether the association of Set1 is compromised.  
TAP tagged Bre2 was used to purify COMPASS effectively using first IgG beads 
followed by cleavage with TEV protease and then a second step of purification with 
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Calmodulin beads.  Proteins from TAP extracts from a wild type strain and two partial 
function mutants, R1013H and Y967F, were separated using SDS-PAGE gradient gels 
and silver stained (Figure 26).  In each Set1 mutant, seven of the eight subunits of 
COMPASS can clearly be seen including Set1.  Some may argue that Y967F exhibits 
weakened interaction with Set1.  Although the band for Set1 is light, the other six 
subunits would not be present if Set1 failed to associate with COMPASS.  In 
experiments presented in Roguev et al., when purifying COMPASS from a Bre2-TAP 
strain in a set1Δ background only Sdc1 is able to co-purify with Bre2 (Roguev et al., 
2001).  This is not the case in the TAP results shown in Figure 25.     
In vitro assays were performed with purified COMPASS from wild type (lanes 4-
9) and R1013H TAP extracts (lanes 13-18) (Figure 27).  Results were compared to in 
vivo levels of methylated H3K4 in wild type and set1Δ strains.  In both wild type and 
R1013H in vitro assays histone methylation can be seen in the absence of added SAM 
meaning that SAM remains associated with COMPASS throughout an entire 
purification.  Wild type in vitro assays show an increase in histone methylation with 
increasing concentrations of SAM, however, R1013H assays do not suggesting that this 
mutant has a defect in methylation of histone H3 whether it be due to the mutation 
affecting binding of H3K4 or due to a solely catalytic defect.  In the future, the histone 
methylation activity of TAP-purified COMPASS will be analyzed in vitro in order to 
further understand the effect these mutants have on the catalytic mechanism of methyl 




Figure 26.  TAP purification of COMPASS from R1013H and Y967F Set1 mutants.  COMPASS was 
purified from cells that express the Bre2 protein fused to the TAP tag in wild type, R1013H, or Y97F 
strains.  Proteins in the kiloDaltons (kDa) ladder and COMPASS were purified by 4-20% SDS-PAGE and 
visualized by silver staining.  COMPASS proteins are indicated to the left and a molecular weight ladder is 
indicated to the right of the figure.  Each of the three panels represents a separate experiment with wild 












Figure 27.   Western analysis of purified COMPASS from wild type and R1013H strains expressing 
Bre2-TAP.   In vivo (lanes 1-3, 10-12) and in vitro levels of methylated histone H3 (lanes 4-9, 13-18) 
were analyzed using Westerns.  The left panels contain in vitro analysis of wild type purified COMPASS 
(lanes 4-9) while the right panels contain in vitro analysis of R1013H-Set1 purified COMPASS (lanes 13-
18).  Histone methylation was detected in whole cell extracts of SET1
+
 cells (lanes 1 and 3, 10 and 12) but 







 We have designed and characterized thirty mutants within the catalytic SET 
domain of yeast Set1.  Each mutant was characterized for their level of expression in 
vivo with Set1 antisera, for the level of H3K4 methylation in vivo with quantitative 
Westerns, and for their ability to silence an RNA Pol II-transcribed gene inserted into the 
rDNA through Northerns.  R1013H and Y967F were analyzed for their ability to 
associate with COMPASS using tandem affinity purification, and purified R1013H-
COMPASS was analyzed for its ability to methylate full length H3 in vitro.  Set1 
mutants were placed into three categories: wild type mutants, partially active mutants, 
and null mutants.  Several amino acids within the SET domain can be altered without 
any loss of SET domain activity.  In addition, several residues are essential for Set1 
activity, producing a complete loss of methylation, yet are still expressed in vivo at 
levels similar to wild type.  Nearly all Set1 is thought to incorporate into COMPASS; 
otherwise free Set1 is unstable (Roguev et al., 2001).  The fact that all of the Set1 
mutants are expressed and found in vivo suggests that each one is incorporated into 
COMPASS.  This makes for an interesting result where a completely catalytically 
inactive Set1 mutant, such as N1016A, is still able to form COMPASS.  In a set1Δ 
strain, it is unknown what other processes may be affected by disassembling the 
COMPASS complex.  In some ways, this mutant would function as a better control than 
a set1Δ strain because it controls for any unknown functions of COMPASS that do not 
rely on the catalytic ability of Set1.  Additional experiments would be needed to 
determine if a catalytically inactive COMPASS could serve as a control.  For example, 
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ChIP could be used to verify association with RNA Pol II at actively transcribed gene.  It 
would also be important to verify if the proper stoichiometry of COMPASS subunits was 
maintained in a null mutant.   
 Trimethylated H3K4 is required for silencing at the rDNA 
 Our data clearly show that trimethylation of lysine 4 of histone H3 is required for 
silencing of an RNA Pol II-transcribed gene at the rDNA.  The Set1 mutant Y1052A 
shows reduced levels of monomethylated H3K4 with wild type levels of di- and 
trimethylated H3K4 and is proficient in rDNA silencing.  This mutant suggests that 
monomethylated H3K4 is not required for silencing at the rDNA.  Set1 mutants G951A, 
Y967F, and Y993A display wild type levels of monomethylated H3K4 with a loss of di- 
and trimethylated H3K4, and these mutants are all defective for silencing.  These results 
suggest that either di- or trimethylation of H3K4 is required for rDNA silencing.  Set1 
mutants R1013H and Y1054F show wild type and slightly reduced, respectively, mono- 
and dimethylated H3K4 with a complete loss of trimethylated H3K4.  This data suggests 
that trimethylated H3K4 is required for silencing at the rDNA.    
 Set1 mutants classes 
Several of the Set1 mutants analyzed produced greater than wild type levels of 
histone methylation with normal wild type levels of silencing at the rDNA: H1017A, 
T1024Y, T1024A, R1042A, E1048A, L1050A, Y1052F, and Y1052V.  These mutants 
were also unable to suppress the ipl1-2 growth defect at 30°C meaning these Set1 mutant 
proteins are able to properly methylate Dam1.  These mutants are prime candidates for 
further analysis to determine kinetic constants.  Some of these Set1 mutants (H1017A, 
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R1042A, E1048A, and L1050A) result in increases in all three levels of H3K4 
methylation in vivo.  It is likely that these mutants have lost the ability to regulate the 
rate at which histone methylation occurs relative to wild type; however, only further 
study will confirm this theory.   
 Another class of mutants is partial function mutants: G951A, Y967F, Y993A, 
R1013H, E1049G, Y1052A, and Y1054F.  These mutants produce levels of methylated 
H3K4 less than 50% of wild type levels yet produced conflicting effects on rDNA 
silencing.  For instance, G951A, Y967F, and Y993A all produced ~50% of 
monomethylated H3K4 with a complete loss of di- and trimethylated H3K4.  Yet, 
G951A and Y993A are defective for silencing while Y967F only gives a slight defect.  
The same situation exists with R1013H, E1049G, and Y1054F.  This group of mutants 
are targeted for TAP to determine if this conflicting data is a result of subunit 
composition and for kinetic in vitro assays.     
GXG motifs are involved in SAM binding 
G951A is part of the GXG motif (I) known to be important in binding SAM 
(Shields et al., 2003).  This mutant has relatively wild type levels of monomethylated 
H3K4 in vivo, but a complete loss of di- and trimethylation with a partial defect in Dam1 
methylation.  Mutation of this glycine to alanine in other methyltransferases observed a 
decreased ability to bind SAM (Shields et al., 2003).  Binding of SAM could be assessed 
through TAP purification of COMPASS in in vitro kinetic assays with increasing 
amounts of SAM.  The higher the amount of SAM required to overcome a binding 
defect, the weaker the binding is between yeast Set1 and SAM.  In addition, in vitro 
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binding assays could be performed as described in Shields, et al. by measuring the 
amount of bound 
3
H-SAM to purified G951A-COMPASS using scintillation counting. 
Histidine residues in SET domain proteins are responsible for positioning 
key tyrosine residues 
 We found that substitutions at His1017 in yeast Set1 are associated with a variety 
of phenotypes.  His1017, along with Arg1013, is part of a conserved motif (III) 
RXXNHS/C in SET domain proteins (Figure 5).  The residues in motif III along with 
motif II (YXG) and IV (EELXY/FXY) form the active site pocket, with motif III 
thought to serve a role in binding SAM.  Arg1013 and His1017 align with two histidines 
in Set7/9 theorized to assist Tyr245 and Tyr335 with catalysis by properly positioning 
these tyrosine residues in the active site (Table 2) (Kwon et al., 2003; Xiao et al., 2003).  
These residues largely have a structural role and do not make direct contact with either 
SAM or lysine 4 of histone H3.  Positioning of these residues within both human Set7/9 
and human MLL1 (Table 2) show the functional group of both residues oriented away 
from the active site (Figure 7, 9).  Although it is unlikely that either yeast Set1 residues 
(Arg1013 and His1017) form contacts with either SAM or lysine 4 of histone H3, 
mutations of both residues produced interesting results.  Yeast Set1 mutant H1017L 
produced a null mutant.  In addition, H1017R is a null mutant suggesting that the 
conservation of His1017 in SET motif III is due to more than just the need for a 
positively charged functional group at that position.  Interestingly, H1017A produced a 
gain of function SET1 allele, with a 1.5-fold increase of monomethylated H3K4, a 2-fold 
increase of dimethylated H3K4, and a 3.2-fold increase of trimethylated H3K4.  His1017 
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may serve a more structural role in yeast Set1 although it is unknown if it functions to 
position any tyrosines within the active site of yeast Set1.   
 Yeast Set1 Arg1013 aligns with His293 in human Set7/9, and as described 
above, is one of two histidines in Set7/9 theorized to assist Tyr245 and Tyr335 with 
catalysis by properly positioning these tyrosine residues in the active site (Kwon et al., 
2003; Xiao et al., 2003).  R1013H produces a complete loss of trimethylated H3K4 and 
decreased levels of dimethylated H3K4, in contrast to H1017R which produced a null 
yeast Set1 mutant.  With R1013H, there is a change in the length of the functional group 
but it is unknown what other amino acids may be affected by this change.   
The Phenylalanine/Tyrosine switch in SET domain proteins  
 In SET domain proteins there is a phenomenon that exists called a 
phenylalanine/tyrosine switch that controls product specificity.  The presence of the 
hydroxyl group of a tyrosine residue blocks the rotation of methylated lysine 4 of histone 
H3 and prevents higher levels of methylation (Collins et al., 2005).  This switch is used 
to explain why Set7/9 cannot perform higher levels of methylation and remains a 
monomethyltransferase.  SET domain proteins are rich in tyrosine residues, any one of 
which could control product specificity.  In Set7/9, Tyr245 and Tyr305 are believed to 
serve this function, while in other SET domain proteins other tyrosine residues may 
fulfill this role.   
 Yeast Set1 Tyr967 aligns with Tyr245 in human Set7/9.  As mentioned above, 
Tyr245 is one of two amino acids in Set7/9 studied for its role in product specificity in 
the phenylalanine/tyrosine switch.  Mutant Y245A removes steric hindrance within the 
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active site by disrupting hydrogen bonding within the active site and allows Set7/9 to 
trimethylate H3K4 where normally it only monomethylates.  The presence of the 
hydroxyl group of Tyr245 prevents monomethylated H3K4 from rotating and aligning 
with a new molecule of SAM for further methylation (Xiao et al., 2003; Hu and Zhang, 
2006; Zhang and Bruice, 2007).  It was thought that mutation of Y967F would allow 
higher than normal levels of methylation, however the opposite occurred producing a 
mutant with ~50% of wild type monomethylated H3K4 and a loss of di- and 
trimethylated H3K4.  Furthermore, although the H3K4 methylation profile is nearly 
identical to G951A and Y993A with a complete loss of silencing at the rDNA, only a 
slight loss of rDNA silencing is detected (1.5-fold increase over wild type) in Y967F.  
Y967F is able to methylate Dam1 suggesting that the methylation defect is substrate 
specific and only affecting methylation of histone H3 and not Dam1.  It is possible that 
substitutions at Y967 weaken interactions with other COMPASS members.  Spp1 is a 
PHD containing protein required for trimethylation of H3K4 and for silencing at the 
rDNA but is not required for methylation of Dam1 (Schneider et al., 2005; Zhang et al., 
2005; Mueller et al., 2006).  This could explain why Y967F loses histone methylation 
but is still able to methylate Dam1.  TAP purification of Y967F Set1 (Figure 25) shows 
seven of the eight subunits can be purified.  However, silver staining is not quantitative.  
Another possibility is that Y967F continues to associate with and methylate H3K4 at 
silent chromatin but is unable to interact with H3 at active chromatin.  This can be tested 
by ChIP with antisera against Set1 or another COMPASS protein in active and silencing 
regions of the genome.   
 138 
Yeast Set1 Tyr993 is part of a previously uncharacterized YXF motif in SET 
domain proteins and aligns with Tyr3883 of MLL1 (Table 2, Figure 5).  The crystal 
structure of MLL1 shows hydrogen bonds between the adenine ring of SAM and 
Tyr3883 (Southall et al., 2009).  The mutant of Y993A produces 50% of 
monomethylated H3K4 with a complete loss of di- and trimethylated H3K4.  As with 
G951A, this mutant may affect binding of SAM and will therefore be tested in vitro with 
increasing concentrations of SAM.  If there is no effect on SAM binding it is possible 
Tyr993 is essential for forming hydrogen bonds within the active site.     
Thr1024 aligns with Tyr305 of Set7/9 (Table 2), a residue studied for its role in 
product specificity.  The active site contains several water molecules, one of which is 
close to the amine group of lysine 4 of histone H3 and forms a hydrogen bond with 
Tyr305.  Hydrogen bonding within the active site of Set7/9 is essential in forming a 
water channel which shuttles protons out of the active site allowing deprotonation of 
lysine 4 of histone H3, the first step in the mechanism of histone methylation (Wang et 
al., 2007b; Zhang and Bruice, 2007, 2008a, b).  Hydrogen bonding is also necessary for 
proper alignment of lysine 4 of histone H3 with SAM molecules for methylation to 
occur (Couture et al., 2006c).  Hydrogen bonds between Tyr305, Tyr245, and 
monomethylated H3K4 hinder the rotation of monomethylated H3K4 and alignment 
with an additional SAM molecule preventing additional methylation.  When mutated to 
Y305F steric hindrance is removed and allows the monomethyltransferase Set7/9 to 
dimethylate H3K4 (Kwon et al., 2003; Xiao et al., 2003; Wang et al., 2007b; Zhang and 
Bruice, 2007; Hu et al., 2008).  We expected that removal of the hydroxyl group of 
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Thr1024 would cause higher levels of trimethylated H3K4 at the expense of mono- and 
dimethylated H3K4.  The presence of a threonine in yeast Set1 could account for why 
yeast Set1 is able to produce all three levels of histone methylation.  Set1 mutants 
T1024Y and T1024A produce 3- and 4.5-fold increases, respectively, in 
monomethylated H3K4 in vivo with relatively wild type levels of di- and trimethylated 
H3K4.  The presence of this threonine is essential to maintaining wild type levels of 
histone methylation and it is possible that these mutations affect the rate of histone 
methylation.  It is unlikely that these mutants are functioning by steric hindrance as both 
a mutation to a tyrosine and alanine residue produce similar results.  It is also unlikely 
that the mutants are affecting hydrogen bonding as T1024Y still retains a hydroxyl 
group.   
 Yeast Set1 Tyr1052 aligns with Tyr3942 in human MLL1 (Table 2) and Tyr3942 
is considered the Phe/Tyr switch for MLL1.  Without additional complex members 
MLL1 alone is a monomethyltransferase that utilizes positioning of Tyr3942, which is 
not conserved in Set7/9, to prevent di- and trimethylation (Patel et al., 2009).  When 
MLL1 associates with RBBP5, WDR5, and Ash2L in vitro, the complex is still only able 
to mono- and dimethylate H3K4.  Only by mutating Y3942F in an in vitro system with 
MLL1, RBBP5, WDR5, and Ash2L is it able to trimethylate H3K4 (Patel et al., 2009).  
The orientation of Tyr3942 depends upon whether or not MLL1 binds a histone H3 
peptide (Figure 9).  Upon binding of a histone H3 peptide, the position of Tyr3942 re-
orients and points towards Tyr3858 (Tyr967 in yeast Set1); otherwise, Tyr3942 is 
positioned ~90° away pointing towards Tyr3914 (Thr1024 in yeast Set1).  The 
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orientation of Tyr3942 shown in Figure 9 is the position it obtains when bound with a 
histone H3 peptide (Southall et al., 2009).  Yeast Set1 is believed to be an exception to 
the Phe/Tyr switch since it retains a tyrosine residue at 1052 yet can still perform mono-, 
di-, and trimethylation of H3K4.  Y1052F shows a 1.5-fold increase over wild type in 
trimethylated H3K4, consistent with previously published work who reported that a 
Y1052F substitution mutant can suppress a trimethylated H3K4 defect associated with 
deletion of the gene encoding Spp1, a member of the COMPASS complex that 
stimulates the trimethylation of H3K4 of Set1 (Takahashi et al., 2009).  Y1052V 
produces a 2.7-fold increase over wild type in trimethylated H3K4.  Our results show 
that the hydroxyl group in Y1052 limits trimethylation of H3K4.  This restriction if lifted 
when Tyr1052 is mutated to either phenylalanine or valine but not with alanine.  
Y1052A is a partial function mutant with reduced monomethylated H3K4 and normal 
levels of di- and trimethylated H3K4.  Overall, the hydroxyl group of Y1052 can limit 
methylation activity and the size of the amino acid at this position also impacts activity.  
In vitro testing would allow us to measure the rate of each methyl addition and 
determine how these mutants are affecting catalysis.   
 Conserved arginine residue involved in protein-protein interactions 
Arg1042 is a highly conserved residue among SET domain proteins.  In general, 
arginine residues have a role in protein-protein interactions.  Human H3K4 
methyltransferases interact with WDR5 (WD repeat domain 5), a doughnut shaped 
structure with propeller-like domains containing a substrate specific channel through the 
middle that interacts with dimethylated lysine 4 histone H3 (Wysocka et al., 2005b; Dou 
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et al., 2006).  Crystal structures have clearly shown an N-terminally truncated WDR5 is 
able to orient and present a tightly bound dimethylated H3K4 substrate to the 
methyltransferase for trimethylation (Couture et al., 2006b; Han et al., 2006; Ruthenburg 
et al., 2006).  WDR5 is a homolog to yeast Swd proteins and is most similar to Swd2.  
Co-crystallization of WDR5 with a portion of MLL1 identified an arginine containing 
domain called Win for WDR5 interaction motif that is highly conserved among 
multicellular organisms (Patel et al., 2008a).  Win has not been found in yeast.  WDR5 
recognizes Arg3765 within the C-terminal region of SET domain of MLL1, causing the 
MLL1 complex to form and become enzymatically active (Patel et al., 2008a; Patel et 
al., 2008b).  This interaction between WDR5 and MLL1 occurs within the same surface 
as interaction with H3K4 and relies on phenylalanine residues (like Phe133) present on 
the surface of WDR5 (Song and Kingston, 2008).   
Yeast R1042 does not align with Arg3765 in MLL1 and is not located within the 
same motif (GSARAE) as Arg3765.  However, because it is highly conserved there is 
the possibility that it might function in protein-protein interactions.  Our results indicate 
that both R1042H and R1042A produced wild type levels of H3K4 methylation yet 
produced different effects for rDNA silencing (Table 10, Figure 24).  R1042H is 
defective for silencing while R1042A is proficient.  Previous work from our lab showed 
that Swd2, the homolog of WDR5, is required for silencing of RNA Pol II transcription 
at the rDNA (Mueller et al., 2006).  If R1042 interacts with Swd2 in yeast, perhaps 
R1042A is a mutant that is able to bypass the requirement for Swd2 resulting in normal 
silencing of RNA Pol II transcription at the rDNA while R1042H is unable to bypass the 
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requirement for Swd2.  Further study should include analyzing the subunit composition 
of COMPASS by TAP purification to determine if any of the Swd proteins in 
COMPASS are compromised by these mutants.  
 The EEL domain is important in active site structure  
 The EEL domain is part of the EELXY/FXY motif that, along with RXXNHS/C 
and YXG, forms the pseudoknot and overall structure of the active site in SET domain 
proteins (Jacobs et al., 2002; Kwon et al., 2003; Xiao et al., 2003).  E1049 is part of 
motif IV of the EEL domain that serves a structural role in SET domain proteins and out 
of the three amino acids E1049 is the most conserved.  Yeast Set1 E1049G is a mutant 
discovered through a random mutagenesis screen as a mutant with partial silencing of 
RNA Pol II silencing at the rDNA.  The data produced supports the idea that E1049 is 
the critical residue as E1048A and L1050A are wild type in nature (Table 10).  Mutation 
to a smaller residue, either E1049A or E1049G, abolishes H3K4 methylation and the 
structure of the active site could be compromised.  Because the distance between the 
EEL domain and SAM and lysine 4 of histone H3 it is unlikely that the EEL domain 
forms direct interactions with either one (Figure 7, 9).  Future work will focus on 
determining the role of E1049 in SET domain proteins, whether it be active site structure 
or binding of lysine 4 of H3 or SAM.  Defects in the structure of the active site could 
affect overall Set1 structure and thus affect its association with COMPASS.  In vitro 




Mechanism of SET domain proteins 
Studies with the crystal structure of Set7/9 have provided two possibilities on 
how the mechanism of SET domain proteins occurs, primarily the initial step of 
deprotonation of lysine 4 of histone H3.  One model is that an active site base from a 
tyrosine residue functions to deprotonate lysine 4 while another model suggests the 
formation of a water channel through hydrogen bonding with tyrosine residues and water 
molecules in the active site serve as proton acceptors to deprotonate lysine 4 of histone 
H3.  Yeast Set1 Tyr1054 aligns with human Set7/9 Tyr335, an amino acid that has been 
studied as a possible active site base (Guo and Guo, 2007).  Formation of an active site 
base with Tyr335 has largely been disproven based on computer simulations with Set7/9 
that show that while bound with lysine 4 of histone H3 and SAM the pKa of Tyr335 is 
18.7 while the pKa of lysine 4 of histone H3 is 8.5 (Zhang and Bruice, 2007).  Our data 
also argues against the presence of an active site base.  None of the tyrosine residues 
mutated to phenylalanine produced a complete loss of histone methylation.  Based on the 
positioning of Tyr335 in Set7/9 (Figure 7) and Tyr3944 in MLL1 (Figure 9) it is likely 
that Tyr1054 could affect interaction with both lysine 4 of histone H3 and SAM.  
Y1054F is a partial function mutant with reduced mono- and dimethylated H3K4 and a 
loss of trimethylated H3K4 in vivo.  The hydroxyl group of Tyr1054 is required for full 
levels of methylation but the presence of the phenyl ring, by Y1054F, still permits low 
levels of methylation.  Y1054A shows a complete loss of all methylation.  Future work 
will focus on an in vitro analysis to further analyze the effect these mutants have on 
catalysis.    
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
 My research has focused on understanding how chromatin transitions from 
actively transcribed euchromatin to silent heterochromatin and factors that affect this 
transition, namely Set1 a protein methyltransferase that targets lysine 4 of histone H3 
and Dam1.  This change in chromatin forms some of our fundamental questions of how 
chromatin structure and  protein methylation affects gene expression.  One of my 
projects consisted of using a single molecule technique to analyze changes in chromatin 
structure through the in vivo expression of a DNA methyltransferase M.CviPI.  My 
second project focused on identifying critical residues in yeast Set1involved  in binding 
of SAM and lysine 4 of histone H3, in the phenylalanine/tyrosine switch, and in the 
mechanism of SET domain proteins.   
In vivo expression of M.CviPI 
Chapter II details a single molecule technique that was used to analyze changes 
in chromatin structure through the in vivo expression of a DNA methyltransferase 
M.CviPI.  These experiments focused on the NTS2 region in the rDNA, a region our lab 
has previously studied using MNase mapping experiments (Li et al., 2006a).  With an in 
vivo expression of M.CviPI, we hoped to gain knowledge of the changes in chromatin 
structure within NTS2 region of the rDNA due to a silencing defect caused by the 
deletion of SIR2 and due to RNA Pol I transcription by using a 25 rDNA copy array with 
all twenty five 35S rRNA genes actively transcribed by RNA Pol I.  Our experiments 
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were based on the hypothesis that an actively transcribed 35S rRNA gene remains active 
throughout a single cell cycle.  Overall, we observed changes in positioning of 
nucleosomes 5, 4, and 3 in sir2Δ and 25 copy strains.  Furthermore, we have shown the 
presence of a bound factor within the 35S rRNA promoter that associates exclusively 
with actively transcribed 35S rRNA genes within the upstream element which is likely to 
be Hmo1.   
 Although we have been able to utilize a single molecule technique to observe 
changes in nucleosome positioning there are various limitations to using this technique.  
Few conclusions can be drawn from visualizing single molecules of our data, like those 
displayed in Figure 15 due to the sheer number of clones produced in each experiment.  
The data must be summarized and visualized as a whole in order to obtain information 
on how the chromatin structure is changing.  In order to visualize nucleosome 
positioning, sequencing data is summarized in graphs such as Figure 13.  The correlation 
analyses combine and summarize the data as a whole in order to show changes in 
chromatin structure (Figure 14).  In addition, although we have focused on a single 
region of the rDNA our results are still obtained from a population of cells in various 
stages of the cell cycle. 
 Data presented by Tan, R.Z. and Van Oudenaarden, et al. 2010 changes the 
outlook of this project.  A 35S rRNA gene is only transcribed for five minutes by RNA 
Pol I before becoming inactive; however, we induced M.CviPI for far longer.  Single 
molecules, like that in Figure 15, do not represent open and closed repeats.  Instead, our 
single molecules likely represent a mixture of open and closed repeats.  Because of this, 
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single molecules will not be easily segregated in to open and closed classes because they 
will not contain definable features that will discriminate between open and closed 
chromatin.  Future work will need to be done to find a way of analyzing this data and 
producing a significance value.  Dr. Mary Bryk has been working with Dr. Heather 
Wilkinson from the Department of Plant Pathology and Microbiology at Texas A&M 
University on new ways of analyzing our data.  One way is through utilizing an outlier 
distance plot which compares an unknown data set to a known data set.  Since the 25 
copy array is actively transcribed by RNA Pol I and has an open chromatin structure, 
this serves as a basis of comparison in other strains to determine differences in 
accessibility and chromatin structure.  Included in Dr. Wilkinson‟s work is forming a 
dendrogram to show how different data sets cluster in relation to each other based on 
accessibility to M.CviPI.  This is another technique that will be used in the future to 
separate clones into classes based on accessibility to M.CviPI.   
With that said, the project is significant in that it will lay the foundation to 
understand the physical structure of actively transcribed rDNA repeats and silent repeats 
using a single molecule approach.  It has long been known that the rDNA contains half 
of the repeats actively transcribed by RNA Pol I and the other half silent.  To be able to 
definitively say what characterizes the structure of active and inactive rDNA repeats 
using a single molecule technique would provide much more detail than  a technique that 
gives average changes, such as MNase and psoralen.  The project has the possibility to 
provide the lab with a new tool to analyze the rDNA that can easily be assessed with 
statistical methods such as the correlation analyses presented in Chapter II.  
 147 
Mutagenesis of yeast Set1 
 Chapter III describes a second area of research which focused on a mutagenesis 
of yeast Set1.  We have focused on critical residues in yeast Set1involved  in binding of 
SAM and lysine 4 of histone H3, in the phenylalanine/tyrosine switch, and in the 
mechanism of SET domain proteins.  Thirty mutants were created and characterized for 
their effect on in vivo H3K4 methylation, silencing of RNA Pol II transcription at the 
rDNA, and methylation of Dam1.  Y967F and R1013H Set1 mutants were purified from 
whole cell extracts to verify their association with additional complex members of 
COMPASS.  In vitro assays of wild type and R1013H COMPASS were analyzed by 
Western blot, showing a defect in H3K4 methylation for R1013H.  Our mutants have 
shown that trimethylated H3K4 is required for silencing at the rDNA.  These mutants 
also provide information on the presence of a phenylalanine/tyrosine switch in SET 
domain proteins by mutating several tyrosine residues to phenylalanine and to alanine.  
Several of these conserved tyrosine residues produced  interesting results.  Y967F and 
Y993A produced a mutant with only monomethylated H3K4.  T1024Y/A produced 
mutants with higher than normal monomethylated H3K4 suggesting that these mutants 
have lost the ability to regulate H3K4 methylation.   
These mutants have also provided a greater understanding on the catalytic 
mechanism of SET domain proteins, arguing against the presence of a base-catalyzed 
reaction and towards the use of hydrogen bonding and formation of a water channel in 
yeast Set1 for the deprotonation of lysine 4 of histone H3.  None of the tyrosine to 
phenylalanine mutants would have produced a complete loss of H3K4 methylation.  
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Conclusions about these mutants are limited because in vitro kinetic and binding assays 
have not been performed.  Many of the yeast Set1 mutants discussed above would be 
prime candidates for these in vitro assays.  There are several ways this can be 
accomplished.  One way would be to use in vitro assays with 
3
H-SAM in filter binding 
assays modeled after an article published on using such assays to study histone 
acetyltransferases (Berndsen and Denu, 2005).  This article describes in detail how to 
perform such assays and analyze the results to obtain Km, Vmax, kcat, and V/K.  These 
experiments would be carried out with recombinant full length H3 purified from 
inclusion bodies from E. coli.  A drawback of these experiments is that it would only 
provide an overall rate for the conversion of unmodified H3 to methylated H3.  This 
could possibly be addressed by first treating full length H3 with Set7/9, a 
monomethyltransferase purchased from New England Biolabs (NEB).  This would 
create a second substrate to use in these assays, monomethylated H3K4.   
 A second avenue would be to use histone H3 peptides purchased as unmodified, 
monomethylated and dimethylated H3K4, and use these peptides in assays to determine 
each individual rate.  It is unknown if small peptides could be used in these filter binding 
assays as conflicting reports of using peptides have been found in the literature.  If not, 
in vitro assays could be analyzed using mass spectroscopy to identify the products of 
these reactions.  Dr. Michelle Henderson at Texas A&M University has been working 
with Dr. Larry Dangott in using mass spectroscopy to quantitatively analyze products 
produced in in vitro assays.   In vitro binding assays could be modeled after a paper 
studying GXG motifs and their role in binding SAM (Shields et al., 2003).  As above, 
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3
H-SAM would be utilized with purified mutant COMPASS followed by measuring 
bound and unbound 
3
H-SAM through scintillation counting.   
 Results from kinetic assays would be relatively new to the field where others 
who have attempted these experiments have met with little success and questionable 
results.  Even if using peptides is not feasible, using full length H3 and monomethylated 
H3, as mentioned above, would still allow us the ability to measure the conversion to 
monomethylated H3K4 using unmodified H3, and to measure the conversion to 
trimethylated H3K4 using monomethylated H3.  Again, these results would provide 
information about how these mutants are affecting the ability of Set1 to methylated 
lysine 4 of histone H3.  Binding assays discussed above would also provide ample 
information about how these Set1 mutants are affecting association of SAM and lysine 4 
of histone H3.  Conclusions about these mutants would enable us to provide 
explanations on which residues are critical for interactions with SAM and lysine 4 of 
histone H3, on how these mutants affect the mechanism of histone methylation, and 
which mutants are critical for that reaction to occur.  Beyond in vitro assays, these 
mutants also provide the possibility of understanding how association of the subunits of 
COMPASS might be affected.  This would result in being able to draw conclusions 
about the overall COMPASS structure and composition, something that is lacking in our 
field.  Overall, our results have a greater implication in understanding human H3K4 
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HUMAN LYSINE 4 HISTONE H3 METHYLTRANSFERASES 
A vast amount of literature has been generated in the field of histone 
methyltransferases with a large focus on understanding histone methyltransferases and 
their role in leukemia and certain kinds of cancers.  Human histone H3 
methyltransferases are a complex group, comprising over a hundred different proteins.  
Specifically there are six known groups of histone methyltransferases that methylate 
H3K4 in humans: MLL complexes (which include the five separate MLL proteins 
MLL1-5), Set1A/Set1B complexes, Set7/9, Ash1, Smyd3, and Meisetz.  It has been 
proposed that the need for so many different histone methyltransferases in humans may 
be due to the need for different HMTs at different developmental stages (Malik and 
Bhaumik, 2010).  In S. cerevisiae there is only one SET domain protein responsible for 
methylation of H3K4.  In yeast, Set1 is part of a larger complex called COMPASS 
(Complex associated with Set1) with seven other subunits that associate with RNA 
polymerase II (RNA Pol II) to methylate H3K4 (Ng et al., 2003b).  Of the human 
methyltransferases mentioned above, the MLL complexes and human Set1 complexes 
contain closely related subunits to yeast COMPASS.   
 
SHARED SUBUNITS AMONG HUMAN H3K4 METHYLTRANSFERASES 
Certain subunits are commonly shared among SET methyltransferases to form a 
core complex: WDR5, RBBP5, and Ash2L.  The most studied, WDR5 for WD repeat 
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domain 5, is a doughnut shaped structure with propeller-like domains containing a 
substrate specific channel through the middle that interacts with dimethylated lysine 4 
histone H3 (Wysocka et al., 2005b; Dou et al., 2006).  WDR5 contains many copies of a 
WD40 repeat that is highly conserved from humans to yeast and works as a sort of 
adaptor protein allowing methyltransferases to interact with a dimethylated histone.  
WDR5 is a promiscuous subunit of SET domain methyltransferases and interacts with 
many methyltransferase complexes like the MLL family and human Set1A/Set1B 
complex.  WDR5 is believed to form an initial complex of RBBP5 and Ash2L and then 
recruit MLL1 for methylation (Steward et al., 2006).  A knockdown of WDR5 leads to a 
decrease in trimethylated H3K4 but methyltransferase complexes are still able to interact 
with chromatin.  WDR5 allows trimethylation of H3K4 and is required for MLL proteins 
to recognize dimethylated H3K4 (Wysocka et al., 2005b).  Crystal structures have 
clearly shown an N-terminally truncated WDR5 is able to orient and present a tightly 
bound dimethylated H3K4 substrate to the methyltransferase.  Once bound and oriented 
the dimethylated lysine 4 substrate is stabilized by tyrosine and phenylalanine residues 
nearby (including Phe133 of WDR5) forming what is typically called in the literature as 
an „aromatic cage‟ (Couture et al., 2006b; Han et al., 2006; Ruthenburg et al., 2006).  
These crystal structure data are further supported by biochemical data showing WDR5 
as a middle man to the histone tail of H3 and the MLL1 methyltransferase complex (Dou 
et al., 2006).  Co-crystallization of WDR5 with a portion of MLL1 identified an arginine 
containing domain called Win for WDR5 interaction motif that is highly conserved 
among multicellular organisms (Patel et al., 2008a).  WDR5 recognizes Arg3765 within 
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the C-terminal region of SET domain of MLL1, causing the MLL1 complex to form and 
become enzymatically active (Patel et al., 2008a; Patel et al., 2008b).  This interaction 
between WDR5 and MLL1 occurs within the same surface as interaction with H3K4 and 
relies on phenylalanine residues (like Phe133) present on the surface of WDR5 (Song 
and Kingston, 2008).  Although most of the data presented here focused on a specific 
human methyltransferase MLL1, the results are believed to be universal to all human 
methyltransferase complexes.   
Retinoblastoma binding protein 5 (RBBP5) is also a WD40 domain.  Not much 
information exists on the role of RBBP5 in MLL complexes other than it serves as a 
scaffold protein upon which other members of MLL complexes associate (Dou et al., 
2006).  As discussed above, WDR5 interacts with MLL1 and the histone H3 tail.  On the 
other side of WDR5 lies a binding site for RBBP5 characterized by a sequence of 
EVDVT that is conserved in mice and zebra fish but not in S. cerevisiae (Odho et al., 
2010).  RBBP5 is specifically required for interaction with Ash2L (absent, small, or 
homeotic-like).  These two proteins do have a direct effect on H3K4 methylation.  With 
the loss of either RBBP5 or Ash2L, di- and trimethylated H3K4 methylation is 









The MLL family has five members: MLL1, MLL2, MLL3, MLL4, and MLL5
2
.  
These members are essential in growth and development and are known for their role in 
regulating HOX gene expression.  HOX proteins have important roles in embryonic 
development, especially in proper limb development with irregular expression of these 
HOX proteins common in cancer (Yu et al., 1998; Lappin et al., 2006).  The MLL 
family forms multi-subunit complexes characterized by three core subunits of WDR5, 
RBBP5, and Ash2L forming a core platform to which other MLL proteins can associate 
(Dou et al., 2006).  These subunits have counterparts in the yeast Set1 COMPASS 
complex through conserved domains: WDR5 is similar to Swd3, RBBP5 is similar to 
Swd1, and Ash2L is similar to both Bre2 and Spp1.   
The mixed lineage leukemia (MLL) gene, also known as MLL1, ALL-1, HRX, 
and Htrx, was first discovered due to its link to childhood leukemia such as acute 
lymphoid leukemia (ALL) and acute myeloid leukemia (AML).  A chromosomal 
translocation occurs within a breakpoint cluster region (BCR) consisting entirely of 
repeated Alu retrotransposons in an intron of the MLL1 gene on chromosome 11 
(Ziemin-van der Poel et al., 1991; Djabali et al., 1992; Gu et al., 1994).  Alu repeats are 
a hotspot for recombination and are associated with numerous diseases ranging from 
                                                 
4
 Over the years the names of different MLL genes were switched and confused between many papers, 
making it difficult to present a clear description of each MLL protein.  MLL2 and MLL4 were frequently 
switched in the literature, and MLL5 was also confused with other MLL genes.  As a solution the 
nomenclature used in this dissertation was based upon the National Center for Biotechnology Information 
(NCBI).  Accordingly: MLL1 (ch11q23), MLL2 (ch12q12-q14), MLL3 (ch7q36.1), MLL4 (ch19q13.1), 
and MLL5 (ch7q22.1).  (Ex. chromosome #, then q referring to the long arm of the chromosome while p 
refers to the short arm, followed by a numerical designation for location on that arm).  
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many types of cancers and diabetes to Alzheimer‟s disease (Deininger and Batzer, 
1999).  It is estimated that there are ~500,000 copies of the Alu repeat in a single human 
genome, forming 5% of the human genome.  Recombination can occur between two Alu 
rich regions or between an Alu rich region and a region lacking Alu repeats, resulting in a 
chromosomal translocation where the arms of two different chromosomes are switched.  
About 80% of childhood leukemias are a direct result of a translocation event within the 
MLL1 gene that result in the carboxy terminus replaced with over 70 possible different 
loci (Rowley, 1998; Harper and Aplan, 2008).  Initial studies into translocations within 
MLL1 focused on identifying a specific gene with which translocation occurs; however 
there does not seem to be one translocation more common than any of the other 70 
possible loci.     
MLL1 is a protein made up of several different conserved domains including: a 
cysteine-rich zinc CXXC domain, multiple plant homeodomain (PHD) finger motifs, a 
bromo domain that recognizes acetylated lysines, a WDR5 interaction or Win motif, a 
nuclear receptor (NR) box and a C-terminal SET domain.  MLL1 is a histone 
methyltransferase with a catalytic SET domain that can add one, two, or three methyl 
groups to H3K4 using S-adenosyl methionine (Milne et al., 2002; Nakamura et al., 
2002).  In addition to its ability to methylate, the full MLL1 complex (~1 MDa) plus 
associated HDACs also acetylate and deacetylate histones (Milne et al., 2002; Nakamura 
et al., 2002).  MLL1 interacts with RNA Pol II transcriptional machinery at the promoter 
region of a specific set of genes, HOX genes, to regulate transcription (Prasad et al., 
1995; Milne et al., 2005).   
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Initially MLL1 was characterized as having two domains that activate and 
repress transcription (Zeleznik-Le et al., 1994; Prasad et al., 1995).  MLL1 is 
proteolytically processed at a conserved amino acid sequence to produce an N-terminal 
(MLL
N
/N320/p320) form containing a DNA methyltransferase activity that represses 
transcription and a C-terminal (MLL
C
/C180/p180) form containing the SET domain that 
activates transcription.  These two forms associate together in vivo and have different 
effects on transcription (Nakamura et al., 2002; Yokoyama et al., 2002; Hsieh et al., 
2003b).  Cleavage occurs by Taspase1 at a conserved amino acid sequence also found in 
MLL2 (Hsieh et al., 2003a).  Once the protein has been cleaved, MLL
C 
is 
phosphorylated causing the two forms to associate (Yokoyama et al., 2002) with the 
remaining MLL1 complex members (Nakamura et al., 2002) and localize together at 
specific sites within the nucleus (Hsieh et al., 2003b).  MLL1 genes that have undergone 
translocation cannot be cleaved and therefore cannot undergo phosphorylation 
(Yokoyama et al., 2002; Hsieh et al., 2003b).  Cleavage is also required for proper HOX 
expression, with a decrease in HOX gene expression in cells lacking Taspase1 (Hsieh et 




 with Ash2L, 
WDR5, and RBBP5 (Yokoyama et al., 2004).  This core complex is generally believed 
to be conserved among all other MLL complexes.  Early work focused on its localization 
to the promoter region of various HOX genes causing methylation of H3K4 and 
acetylation of histones (Milne et al., 2002; Nakamura et al., 2002) and activating 
transcription (Blobel et al., 2009; Robert et al., 2009).  The MLL1 complex is recruited 
to RNA Pol II by the Paf1 complex through MLL1‟s CXXC domain, leading to 
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ubiquitylation of histone H2B followed by methylation of H3K4 and initiation of 
transcription (Chang et al., 2010; Muntean et al., 2010).  Studies in mice have shown 
that MLL1 is believed to provide less than 5% of the total methylated H3K4 present in 
the cell, specifically at HOX loci, with a loss of MLL1 resulting in decreased H3K4 
methylation and decreased RNA Pol II recruitment to these promoter regions (Wang et 
al., 2009).  The majority of methylation seems to be carried out by the human 
Set1A/Set1B complex (Wu et al., 2008). 
 The repression domain of MLL1 (MLL
N
) contains a DNA methyltransferase 
domain with a cysteine-rich CXXC region that is critical for binding unmethylated CpG 
DNA (Birke et al., 2002; Ayton et al., 2004).  In humans, DNA methylation is a 
naturally occurring process that recruits transcriptional silencing complexes forming 
heterochromatin, while unmethylated regions are associated with areas of active 
transcription.  In in vitro assays, binding to specific targets by MLL1 was abolished if 
DNA is methylated, a sign of heterochromatin (Birke et al., 2002).  MLL
N
 interacts with 
HDACs through the binding of Cyp33 to the PHD finger domain of MLL1 (Xia et al., 
2003).  Cyp33 is a protein that binds the PHD zinc finger domain of MLL1 (Fair et al., 
2001), causing the function of MLL1 to change from activation of HOX transcription to 
repression of HOX transcription (Chen et al., 2008; Park et al., 2010).   
 PHD domains are known for their interactions with methylated lysines residues 
leading to activation of transcription (Shi et al., 2006; Wysocka et al., 2006), but within 
MLL1 the PHD domain has a dual role in activation or repression depending upon 
whether or not Cyp33 associates.  The interaction of Cyp33 and the PHD finger of 
 189 
MLL1 has been studied structurally using NMR spectroscopy.  Binding of trimethylated 
H3K4 by the PHD domain of MLL1 leads to activation of transcription by inhibiting 
binding of Cyp33, and binding of Cyp33 at the PHD domain of MLL1 inhibits binding 
of trimethylated H3K4 and represses transcription (Park et al., 2010; Wang et al., 2010).  
Repression by binding Cyp33 at the PHD domain is characterized by a decrease in the 
level of methylation of H3K4 and of acetylation of HOX genes although it in unknown 
how that occurs (Park et al., 2010).  The association of Cyp33 binding MLL1 causes the 
PHD domain, in combination with the bromo domain responsible for recognizing 
acetylated lysines, to shift structurally in such a way as to inhibit recognition of 
methylated and acetylated histones, respectively (Wang et al., 2010).  Although it is 
known that binding of Cyp33 at the PHD domain of MLL1 recruits HDACs to MLL1 
(Xia et al., 2003), it has not been shown that H3K4 demethylases are recruited. 
MLL1 also has a role in methylating and controlling transcription and stability of 
telomeres in humans (Caslini et al., 2009).  MLL1 associates with the nuclear envelope 
and the outside border of the nucleolus in humans, suggesting a role in the forming 
heterochromatin (Caslini et al., 2000).  MLL1 localizes to telomeres with RNA Pol II to 
methylate H3K4.  Knockdown of MLL1 leads to decreased levels of methylated H3K4 
at telomeres, stimulating a DNA damage response and cellular senescence.  RNA Pol II 
transcribes telomeric DNA forming RNA transcripts that are polyadenylated as part of a 
DNA damage response (Schoeftner and Blasco, 2008; Caslini et al., 2009). 
 MLL1 is regulated by ubiquitylation and subsequent degradation by the 






) is expressed in two phases throughout the cell cycle, 
peaking at G1/S and G2/M transitions with degradation by the proteasome in S and M 
phases by ubiquitylation at the N-terminus (Liu et al., 2007).  When the MLL gene 
undergoes translocation and a fusion protein is made the N-terminus is lost possibly 
explaining why fusion proteins are so detrimental, i.e. they cannot be degraded properly 
in response to the cell cycle (Liu et al., 2007).  Knockdown of MLL1 leads to decreased 
proliferation with cell cycle arrest at G2/M phase (Liu et al., 2007; Mishra et al., 2009), 
but the level of H3K4 methylation remains constant (Mishra et al., 2009).  The peak of 
MLL1 in the cell cycle at G1/S and G2/M coincides with increased levels of RNA Pol II 
and MLL1 at the promoter region of specific HOX genes resulting in their increased 
expression (Mishra et al., 2009).   
 MLL2, also known as ALR (for ALL-1 Related), was originally found due to its 
similarities to MLL1 with similar PHD domains, CXXC domain and zinc finger motifs, 
multiple nuclear receptor (NR) boxes, and a SET domain (Prasad et al., 1997).  As with 
MLL1, MLL2 associates with a core complex of ASH2L, RBBP5, and WDR5 (Mo et 
al., 2006) and associates to the promoter regions of target genes to methylate H3K4 
(Issaeva et al., 2007).  Cleavage of MLL2 by taspase in humans has been shown, with 
incomplete cleavage in certain types of cancers (Natarajan et al., 2010).       
The location of the MLL2 gene is close to an area known for translocations that 
result in many types of cancers and tumors (Prasad et al., 1997), however due to changes 
in its CXXC domain MLL2 very rarely forms fusions (Bach et al., 2009).  The few 
fusion proteins that are formed are not cancer causing.  This does not mean that MLL2 
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does not have a role in cancer.  A study of breast and colon cancer cells revealed 
increased expression of MLL2 (Natarajan et al., 2010).  When comparing both CXXC 
domains of MLL1 and MLL2, both are able to bind DNA however the CXXC domain 
targets both proteins to different loci (Bach et al., 2009).  This difference can be found in 
changes in the sequence of the CXXC domain of MLL2 (Bach et al., 2009).  This 
supports the idea that the MLL genes are non-redundant and may each have an important 
role with a subset of particular target genes.   
 In mice, studies have shown that MLL2 has a role in total transcriptional 
silencing that occurs during female oocyte development and fertilization (Andreu-Vieyra 
et al., 2010).  Oocytes are transcriptionally active during development until they reach 
puberty.  After this point, oocytes become completely transcriptionally silent until 
fertilization occurs (Kageyama et al., 2007).  A Cre-lox system was utilized in mice to 
conditionally knockout MLL2.  In this system lox sites (recognition sequences for Cre) 
are inserted flanking a target gene with expression of Cre recombinase to cleave and 
remove the MLL2 gene when needed.  In these mice with a conditional knockout of 
MLL2, transcriptional silencing does not occur after puberty and there is a loss in di- and 
trimethylated H3K4 but not in monomethylated H3K4 (Andreu-Vieyra et al., 2010).      
 As mentioned above MLL proteins contain nuclear receptor interaction motifs 
(NR boxes) that provide a role in activation of gene expression via nuclear receptors and 
hormone signaling.  Nuclear receptors are factors that can sense hormones and translate 
these signals into activating gene expression of a target protein.  Of the MLL family, 
MLL1 contains only one NR box while MLL2, 3, and 4 contain three or more NR boxes.  
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Although MLL1 contains an NR box, no role in nuclear receptor activation has been 
found.  The MLL2 complex, along with the three core members of Ash2L, RBBP5, and 
WDR5, is known to interact with estrogen receptor α (ERα) to recruit ERα with the 
MLL2 complex and induce expression of estrogen specific genes (Mo et al., 2006).  The 
association of ERα and the MLL2 complex is dependent on the presence of estrogen, 
while ChIP experiments showing association of MLL2 to the promoter region of 
estrogen-inducible genes and a knockdown of MLL2 showing decreased expression of 
these genes (Mo et al., 2006).  This link between MLL2 and ERα supports research 
showing a link between MLL2 and breast cancer (Natarajan et al., 2010).   
 In addition to MLL2, both MLL3 and MLL4 interact with nuclear receptors.  
Much of the nuclear receptor work discussed below has been performed in mice as well 
as human systems.  MLL3 is also known as HALR meaning homologous to ALR and 
contains many of the same domains as other MLL proteins like PHD domains and a SET 
domain, as well as multiple nuclear receptor interaction motifs (NR box).  However, 
MLL3 lacks a CXXC domain.  Deletions commonly occur within the MLL3 gene 
resulting in defects in embryonic brain development and myeloid leukemia (Tan and 
Chow, 2001; Ruault et al., 2002).  MLL4 also contains many of the same domains as 
mentioned above: a CXXC domain, PHD domains, SET domain, and a NR box 
(FitzGerald and Diaz, 1999; Huntsman et al., 1999).  A common activator of nuclear 
receptors is Asc-2 (for activating signal cointegrator-2) that functions with a variety of 
nuclear receptors to activate transcription (Goo et al., 2003; Lee et al., 2008b).  In mice, 
Asc-2 together with a MLL protein forms the ASCOM complex: activating signal 
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cointegrator-2 complex.  Asc-2 recruits either MLL3 or MLL4 along with the core 
components of RBBP5, WDR5, and Ash2l to form ASCOM-MLL3 or ASCOM-MLL4, 
respectively (Lee et al., 2006; Lee et al., 2008b).  Asc-2 is known to recruit these 
complexes to the liver X receptor that controls cholesterol and fatty acid metabolism to 
induce expression of target genes and to trimethylate H3K4 (Lee et al., 2008b).  Asc-2 
also recruits these complexes to the universal retinoic acid receptor (RAR) that is 
important a variety of areas like growth and development, embryogenesis, and 
metabolism (Lee et al., 2006).  Knockdowns in mice of either MLL3 or MLL4 are still 
viable with normal levels of gene expression at targeted receptor genes and partial 
trimethylation suggesting that these two complexes are redundant.  Only by affecting 
both MLL3 and MLL4 is gene expression and trimethylated H3K4 decreased at target 
genes (Lee et al., 2008a).   
 Of the five MLL proteins, MLL5 contains only a PHD domain, three nuclear 
localization signals (NLSs), and a SET domain that is located at the C-terminus and not 
at the N-terminus like the majority of SET domain proteins.  A complete or partial 
deletion of chromosome 7, the location of the MLL5 gene, is common in myeloid 
leukemias and is referred to as monosomy 7 (Luna-Fineman et al., 1995; Le Beau et al., 
1996; Kratz et al., 2001; Emerling et al., 2002).  MLL5 localizes within the nucleus 
through three nuclear localization signals (NLSs) and forms discrete foci within 
chromatin.  The importance of these foci and NLS domains is unknown (Deng et al., 
2004).    
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MLL5 does have a role in cell cycle progression.  Overexpression of MLL5 
causes cell cycle arrest at G1, a checkpoint for DNA damage and genome stability (Deng 
et al., 2004).  Knockdown of MLL5 arrests cells in both G1 and G2/M by activating the 
CDK inhibitor p21, causing downstream targets essential in cell cycle progression to 
lack phosphorylation required for proper function (Cheng et al., 2008).  The protein 
kinase Cdc2 phosphorylates MLL5 in G2/M phase causing MLL5 to leave chromatin.  
Once cells exit mitosis MLL5 is dephosphorylated and is able to reassociate with 
chromatin (Liu et al., 2010).  In addition to phosphorylation, MLL5 is modified with β-
N-acetylglucosamine (GlcNAc) resulting in the maturation of white blood cells called 
granulocytes by associating with the nuclear retinoic acid receptor (RARα).  Recruitment 
by these receptors is in concurrence with di- and trimethylated H3K4 at target genes 
(Fujiki et al., 2009).  The methyltransferase activity of MLL5 is dependent upon 
GlcNAcylation.  From this work, MLL5 was shown for the first time to methylate H3K4 
however it does not show what if any common MLL subunits might be associated with 
MLL5.   
 
SET1A AND SET1B METHYLTRANSFERASES  
The human Set1A/Set1B complex contains subunits that are homologous to the 
yeast Set1 COMPASS complex.  Set1A was originally found through experiments to 
identify interacting partners to CFP1, a protein containing a CXXC domain that 
recognizes unmethylated CpG sites in genomic DNA (Lee and Skalnik, 2005), while 
Set1B was identified through its similarity to Set1A (Lee et al., 2007).  As in yeast, 
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human Set1 contains an RNA recognition motif (RRM) and a SET domain.  Set1A and 
Set1B associate with the same set of subunits: Ash2L (homolog of Bre2 in yeast), 
WDR5 (as Swd3 in yeast), RBBP5 (as Swd1 in yeast), CFP1 (as Spp1 in yeast), 
WDR82/Swd2 (as Swd2 in yeast), and DPY-30 (as Sdc1 in yeast).  These subunits share 
conserved domains and are thought to act accordingly with similar functions and roles in 
histone methylation.  Both Set1A and Set1B form distinct and separate complexes that 
each bind to a separate regions of euchromatin, shown by confocal microscopy 
experiments with differential staining between localization of Set1A and Set1B in 
human nuclei (Lee et al., 2007).  It is believed that human Set1A/Set1B complexes are 
responsible for ~95% of all methylation, with MLL complexes contributing the 
remaining 5% of total methylation to specifically targeted HOX genes.  In mice, 
knockdown of Set1A and Set1B together causes a slight decrease in the level of 
trimethylated H3K4 and no effect on the levels of mono- and dimethylated H3K4.  The 
presence of other H3K4 methyltransferases skews the results of these experiments by 
focusing on the global level of H3K4 methylation (Wu et al., 2008).    
Wdr82 is one of the more well studied subunits of human Set1A/Set1B 
complexes.  Wdr82 is a WD40 domain protein similar to WDR5 and a homolog of Swd2 
in yeast COMPASS.  In yeast, COMPASS interacts with RNA Pol II containing a C-
terminal domain (CTD) that is phosphorylated on serine 5 (Ng et al., 2003b).  
COMPASS interacts with RNA Pol II through the Paf1 complex that is responsible for 
recruiting Rad6/Bre1 to ubiquitylate lysine 123 of histone H2B, a prerequisite to di- and 
trimethylation of lysine 4 of histone H3 at active genes (Dover et al., 2002; Ng et al., 
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2003a; Shahbazian et al., 2005).  Human Set1A and Set1B also associate with the 
phosphorylated serine 5 of RNA Pol II CTD at the promoter region of active genes; 
however, the Paf1 complex is not used to tether the complex to the polymerase.  Instead, 
human Set1A complex is tethered by Wdr82 by associating with the RRM domain of 
Set1A and recognizing the phosphorylation of serine 5 of RNA Pol II CTD (Lee and 
Skalnik, 2008).  Knockdown of Wdr82 causes a decrease in Set1A expression, a 
decrease in the association of the human Set1A complex at targeted promoter regions, 
and a subsequent decrease in methylated H3K4.  While Wdr82 associates with the N-
terminal RRM domain of Set1A, the other complex subunits associate with the C-
terminus of Set1A near or at the SET domain.  By using multiple truncated versions of 
Flag-tagged Set1A in combination with nuclear extracts, Western analysis of pulldowns 
show the association of each subunit of the Set1A complex with distinct regions of 
human Set1A (Lee and Skalnik, 2008).  Wdr82 association with chromatin does require 
histone H2B ubiquitylation by human Bre1 (Wu et al., 2008).  Partial knockdown of 
human Bre1 decreased the association of Wdr82 at actively transcribed genes by 
approximately 50% and a decrease in total trimethylated H3K4.   
 
SET7/9 
Set7 (Wang et al., 2001) and Set9 (Nishioka et al., 2002) were originally 
published as separate proteins and only later determined to be the same protein.  The 
protein is referred to as Set7/9 in the literature.  Set7/9 is a small 366-aa monomer that 
functions without the commonly associated subunits mentioned above to monomethylate 
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H3K4 through its catalytic SET domain and activate transcription (Wilson et al., 2002; 
Kwon et al., 2003; Xiao et al., 2003).  For these reasons Set7/9 was the first human 
H3K4 methyltransferase crystallized (Wilson et al., 2002).  Set7/9 has been linked to 
inflammation of the pancreas and diabetes in mice and humans, specifically by affecting 
islet β-cells that produce insulin (Li et al., 2008; Deering et al., 2009).  Also, Set7/9 is 
known to modify many non-histone proteins including p53, TBP components TAF10 
and TAF7, and estrogen receptor α.    
 
ASH1L 
Human Ash1L (ASH1-like) was discovered due to its similarity to Ash1 in 
Drosophila melanogaster. Drosophila Ash1 is responsible for regulation of HOX 
transcription during development.  Human Ash1 contains several domains similar to 
MLL1: a bromo domain known to recognize acetylated lysines, a PHD finger, and a 
catalytic SET domain (Nakamura et al., 2000).  Some controversy surrounds this 
protein.  In vitro data has shown Ash1 from Drosophila to trimethylate H3K4, H3K9, 
and H4K20 (Beisel et al., 2002).  However, another group reported in vitro data with 
3
H-
SAM that human Ash1L mono- and dimethylates H3K36 but not H3K4, H3K9, or 
H4K20 (Tanaka et al., 2007).  Gregory et al. 2007 has used ChIP to show that the 
association of human Ash1L peaks at the promoter regions of actively transcribed genes 
along with RNA Pol II and trimethylated H3K4, and that Ash1L occupancy is decreased 
in the middle of the gene where there are high levels of H3K9 and H4K20 methylation 




shows Ash1L methylates only H3K4 and not H3K9 or H4K20.  They do not test H3K36 
as a possible site of methylation (Gregory et al., 2007).  In human and mouse cell lines, 
Ash1L is a member of general transcription machinery and does not activate 
transcription at a specific subset of genes (Gregory et al., 2007).  Ash1L does associate 
with HOX genes to trimethylate H3K4, but Ash1L and MLL1 seem to work together at 
the promoter region of HOX genes.  Ash1L and MLL1 associate with the same genes 
independent of one another and have the same level of occupancy at these genes 
(Gregory et al., 2007).  
 
SMYD3 
Smyd3 is for SET and MYND domain containing 3 where the MYND domain is 
a zinc finger domain known to bind DNA.  Upregulation of Smyd3 is associated with a 
variety of cancers: colorectal carcinoma, hepatocellular carcinoma, breast cancer, and 
cervical cancer (Hamamoto et al., 2004; Hamamoto et al., 2006; Wang et al., 2008; Kim 
et al., 2009; Zou et al., 2009).  Within the promoter region of Smyd3, a tandem repeat of 
CCGCC is an important recognition site for the transcription factor E2F-1 (Tsuge et al., 
2005).  This repeat, when duplicated in the promoter region causes a higher expression 
level of Smyd3 that is known to be a common characteristic of the cancers listed above.  
Smyd3 interacts with RNA Pol II along with RNA helicase (HELZ) and HSP90α (heat 
shock 90kDa protein α) to di- and trimethylate H3K4 at the promoter regions of selected 
genes to activate transcription (Hamamoto et al., 2004).  RNA helicase is required for 
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association of Smyd3 to RNA Pol II and the presence of HSP90α is able to enhance 
methylation of H3K4 in vitro.    
There are multiple forms of Smyd3, one formed from an internal promoter and 
another formed by post-translational cleavage.  Smyd3-NY is an mRNA transcript 
variant resulting from an internal promoter within the Smyd3 gene, and is expressed 2.3 
fold higher in adult testis than in fetal testis.  Smyd3-NY may have a role in 
spermatogenesis in adult humans (Zhou et al., 2005).  A separate form was found from 
post-translational cleavage of Smyd3 that lacks the first 34 amino acids of the N-
terminus (Silva et al., 2008).  The N-terminus is responsible for association with 
HSP90α (Silva et al., 2008).  This truncated form has a higher level of total methylated 
H3K4 than wild type.  Cleavage of Smyd3 might be a way to control its histone 
methyltransferase activity (Silva et al., 2008).  It is possible that these two forms could 
be the same truncated version of Smyd3.  Although Silva et al. 2008 did not find any 
other variant of SMYD3 than full length wild type this data has not been confirmed by 
others.   
 Smyd3, like other H3K4 methyltransferases mentioned above, has a role in 
estrogen receptor mediated transcription.  Smyd3 interacts with the ligand binding 
domain of estrogen receptor α (ERα) (Kim et al., 2009), a nuclear receptor that senses 
hormones and translates these signals into activating gene expression of a target protein.  
Smyd3 specifically interacts with ERα to di- and trimethylate H3K4 at the promoter 
region of specific target genes.  With a knockdown of Smyd3, the level of gene 
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expression of ERα-targeted genes and the level of di- and trimethylated H3K4 decrease 
(Kim et al., 2009).  
 
MEISETZ 
 Meisetz was named for its role in controlling transcription during early meiosis: 
meiosis-induced factor containing a PR/SET domain and zinc-finger motif (Hayashi et 
al., 2005).  The centrally located SET domain of meisetz is unique from all other SET 
domain proteins in that it lacks the critical domain RXXNHS/C important in catalysis of 
H3K4 methylation, meaning that this protein catalyzes methylation with a unique 
mechanism.  Meisetz is the first tissue specific histone methyltransferase, located 
exclusively in fetal ovaries and adult testis with increased expression in cells entering 
early meiosis during prophase.  Meisetz has a role in controlling gametogenesis in both 
sexes but has been studied more in males.  Mice with both copies of meisetz deleted are 
viable but sterile for both sexes with an accumulation of dimethylated H3K4 in 
spermatocytes (Hayashi et al., 2005).  Meisetz is specific only for dimethylated H3K4 
peptide, catalyzing trimethylation.  In these cell lines, gametogenesis arrests in both 
sexes due to mislocalization of DMC1 which is responsible for recognizing double 
strand breaks.  This mislocalization disrupts double strand break repair and damages 
pairing between homologous chromosomes (Hayashi et al., 2005).   
Three single nucleotide polymorphisms identified in meisetz have been linked to 
azoospermia, a condition affecting ~1% of the male population with low sperm count, 
infertility, and sterility due to impaired gametogenesis (Miyamoto et al., 2008; Irie et al., 
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2009).  Meisetz has also been linked to recombination.  During meiosis, genetic 
variation is created by maternal and paternal chromosomes assorting randomly forming 
gametes.  Homologous chromosomes can exchange information through recombination 
termed crossing over at specific “hot spot” regions.  Meisetz binds to a 13bp DNA 
sequence through its zinc finger domain to initiate crossing over at these recombination 





Methylation of lysines was once believed to be a permanent mark, with 
modifications being lost over the course of cell division (Bannister et al., 2002).  We 
now know that there are two groups of histone demethylases: LSD conserved proteins 
and Jumonji conserved domains.  The first demethylase discovered was Human LSD1 
for lysine-specific demethylase, which demethylates dimethylated H3K4 (Shi et al., 
2004).  Sequence analysis of LSD1 found similar proteins conserved in Arabidopsis, C. 
elegans, S. pombe, and Drosophila; however, a similar conserved protein in S. cerevisiae 
was not found (Shi et al., 2004).  Only through the interaction of LSD1 with a repressor 
of transcription complex called CoREST can LSD1 demethylate dimethylated H3K4 
(Lee et al., 2005; Shi et al., 2005).  Crystallization of LSD1 bound to CoREST clearly 
shows a substrate specific channel for histone H3 (Yang et al., 2006).  LSD1‟s substrate 
specificity can change to mono- and dimethylated lysine 9 of histone H3 through 
interacting with the androgen receptor, a nuclear receptor responsible for binding 
chromatin in the presence of testosterone and activating gene expression (Metzger et al., 
2005).  Methylated H3K9, a mark present in higher eukaryotes and absent in S. 
cerevisiae, is a mark of heterochromatin and silenced transcription.  With this evidence it 
is unsurprising that elevated levels of LSD1, leading to elevated demethylation of H3K9 
and increased gene expression, are a characteristic of prostate cancer (Shi, 2007).  To 
summarize, human LSD1 can function to repress transcription by removing methylation 
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of H3K4 or can function to activate transcription by removing methylation of lysine 9 of 
histone H3 depending on what protein complex it is associated with (Wysocka et al., 
2005a).  
As mentioned above, a conserved LSD1 protein was not found in S. cerevisiae 
(Shi et al., 2004); however four conserved Jumonji (JmjC) domain proteins in yeast have 
been analyzed: Jhd1, Rph1, Gis1, and Yjr119C/Jhd2/KDM5 (hereafter referred to as 
Jhd2) (Tu et al., 2007).  Jumonji proteins are characterized by a JmjC domain and a PHD 
domain that associate specifically with methylated tails of histone H3 (Shi et al., 2007).  
Jhd1 (Tsukada et al., 2006; Fang et al., 2007; Kim and Buratowski, 2007), and Rph1 
(Kim and Buratowski, 2007; Klose et al., 2007) both target lysine 36 of histone H3 
(methylated by Set2) and characterize transcriptional elongation, while Jhd2 specifically 
demethylates H3K4 (methylated by Set1 of COMPASS) (Ingvarsdottir et al., 2007; 
Liang et al., 2007; Seward et al., 2007).  Jhd2 utilizes its PHD domain to associate with 
active and silent chromatin to regulate H3K4 methylation (Huang et al., 2010).  Deletion 
of Jhd2 causes an increase in methylated histones and an increase in Set1 at regions of 
active transcription (Ingvarsdottir et al., 2007; Liang et al., 2007; Huang et al., 2010).  
H3K4 methylation has been shown to depend on specific subunits of the proteasome 
(Laribee et al., 2007; Mulder et al., 2007), but it wasn‟t until the discovery that Jhd2 is 
polyubiquitinated by Not4, a ubiquitin ligase, and degraded by the proteasome 
(Mersman et al., 2009) that it was suggested that Not4 could control demethylation by 





ALTERNATIVE SUBSTRATES OF HUMAN LYSINE 4 HISTONE H3 
METHYLTRANSFERASES 
 Human SET domain proteins have been found to methylate non-histone proteins 
at lysine residues forming new roles of SET domain proteins (Huang and Berger, 2008).  
Human H3K4 methyltransferases have seven known non-histone substrates: p53, TAF10 
and TAF7, estrogen receptor α, NF-κB, Dnmt1, and VEGFR1.  There is not a consensus 
sequence when comparing the amino acid sequences of these proteins with the N-
terminus sequence of histone H3 (Yang et al., 2009).  NF-κB, a transcription factor 
involved in inflammatory and immune responses, and Dnmt1, a DNA methyltransferase, 
are monomethylated by Set7/9.  Methylation of these targets leads to increased 
degradation by the proteasome and are discussed elsewhere (Yang et al., 2009).  
VEGFR1, for vascular endothelial growth factor receptor 1, is tyrosine kinase receptor 
with a role in angiogenesis and vascular development is dimethylated by Smyd3 causing 
elevated autophosphorylation.  This topic is not a focus of this dissertation and is 
discussed elsewhere (Kunizaki et al., 2007).  Although these are alternative substrates, 
the interaction and the role of certain amino acids are similar to when Set7/9 interacts 
with lysine 4 of histone H3.  In some ways, these studies have led to a greater 
understanding of certain amino acids within Set7/9 than studies with histone H3.  These 
studies have also broadened the understanding of the role of Set7/9 in cancer outside of 
its role in methylating H3K4.      
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P53 TUMOR SUPPRESSOR 
p53 is a DNA binding protein that is highly expressed in tumor cells in response 
to stress or damage, leading to a change in gene expression of many target gene.  p53 is 
mutated in 50% of human cancers.  p53 expression has been linked to apoptosis, cell 
cycle arrest, senescence, DNA repair and metabolism, forming the conclusion that p53 
functions to inhibit growth and invasion of tumor cells (Olivares-Illana and Fahraeus, 
2010).  p53 is a lysine-rich protein known to be modified by many post-translational 
modifications such as phosphorylation, ubiquitylation, acetylation, and sumoylation.  
Set7/9 monomethylates p53 at K372 in a region of the N-terminus that contains the 
additional modifications listed above (Chuikov et al., 2004).  Monomethylation by 
Set7/9 of p53 leads to increased expression of its target genes (Chuikov et al., 2004) and, 
in mice, methylation at K372 is required for acetylation of p53 (Kurash et al., 2008).  
While methylation by Set7/9 activates p53, methylation by Smyd2 represses p53.  
Smyd2 is a lysine methyltransferase that methylates lysine 36 of histone H3, not to be 
confused with Smyd3 that methylates lysine 4 of histone H3, that monomethylates p53 
at K360 and represses the binding of p53 to the promoter regions of target genes and the 
ability of p53 to activate target genes.  Methylation of p53 at K372 by Set7/9 inhibits 
methylation at K370 by Smyd2 (Huang et al., 2006b).   
Structural studies of Set7/9 with a peptide of p53 shows positioning of the target 
lysine of the p53 peptide within the same substrate specific channel as the H3 tail 
described above, however interactions with active site amino acids are different.  Five 
amino acids within Set7/9 form important interactions with the p53 peptide, but only 
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Tyr335 has a dual role in p53 and the histone H3 tail (Chuikov et al., 2004).  In 
interacting with p53, the position of Tyr335 is highly similar to its position in relation to 
lysine 4 of histone H3, forming hydrogen bonds to the backbone of the p53 peptide.  
Computer simulations identical to that described above were performed with Set7/9 
bound with a p53 peptide and s-adenosyl homocysteine, and produced similar results as 
with lysine 4 of histone H3.  A water channel is required for deprotonation of lysine 372 
of p53 leading to monomethylation through a SN2 reaction.  Positioning of 
monomethylated p53 prevents the formation of a second water channel and further 
methylation (Zhang and Bruice, 2008b). 
 
TAF10 AND TAF7 
 TAF10 and TAF7 are components of the TFIID transcription factor complex that 
binds within the promoter region of genes to recruit RNA Pol II.  Set7/9 monomethylates 
TAF10 at K189 in vivo, increasing the association of TAF10 with RNA Pol II and thus 
increasing the transcription levels of specific genes (Kouskouti et al., 2004).  Set7/9 
methylates TAF7 in vitro at K5 but this has not been supported by in vivo analysis and 
this effect of this methylation on RNA Pol II is unknown (Couture et al., 2006a).    
 Structural studies of Set7/9 associated with TAF10 show Tyr335 as the only 
amino acid in common with Set7/9 interacting with lysine 4 of histone H3.  As before, 
Tyr335 forms hydrogen bonds with the backbone of its substrate TAF10 backbone 
(Couture et al., 2006a).  Crystal structures of Set7/9 mutants Y245A and Y305F with 
TAF10 peptides provided similar results discussed above with crystal structures of wild 
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type Set7/9 with lysine 4 of histone H3 (Del Rizzo et al., 2010).  The two mutated Set7/9 
structures differ between 0.3-0.4 Å from the wild type structure and thus provide 
information of how these mutations affect the function of Set7/9.  As with lysine 4 of 
histone H3, Y305F allows dimethylation of TAF10 while Y245A allows trimethylation 
of TAF10 by Set7/9 (Del Rizzo et al., 2010).  Y305F binds unmodified and 
monomethylated TAF10 peptides 4-7 fold more tightly than wild type, while Y245A 
binds unmodified and methylated substrates with equal affinities.  In the Y305F mutant, 
Y245 is responsible for positioning the lysine residue of TAF10 through hydrogen 
bonding with its hydroxyl group.  In the Y245A mutant, Y305 is responsible for 
positioning the lysine residue through hydrogen bonds to mono- and dimethylated 
TAF10.  Positioning of water molecules and hydrogen bonding has changed within the 
active site in both mutants, but nothing is mentioned on how these mutants affect the 
formation of a water channel.  Both Y305F and Y245A follow a distributive model of 
methylation, where intermediate products are released by Set7/9 before further 
methylation occurs (Del Rizzo et al., 2010).  This conflicts with wild type data that 
shows forming monomethylated H3K4 is distributive, while di- to trimethylation is 
successive (Dirk et al., 2007).     
 
ESTROGEN RECEPTOR α 
 Estrogen receptor α (ERα) is a nuclear receptor known to interact with a core 
complex of MLL2, Ash2L, RBBP5, and WDR5 in the presence of estrogen to induce 
expression of estrogen-specific genes (Mo et al., 2006).  ERα is monomethylated at 
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K302 by Set7/9.  Knockdown of Set7/9 results in a decrease in protein levels of ERα, 
possibly through proteasome degradation, and a decrease in activation of transcription of 
estrogen-specific genes (Subramanian et al., 2008).  Methylation of ERα by SET7/9 is 
required for localization of ERα to the promoter region of target genes.  A crystal 
structure was created with Set7/9, an ERα peptide, and S-adenosyl homocysteine.  As 
with other structures, the targeted lysine 302 lies within a narrow substrate channel with 
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